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ABSTRACT 
Repeated use of drugs of abuse induces permanent changes in the brain 
that together with environmental factors can promote the development of 
addiction. Addiction to alcohol or drugs is a chronic disease that is 
characterized by a compulsion to seek and take the drug, loss of control in 
limiting intake, continued use despite obvious harm, and recurrent relapses. 
Behavioral animal models of addiction are invaluable tools for evaluating the 
neuroadaptations underlying these behaviors. 
 
Behavioral sensitization is a form of neuronal plasticity where repeated 
administration of drugs induces a progressive and enduring enhancement in 
their behavioral and neurochemical effects. The aim of this study was to 
investigate differences in susceptibility to morphine-induced behavioral  and 
neurochemical sensitization in alcohol-preferring AA and alcohol-avoiding 
ANA rat lines, and to clarify its role on voluntary intake of ethanol. In vivo 
microdialysis was used to examine dopaminergic, glutamatergic and 
GABAergic neurotransmission in the brain. Interactions between behavioral 
sensitization and voluntary ethanol intake were assessed in AA rats during 
and after the rats were sensitized to morphine.  
  
The results showed that AA rats are more susceptible to morphine-induced 
behavioral sensitization than ANA rats. Neurochemical studies indicated a 
dissociation between the locomotor stimulant effects of morphine and 
extracellular levels of dopamine in the nucleus accumbens. In addition, 
sensitization to morphine affected glutamatergic transmission in the ventral 
tegmental area differently in AA and ANA rats. In contrast, extracellular 
levels of GABA differed neither between the lines nor between morphine-
sensitized rats and controls. Glutamatergic transmission is therefore 
potentially involved in the higher susceptibility to morphine-induced 
sensitization in AA rats relative to ANAs, but the role of GABA remains 
unclear. 
 
 
 Morphine-induced behavioral sensitization or other long-term adaptations in 
the brain induced by repeated morphine administration were not critically 
involved in the regulation of voluntary ethanol drinking. Opioid receptor 
activation with morphine injection, however, was shown to dramatically 
increase ethanol drinking in morphine-sensitized AA rats. Thus, the neuronal 
mechanisms underlying behavioral sensitization to morphine probably are 
distinct from those mediating ethanol reinforcement. In contrast, when given 
an additional morphine injection, reinforcing effects of ethanol were 
enhanced in AA rats sensitized to morphine. 
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 Sami Ojanen, Morfiinille herkistyminen alkoholia suosivissa ja välttävissä 
rottakannoissa 
 
TIIVISTELMÄ 
Alkoholi- ja huumeriippuvuuden synnylle altistavat monet geneettiset ja 
psykososiaaliset tekijät, mutta varsinaista riippuvuutta ei alttiudesta 
huolimatta synny ilman toistuvaa alkoholin tai huumeiden käyttöä. Toistuva 
päihteiden käyttö aiheuttaa muutoksia aivojen välittäjäainejärjestelmien 
toiminnassa, jotka yhdessä ympäristön altistavien tekijöiden kanssa voivat 
johtaa riippuvuuden kehittymiseen. Riippuvuuden tunnusmerkkeinä ovat 
päihteenhimon kasvaminen, käytön lisääntyminen ja muuttuminen 
hallitsemattomaksi sekä toistuvat retkahtamiset. Näiden tutkimiseksi on 
kehitetty koe-eläinmalleja, joiden avulla riippuvuuden taustalla olevien 
neurobiologisten mekanismien toimintaa voidaan mallintaa.  
 
Ilmiötä, jossa päihteiden palkitsevat tai muut käyttöä lisäävät vaikutukset 
voimistuvat toistuvan käytön seurauksena, kutsutaan herkistymiseksi. Tässä 
projektissa tutkittiin herkistymiseroja geneettisesti valituissa paljon ja vähän 
alkoholia juovissa AA- ja ANA-rotissa ja herkistymiseen liittyviä aivojen 
välittäjäainejärjestelmien toiminnan muutoksia sekä niiden yhteyttä etanolin 
juomiseen näissä kannoissa. Tutkimuksissa seurattiin eläinten 
liikeaktiivisuutta ja mitattiin aivojen solunulkoisten dopamiini-, glutamaatti- ja 
GABA-pitoisuuksien muutoksia mikrodialyysi-tekniikalla. Lisäksi AA-rottien 
etanolin juomista tutkittiin morfiiniherkistämisen aikana ja sen jälkeen. 
 
Toistuvan morfiinikäsittelyn havaittiin herkistävän AA-rottien liikeaktiivisuutta 
huomattavasti enemmän kuin ANA-rottien, ja accumbens-tumakkeen 
solunulkoisen dopamiinin pitoisuus oli kohonnut vain AA-rotilla. Dopamiinin 
solunulkoisen pitoisuuden kasvu ei kuitenkaan saumattomasti liittynyt 
herkistymiseen morfiinin liikeaktiivisuutta stimuloivalle vaikutukselle. Samoin 
välittäjäaineena toimivan glutamaatin pitoisuus kasvoi dopamiinisolujen 
tumat sisältävän ventraalisen tegmentumin alueella vain AA-rotilla. Sen 
sijaan GABAn pitoisuus ei eronnut rottakantojen tai herkistettyjen ja 
kontrollieläinten välillä. Nämä tulokset viittaavat siihen, että riippuvuudessa 
tärkeäksi osoitetun mesolimbisen dopamiiniradan toiminnan muutokset 
 
 liittyvät herkistymiseen päihteiden pitkäaikaisille vaikutuksille ja niissä 
tapahtuvat muutokset eroavat AA- ja ANA-rotissa. 
 
Toistuvasti annetun morfiinin aiheuttama herkistyminen ei näyttänyt olevan 
keskeisen tärkeässä asemassa alkoholin juomisen oppimisessa tai juomisen 
säätelyssä. Sen sijaan opioidireseptoreiden aktivoiminen herkistetyissä 
eläimissä uudella morfiini-injektiolla johti alkoholin juomisen mittavaan 
nousuun. Tämä viittaa siihen, että herkistymiseen liittyvät 
keskushermotomuutokset ja alkoholin vahvistavia vaikutuksia lisäävät 
mekanismit ovat erilliset, mutta kun opioidireseptoreita aktivoidaan 
morfiinilla, alkoholin aiheuttamat palkitsevat vaikutukset voimistuvat. 
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 ABBREVIATIONS 
 
AA   Alko Alcohol, alcohol-preferring rat line 
ANA   Alko Non-Alcohol, alcohol-avoiding rat line 
ANOVA  Analysis of variance 
DOPAC  3,4-Dihydroxyphenylacetic acid 
EDTA   Ethylenediamine tetraacetic acid 
GABA   γ-Aminobutyric acid 
HVA   Homovanillic acid 
HPLC   High-performance liquid chromatography 
mRNA   Messenger ribonucleic acid 
NAc   Nucleus accumbens 
SNK   Student-Newman-Keuls t test 
Tukey’s HSD  Tukey’s honestly significant difference test 
VTA   Ventral tegmental area 
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 1 INTRODUCTION 
Addiction to alcohol or drugs of abuse is a chronic disease that has a major 
impact on well-being for affected individuals and is a great burden for the 
society. Compulsion to seek and take the drug, loss of control in limiting 
intake, continued use despite obvious harm, and emergence of a negative 
emotional states (e.g. anxiety) when the drug is withdrawn are criteria for a 
diagnose of a substance dependence. However, severe problems in life are 
often seen long before these criteria are fully met (O'Brien and Gardner, 
2005; Volkow and Li, 2005). 
 
Several neurobiological theories of addiction have recognized a key role for 
some component of reward or reinforcement in the development of 
substance dependence, and often mesolimbic dopamine system is 
mentioned in this context (Koob, 2006). Specifically, a projection from 
dopaminergic neurons in the ventral tegmental area to the nucleus 
accumbens has accumulated interest in biomedical research of addiction. 
Drugs of abuse share an ability to intervene with this system by altering the 
function of the dopaminergic cells directly or indirectly through other, e.g. 
glutamatergic and GABAergic, neurotransmitter systems. Furthermore, 
repeated exposure to drugs has long-lasting effects within these neural 
systems increasing the probability to relapse (Robinson and Berridge, 2000). 
 
Endogenous opioid system is another important mediator of drug effects that 
has been implicated in the development and maintenance of addiction. For 
obvious reasons it has an important role in the addictive properties of 
opiates, but also the rewarding effects of ethanol are thought to be 
associated with it (Oswald and Wand, 2004). 
 
When drugs of abuse are given repeatedly they induce behavioral plasticity 
that is underlain by neuronal adaptations within the brain areas (e.g. 
mesolimbic dopamine system) controlling motivational effects of both drugs 
and natural reinforcers like food and sex (Robinson and Berridge, 2001; 
Vanderschuren and Kalivas, 2000). Behavioral sensitization is a form of 
neuronal plasticity where repeated administration of drugs induces a 
progressive and enduring enhancement in their behavioral and 
neurochemical effects. Therefore, it can be used as a tool for studying the 
importance of these phenomena in addiction. 
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Alcohol-preferring Alko Alcohol (AA) and non-preferring Alko Non-Alcohol 
(ANA) rats were outbred for high and low ethanol consumption, but have 
also proven to be valuable tools for investigating behavioral and 
neurochemical aspects of other drug-related phenomena (Eriksson, 1968; 
Sinclair et al., 1989). For example, rats of the AA line are more vulnerable to 
sensitization to repeatedly administered opioid agonist morphine than ANA 
rats (Honkanen et al., 1999; Mikkola et al., 2001b). Moreover, this effect was 
accompanied by increased dopamine levels in the nucleus accumbens only 
in AA rats. The underlying mechanisms may also contribute to the 
differences in ethanol intake between the lines. 
 
The aim of the present study was to investigate further the differences in 
vulnerability to behavioral sensitization and its effects on drug-related 
behaviors and neurochemistry in alcohol-preferring and alcohol-avoiding rat 
lines. Differences between the lines may also address the mechanisms 
underlying a vulnerability to addiction in some individuals. 
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 2 REVIEW OF THE LITERATURE 
2.1 Drug addiction 
 
Drug addiction is a maladaptive pattern of substance use that leads to 
clinically significant impairment or distress. Genetical background, 
environment, stress, and conditioning effects contribute to the vulnerability to 
enter the cycle that leads from social drug-taking and acute reinforcement to 
compulsive use and substance dependence. The initiation of drug abuse 
may be more associated with social and environmental factors, whereas the 
change to addiction probably is underlain by neurobiological factors. 
 
There are several neurobiological theories of addiction, and while they have 
an emphasis on different aspects of drug addiction, many of these have 
implicated a key role for some component of reward or reinforcement that is 
usually mediated through mesolimbic dopamine system (cf. Koob, 2006; 
Robinson and Berridge, 2000; Weiss and Porrino, 2002; Wise, 1996). 
 
2.1.1 Animal models of drug addiction 
 
Studies of drug addiction in animal models have a predictive validity for 
many aspects of drug addiction in humans. Drugs that are used by humans 
are self-administered also by animals, excluding only hallucinogens, and 
those few treatments that are available today for to treat addiction in humans 
have proven to be effective in animal models (O'Brien and Gardner, 2005). 
Generally, animal models try to define some element of drug addiction and 
not to formulate the whole disorder in one setting. 
 
Behavioral animal models of addiction often evaluate drug-seeking or drug-
taking behavior by assessing intravenous, intracranial or oral drug self-
administration in various situations and willingness to put some effort to 
obtain the substance (Koob, 2006). With conditioned place preference, the 
reinforcing efficacy of drugs can be examined by conditioning one 
13 
 
 environment to drug administration and another to neutral stimuli and then 
letting the animal to choose from these environments. The abuse potential of 
a drug can also be studied with intracranial self-stimulation. Drugs of abuse 
decrease the threshold of stimulation in certain brain areas with good 
correspondence to their abuse potential. The neurobiology of the brain 
reward mechanisms and drug reinforcement are studied by investigating the 
neuronal circuits known to be involved in the regulation of these functions 
and changes in their activity induced by addictive drugs (O'Brien and 
Gardner, 2005). 
 
2.2 Dopamine 
2.2.1 Mesocorticolimbic dopamine system 
 
Whether a theory puts dopamine neurotransmission into mediating 
rewarding effects of drugs or determining their incentive salience (a 
motivation to seek and take), a projection from dopamine cells in the ventral 
tegmental area to nucleus accumbens is invariably implicated (Fig. 1.). This 
pathway is a main part of mesolimbic dopamine system. Drugs of abuse 
share an ability to intervene with this system by altering the activity of the 
dopaminergic cells directly (Elliott and Beveridge, 2005; Kahlig and Galli, 
2003), or indirectly through other neurotransmitter systems. The dopamine 
cells also send projections to the prefrontal cortex, amygdala, olfactory 
tubercle and caudate-putamen (Bardo, 1998). These areas together with 
some other nuclei and their interconnections form a so-called motive circuit 
that is involved in the translation of biologically relevant environmental and 
pharmacological stimuli into adaptive motor responses (Pierce and Kalivas, 
1997). 
14 
 
  
 
Figure 1. Schematic drawing of the connections between ventral tegmental 
area (VTA), nucleus accumbens (NAc) and prefrontal cortex (PFC). 
DA = dopamine, D1 = dopamine D1 receptor, Glu = glutamate. 
Adapted from Carr and Sesack (2000) and Klitenick et al. (1992).  
Drugs of abuse elevate the extracellular levels of dopamine in the nucleus 
accumbens (see e.g. Di Chiara and Imperato, 1988; Kiianmaa et al., 1994; 
Leone et al., 1991). The mechanism behind this increase depends on the 
drug. Psychostimulants prevent the uptake of dopamine from the synaptic 
cleft and induce release from synaptic vesicles without electrical stimulation 
of the neuron (Pierce and Kumaresan, 2006). Ethanol increases the firing 
rate of dopamine neurons in the VTA either because of a direct action on 
these cells or through GABAergic, glutamatergic or opioidergic mechanisms. 
Opioids are known to bind to µ-opioid receptors in GABAergic interneurons 
in the ventral tegmental area and by inhibiting the activity of these neurons 
they disinhibit the dopamine cells (Johnson and North, 1992a). Opioid-
induced elevation of extracellular dopamine levels in the nucleus 
accumbens, however, can also be a result of opioids binding to receptors 
within the nucleus accumbens. In addition, dopamine-independent 
mechanisms have been suggested to participate in opioid reinforcement. 
Interactions within so-called extended amygdala (Pierce and Kalivas, 1997), 
specifically in the prefrontal cortex, hippocampus, amygdala and ventral 
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 pallidum may be important (Bardo, 1998; Caille and Parsons, 2004; 
Sotomayor et al., 2005). Besides that acute administration of drugs 
enhances dopamine transmission, repeated exposure to them tends to 
augment this effect and makes the dopaminergic pathways hyperresponsive 
to many drug effects (Vanderschuren and Kalivas, 2000). 
 
2.2.2 Dopamine receptors 
 
Two families of G-protein coupled dopamine receptors are found in the brain 
(Lachowicz and Sibley, 1997). The receptor types D1 and D5 belong to the 
D1 -family and D2, D3, and D4 to the D2 -family. The activation of D1 -family of 
receptors stimulates the enzyme adenylate cyclase, while the receptors in 
the D2 -family are inhibitory. Dopamine receptors are found both pre- and 
post-synaptically. Thus, depending on the receptor type and location 
increased dopaminergic tone can lead to either augmented or attenuated 
activity of the target neurons. 
 
2.2.3 Regulation by Glutamate and GABA 
 
While dopamine transmission in the brain seems to be important in the 
effects of drugs, the most abundant excitatory and inhibitory 
neurotransmitter systems, glutamate and GABA, have also important roles 
both by themselves and in regulating the dopaminergic systems. In the VTA, 
inhibitory γ-aminobutyric-acid (GABA) interneurons together with excitatory 
glutamatergic afferents e.g. from the prefrontal cortex, amygdala and 
tegmental nuclei as well as descending GABAergic afferents from the NAc 
and ventral pallidum control the activity of the dopaminergic neurons 
(Johnson and North, 1992b; Karreman et al., 1996; Steffensen et al., 1998; 
Xi and Stein, 1998). Similarly, in the nucleus accumbens, GABA and 
glutamate have been shown to mediate behavioral and neurochemical 
effects of drugs (Bardo, 1998). Glutamatergic and GABAergic 
neurotransmission have also been shown to have an important role in the 
adaptations induced by repeated administration of drugs of abuse (Laviolette 
et al., 2004; Leite-Morris et al., 2004; Vanderschuren and Kalivas, 2000; 
Vezina and Kim, 1999; Wolf, 1998). 
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 2.3 Opioids 
2.3.1 Endogenous opioid peptides 
 
Endogenous opioids are a group of peptide neurotransmitters that are 
involved in many physiological processes, a few important ones being 
analgesia, mood regulation and mediation of reward from natural reinforces 
as well as from the drugs of abuse (see Kieffer and Gaveriaux-Ruff, 2002, 
for a review). The peptides are cleavaged from large precursors and while 
varying greatly in length they share a common N-terminal sequence. There 
are three major families of opioid peptides, endorphins, enkephalins and 
dynorfins and three types of G protein-coupled receptors, µ, δ and κ. All 
three receptor types are found in high densities in the brain areas that have 
been connected to reinforcement and reward, and are potentially important 
in the effects of drugs of abuse. These areas include the nucleus 
accumbens, striatum, ventral pallidum, amygdala, cortex and many thalamic 
and hypothalamic nuclei (Mansour et al., 1995). 
 
2.3.2 Opiates 
 
Opiates, drugs that mimic the actions of endogenous opioids and originally 
were derived from an opium poppy (Papaver somniferum), have been used 
as analgesics for centuries. The most potent alkaloid in opium, morphine, is 
still commonly used in pain relief. In addition to analgesic and hypnotic 
effects, opiates unfortunately have a strong abuse potential and heroin 
addiction is one of the major illicit drug-related problems in Finland today 
(Virtanen and Sjöberg, 2006). Withdrawal from a prolonged opiate use 
induces severe motivational and physical withdrawal signs, and protracted 
abstinence features powerful craving. Therefore, many years of substitution 
therapy with long-acting opiates or with partial µ-receptor agonist, 
buprenorphine is often necessary to treat opiate addicts (Vocci and Ling, 
2005). 
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 2.3.3 Opioids and drug reward 
 
Opiate drugs activating µ- and δ-receptors induce place preference and 
opioid agonists are readily self-administered both intravenously and 
intracranially by rodents (Bozarth and Wise, 1981; Koob et al., 1984; 
Shippenberg et al., 1996). Furthermore, reinforcing properties of drugs like 
ethanol, cannabinoids and nicotine are diminished in mice lacking the µ-
opioid receptors (Kieffer and Gaveriaux-Ruff, 2002). In addition, both 
analgesic and rewarding effects of morphine are abolished in these mice 
(Matthes et al., 1996). Together these finding suggest that endogenous 
opioids and opioid receptors are involved in reinforcing and rewarding 
effects of several opioid and non-opioid drugs of abuse (Gerrits et al., 2003). 
 
2.3.4 Interactions of ethanol and opioid systems 
 
The link between ethanol and opioid mediated neurotransmission are 
suggested by several findings (see Cowen and Lawrence, 1999, for a 
review). Ethanol has been shown to induce release of β-endorphin in the 
ventral tegmental area and nucleus accumbens, probably through a 
mechanism involving acetaldehyde formation in the hypothalamic arcuate 
nucleus, an area that is important in opioid peptide neurotransmission 
(Pastor et al., 2004; Sanchis-Segura et al., 2005). Moreover, opioid 
antagonists are effective in decreasing ethanol consumption both in rats and 
in humans. They can also diminish ethanol-induced increase in the 
extracellular levels of dopamine in the nucleus accumbens in rats (Herz, 
1997, but see also Koistinen et al., 2001). Self-administration studies have 
shown that opioid agonists given in low doses increase, and in high doses 
attenuate ethanol drinking, indicating a complex relationship between opioid 
system and ethanol effects (Sinclair et al., 1973; Stromberg et al., 1997; 
Volpicelli et al., 1991). 
 
There is also evidence for interactions of chronic effects of ethanol and 
those of opioid agonist (e.g. morphine) that may both be mediated by opioid 
and possibly dopamine systems (Lessov and Phillips, 2003; Nestby et al., 
1997). Furthermore, ethanol is found to attenuate µ-opioid induced 
locomotor activity and sensitization to morphine (Kosten and Bombace, 
2000; Milton et al., 1995). 
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 2.4 Behavioral sensitization 
2.4.1 Drug addiction and behavioral sensitization 
 
Behavioral sensitization is a progressive and enduring enhancement in the 
behavioral and neurochemical effects of drugs elicited by a subsequent 
challenge to the same or different drug (cross-sensitization) that was used in 
the sensitization process (Vanderschuren and Kalivas, 2000). It is implicated 
as a model of neuroplastic changes underlying some aspects of addiction. 
One theory suggests that behavioral sensitization manifests an increase in 
the response of neural network that mediates the incentive salience, ‘drug-
wanting’, of the reinforcer (Robinson and Berridge, 2001). The motivation to 
seek and take drugs is increased by repeated exposure to them and it is 
separate to their pleasurable effects, ‘drug-liking’. 
 
A common way to demonstrate behavioral sensitization in animals is to 
monitor the increase in locomotor stimulant effects of drugs during repeated 
administration. Using this approach, administration of various drugs of 
abuse, including ethanol, morphine, psychostimulants and nicotine, has 
been shown to lead in behavioral sensitization (Babbini and Davis, 1972; 
Kalivas et al., 1988; Kiianmaa et al., 2000; Kuczenski and Leith, 1981; 
Nestby et al., 1997). It can also be induced by mild stressors such as social 
isolation or food deprivation (Marinelli and Piazza, 2002). 
 
2.4.2 The role of dopamine and amino acid neurotransmitters 
 
The area that is most often linked to the development of behavioral 
sensitization is the ventral tegmental area. Drugs of abuse have been shown 
to increase extracellular levels of dopamine in both the nucleus accumbens 
and ventral tegmental area. Repeated exposure to drugs leads to specific 
changes in the activity of dopamine and glutamate receptors in the ventral 
tegmental area. These alterations then coincide with subsequent 
potentiation of drug-induced increases in dopamine and glutamate levels, 
and contribute to behavioral sensitization (Carlezon and Nestler, 2002). The 
mechanism probably involves adaptations in the stimulation of dopamine D1 
receptors and in their connection to excitatory glutamatergic afferents.  
19 
 
 Besides dopamine and glutamate, also GABA, the main inhibitory 
neurotransmitter in the brain, has been suggested to have a role e.g. in 
morphine-induce behavioral sensitization (Leite-Morris et al., 2004). 
Administration of GABAB agonist baclofen into the ventral tegmental area 
was shown to block both the development and expression of opiate-induced 
motor sensitization. In addition to the neurotransmitter systems within VTA 
or between VTA and nucleus accumbens, projections from VTA to prefrontal 
cortex and amygdala are implicated (Vanderschuren and Kalivas, 2000). 
 
While VTA seems to be crucial in the development of behavioral 
sensitization, adaptations in the nucleus accumbens have been suggested 
to be most vital in the expression of sensitization (Wolf, 1998). Dopaminergic 
input from the VTA and glutamatergic projections from prefrontal cortex, 
amygdala, hippocampus and pontine nuclei are integrated in the nucleus 
accumbens and adaptations in it caused by repeated exposure to drugs are 
likely to result in altered behavioral responses to subsequent drug 
encounters. Indeed, dopamine release in the nucleus accumbens was 
enhanced in the morphine-sensitized rats compared to controls (Johnson 
and Glick, 1993). In contrast to psychostimulants amphetamine and cocaine, 
the role of nucleus accumbens may not be as crucial in opioid sensitization. 
Sensitization to dopamine D2 receptor agonist, quinpirole, or to 
amphetamine did not cross-sensitize the rats to morphine (Kalivas, 1985; 
Vanderschuren et al., 1999), suggesting that modified dopamine 
neurotransmission is differently involved in morphine and amphetamine 
sensitization. 
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 2.5 AA and ANA rats 
2.5.1 Intake of ethanol 
 
Alcohol-preferring Alko Alcohol (AA) and non-preferring Alko Non-Alcohol 
(ANA) rats were outbred for high and low ethanol consumption (Eriksson, 
1968; Kiianmaa et al., 1991; Sinclair et al., 1989), but have also proven to be 
valuable tools for investigating behavioral and neurochemical aspects of 
other drug-related phenomena (Hyytiä and Sinclair, 1993; Marinelli et al., 
2000). On average, male AA rats consume 7.6 ± 2.1 g/kg/day of ethanol and 
ANAs 0.4 ± 0.5 g/kg/day, if given a free choice between 10 % ethanol and 
water (Sinclair et al., 1989). This difference cannot probably be accounted 
by different metabolism of ethanol in the lines. The levels of ethanol did not 
differ significantly in the blood or in the brain after intraperitoneal injection of 
ethanol (Kiianmaa et al., 1995; Nurmi et al., 1994). 
 
Self-administration studies have indicated differential reinforcement from 
ethanol between the lines: AA rats, but not ANA rats, rapidly acquired an 
ethanol-reinforced operant response (Kiianmaa et al., 1991). Ethanol-
reinforced responding in AA line was also shown to be significantly greater 
at the high concentrations of ethanol, suggesting that ethanol functioned as 
a qualitatively different reinforcer for these rats, compared with ANA rats 
(Files et al., 1997). Finally, in addition to ethanol, AA rats consume more 
aqueous solution of a µ-opioid receptor agonist, etonitazene, than ANA rats 
(Hyytiä and Sinclair, 1993).  
 
2.5.2 Neurotransmitters systems 
 
Dopamine neurotransmission in the nucleus accumbens has been 
suggested to be important in the reinforcing effects of the drugs. Thus, the 
levels of dopamine have been measured in AA and ANA rats after 
intraperitoneal ethanol administration (Kiianmaa et al., 1995) and after 
voluntary ethanol intake (Nurmi et al., 1996). While ethanol significantly 
increased the extracellular levels of dopamine, suggesting stimulation of 
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 dopamine release by ethanol, no significant differences in the extent or time 
course of stimulation of dopamine release between AA and ANA rats was 
seen. These results suggest that the differential ethanol consumption by AA 
and ANA rats could not be explained in terms of differences in ethanol-
induced stimulation of dopamine release in the nucleus accumbens 
(Kiianmaa et al., 1995). Morphine-induced release of dopamine in the 
nucleus accumbens was similarly shown not to differ between the lines 
(Mikkola et al., 2000). In contrast, morphine increased dopamine levels in 
the caudate-putamen only in AA rats. 
 
Neurochemical studies on opioidergic systems have shown that ethanol 
elevated the amount of enkephalin precursor peptide more within the 
nucleus accumbens of AA rats than ANA rats (Nylander et al., 1994). In 
addition, the distribution of opioid receptors, receptor density, opioid 
propeptide mRNA levels, as well as G-protein coupled receptor function in 
various nuclei of the limbic system differ between the lines (de Waele et al., 
1995; Gianoulakis et al., 1992; Marinelli et al., 2000; Soini et al., 2002). 
Based on these data, one may speculate that higher opioidergic tone in AA 
rats might account for the differences in the effects of drugs between the 
lines. 
 
From other neurotransmitter systems that have been studied in these lines, 
concentration of noradrenaline was higher in the brain of ANA rats than in 
that of AA rats, while the serotonin levels did not seem to differ greatly 
(Kiianmaa et al., 1991). 
 
2.5.3 Behavioral sensitization 
 
Alcohol-preferring AA rats have been found to develop sensitization to 
locomotor stimulatory effects of morphine with smaller doses than ANA rats 
(Honkanen et al., 1999) and to show sensitization of rotational behavior after 
unilateral 6-hydroxydopamine lesion of the ascending dopamine pathways 
(Mikkola et al., 2002). This effect was further accompanied by 
neurochemical differences in the nigrostriatal dopamine system, while no 
significant differences were seen in monoamine metabolism in the nucleus 
accumbens (Mikkola et al., 2000; 2001b).  
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 In addition to morphine, AA rats are more vulnerable to locomotor and 
neurochemical effects of repeated administration of cocaine compared to 
ANAs (Honkanen et al., 1999; Mikkola et al., 2001a). Repeated injections of 
nicotine can also induce behavioral sensitization in AA rats; however, the 
effect was not different from ANA rats (Kiianmaa et al., 2000). 
 
These long-term differences in the effects of drugs implicate that 
vulnerability to drug addiction may be increased in the AA line. In theory, the 
selection for high and low ethanol drinking in AA and ANA rats should create 
differences in other traits than the selected ones only when they are related 
to the selected trait (Bergstrom et al., 2003; Sinclair et al., 1989). Therefore, 
any difference in drug effects could also contribute to differential ethanol 
self-administration in these lines. 
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 3 AIMS OF THE STUDY 
The objectives of the present study were to investigate the effects of 
repeated administration of morphine on locomotor activity, voluntary ethanol 
drinking, and mesolimbic neurotransmission in alcohol-preferring AA and 
alcohol-avoiding ANA rat lines. Repeated exposure to drugs of abuse 
induces adaptations in several neurotransmitter systems and leads to 
behavioral plasticity that is manifested e.g. as increased motivational and 
locomotor effects of drugs. This plasticity in drug-induced effects may 
predispose an individual to the development of addiction. Behavioral 
sensitization, a progressive and enduring increase in behavioral and 
neurochemical effects of drugs can be seen as a model of neuroplasticity 
related to repeated administration of drugs and used as a tool for studying 
neuroplasticity in addiction. In addition, the present work benefited from the 
use of AA and ANA rat lines offering an opportunity to compare animals 
prone to addictive behavior to the ones without such trait. Differences 
between these lines may indicate what are the neurochemical mechanisms 
that predispose some individuals to addiction. 
 
Specific aims of this work were: 
 
1) To study the susceptibility to morphine-induced behavioral 
sensitization morphine in AA and ANA rat lines, and to examine the 
effects of different morphine regimens on induction of sensitization in 
AA rats. 
 
2) To investigate morphine-induced changes in mesolimbic 
neurotransmission after acute or repeated morphine administration 
and to compare the effects between AA and ANA rats. In vivo 
microdialysis was used to determine the extracellular concentrations 
of dopamine and its metabolites in the nucleus accumbens and 
amino acid neurotransmitters, glutamate and GABA, in the ventral 
tegmental area. 
 
3) To elucidate interactions between morphine-induced behavioral 
sensitization and voluntary ethanol intake in AA animals in terms of 
continuous and limited ethanol access, different sensitization 
regimens and variable number and doses of morphine challenges.  
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 4 MATERIALS AND METHODS 
4.1 Animals 
 
Male alcohol-preferring AA and alcohol-avoiding ANA rats (Alcohol 
Research Centre, National Public Health Institute, Helsinki, Finland) from 
generations F82 – 87 were used in the studies. The rats were predominantly 
housed in groups of four or five in plastic boxes (31 x 54 cm x 19 cm), with 
the exception of individuals participating in the microdialysis (I, IV) and 
ethanol intake experiments (II, III), see for details below. The rats had 
unrestricted access to standard laboratory chow (SDS RM1 (E) SQC, 
Witham, Essex, England) and tap water. Ambient temperature was kept at 
22 ± 1ºC and humidity at 55 ± 10%. The light/dark cycle was 12/12 h (lights 
on at 06.00). All the experiments were conducted during the light phase of 
the cycle. The animal experiments were approved by the Chief Veterinarian 
of County Administrative Board and/or the Institutional Animal Care and Use 
Committee at the National Public Health Institute and were conducted 
according to the European Communities Council Directive (86/609/EEC).  
 
4.2 Drugs 
 
Ethanol (Etax A, 96 vol-%, Altia, Rajamäki, Finland) given to rats for drinking 
was diluted in tap water to 10 vol-%. In the microdialysis studies, ethanol 
that was dissolved in isotonic saline (0.9% NaCl, Baxter International Inc, 
Vantaa, Finland) was injected intraperitoneally (1.5 g/kg, 12 % w/v). 
Morphine-hydrochloride (University Pharmacy, Helsinki, Finland) was 
dissolved in saline for a final morphine concentration of 1–20 mg/ml and was 
injected subcutaneously (s.c.) in a volume of 1 ml/kg. 
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 4.3 Locomotor activity (I – IV) 
 
Horizontal locomotor activity was measured in transparent plastic boxes (18 
x 33 x 15 cm) with computer-controlled photocells (Cage Rack Activity 
System, San Diego Instruments, San Diego, CA, USA). The rats were 
familiarized to the measuring apparatus in two sessions without injections (2 
h each) and in one session including a vehicle injection. The rats were 
weighed, placed into the boxes, and left undisturbed for 10 minutes to 
reduce handling-induced activity. The rats were then given a challenge 
injection of morphine or saline and locomotor activity was recorded at 10-min 
intervals for 4 hours. Experiments were conducted in a quiet room with 
standard lighting. 
 
4.4 In vivo microdialysis (I, IV) 
4.4.1 Surgery 
 
Rats anaesthetized with halothane (4 % during the induction for 5 minutes 
and 1.5–2 % during the surgery) were attached to a stereotactic frame for 
implantation of a guide cannula into the brain. The cannula was lowered 
above the shell of the nucleus accumbens (I) or the ventral tegmental area 
(IV). The coordinates for a microdialysis probe, as given in an atlas by 
Paxinos and Watson (1997), were 1.7 mm anterior to bregma, 1.2 mm 
lateral to midline and 6.5 mm below the dura for the nucleus accumbens. For 
the VTA they were 5.2 mm posterior to bregma, 0.6 mm lateral to midline 
and 8.4 mm below the dura angled toward the midline at 11° from the 
vertical for the VTA. The guide cannula was fastened to the skull with three 
stainless steel screws and dental cement. After the surgery, the rats were 
administered buprenorphine (s.c., Temgesic, 0.05 mg/kg) once, placed in 
individual cages, and allowed to recover for 7 days. The rats were 
habituated to the experimental procedures by tethering them to a 
counterbalancing arm several times during this recovery period. 
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 4.4.2 Microdialysis 
 
Microdialysis was performed in individual Plexiglas cages (24 cm x 24 cm x 
30 cm). A probe (CMA/12, membrane length 2 mm (NAc) or 1 mm (VTA), 
o.d. 0.5 mm, polycarbonate membrane with a 20,000-Da cutoff, CMA 
Microdialysis, Stockholm, Sweden) was inserted into the guide cannula and 
modified Ringer solution (147 mM NaCl, 3 mM KCl, 1.3 mM CaCl2, 1 mM 
MgCl2 in 0.1 M Na2HPO4, pH 7.25) was perfused through the probe with a 
flow rate of 1.4 µl/min using a CMA 100 microinjection pump. When 
dopamine transmission was studied, collection of microdialysis samples from 
extracellular fluid (every 15 min, 21 µl/sample) was started 3 h after insertion 
of the probe. The baseline samples were collected for 1 h: thereafter the rats 
were given a morphine or saline injection, and the samples were collected 
for the next 4 h into the vials containing 3 µl of 1 mM glutathione in 0.15 M 
HCl. 
 
In the amino acid studies, the microdialysis probe was inserted at 1600 
hours in the day preceding the experiment and was left there without 
perfusion until the next morning. In the morning, perfusion was turned on 
with a flow rate of 1.5 µl/min and collection of the samples (every 15 min, 
22.5 µl/sample) was started one hour later with a refrigerated sample 
collector (Univentor 820, Zejtun, Malta). After 60 minutes of baseline 
collection, the rats were given an injection of morphine, ethanol, or saline, 
and collection of the samples was continued for four hours. An aliquot (6 µl) 
was taken from the vials for determination of glutamate content, while the 
remaining 16.5 µl was used for determination of GABA content. The samples 
in all experiments were stored at -70ºC, and were analyzed later. 
 
4.4.3 Histology 
 
The positions of the probes were verified by microscopic examination of the 
sections stained with thionine. The brains were fixed in 10 % formalin 
solution, frozen and cut into 100 µm thick coronal sections. Only the rats 
where more than 50 % of the probe membrane was verified to be in the 
target area were included into the results. 
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 4.4.4 Analyses of microdialysis samples 
 
The levels of dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), and 
homovanillic acid (HVA) were determined with high performance liquid 
chromatography (HPLC). The HPLC system consisted of an isocratic pump 
with a degasser unit and a refrigerated autoinjector (Hewlett Packard 1100 
series, Palo Alto, CA, USA). Concentrations were measured with 
amperometric detector (Antec Intro, Leyden, The Netherlands). The glassy-
carbon working electrode was set to +700 mV versus Ag/AgCl reference 
electrode. The column used was MIC 10-3-C18, 100 X 1 mm i.d. with a 
particle size of 3 µm (Hypersil, LC-Packings, The Netherlands). The mobile 
phase was 11 % (v/v) methanol in 50 mM phospate/50 mM citric acid buffer, 
0.15 mM ethylenediaminetetra acetic acid (EDTA), 10 mM NaCl, and 0.22 
mM sodium octylsulfonate at pH 4.8. The flow rate of the pump was set to 35 
µl/min, and the injection volume was 15 µl. The limit of detection for 
dopamine was 0.35 fmol/µl. The chromatograms were processed with 
Waters 820 Maxima Software, version 3.31 (Waters Association, Milford, 
MA, USA). The raw microdialysis data (pmol or fmol/15 min) were converted 
into percentages of the baseline consisting of the mean of the last 3 baseline 
samples. 
 
Concentrations of glutamate and GABA were measured using fluorescent 
detection (Waters 2475, Milford, MA, USA). The detector was equipped with 
an 8 µl flow-cell and was operated at maximal excitation wavelength of 354 
nm and emission at 489 nm. The column was a Discovery RP Amide C16, 
150 X 3 mm i.d. with a particle size of 5 µm (Supelco, Bellefonte, PA, USA). 
The concentrations of GABA and glutamate were determined in separate 
runs. The mobile phase for glutamate was 0.3 M acetic acid buffer 
containing 17 % (v/v) acetonitrile and 0.1 mM EDTA at pH 5.80 and for 
GABA 0.1 M acetic acid buffer containing 37 % (v/v) methanol and 0.1 mM 
EDTA at pH 5.36. The flow rate of the mobile phase was set to 0.3 ml/min. 
The microdialysis samples for glutamate assay were mixed with 1 µl 
(reaction time 90 s at 10°C), and those for GABA assay with 2 µl (60 s) of O-
phthalaldehyde-β-mercaptoethanol for pre-column derivatization. Injection 
volumes were 4.5 µl and 15 µl for glutamate and GABA, respectively. The 
chromatograms were acquired and processed with Class VP software 
(v6.12, Schimadzu Corporation, Kyoto, Japan). The raw microdialysis data 
(µM or nM) were converted into percentages of the baseline consisting of the 
mean of four baseline samples. The limit of detection for glutamate was 20 
nM and for GABA 5 nM. 
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 4.5 Analyses of tissue and plasma samples (I) 
 
Morphine was extracted from 1.0 ml of plasma samples or homogenized 
brain tissue samples by mixing with 1.0 ml of 0.5 M Na2HPO4 · H2O buffer 
and 5 ml of n-butyl acetate containing 17 ng/ml of deuterated morphine as 
internal standard. The derivatization reagent, 100 µl of N-Methyl-N-
trimethylsilyltrifluoroacetamide in acetonitrile (1:4.3) was added to the 
processed sample, and the mixture was injected into the gas 
chromatograph. Quantification of morphine was carried out with an Agilent 
6890 series gas chromatograph equipped with an Agilent 5973 mass 
selective detector (Agilent Technologies, Inc., Palo Alto, CA). The length of 
the HP-35 column was 30 m, internal diameter 0.32 mm and film thickness 
0.25 µm. The inlet and detector temperatures were maintained at 250ºC and 
300ºC, respectively. The column temperature was initially 150ºC with a hold 
time of 1.0 min, and was increased 15ºC/min to 320ºC, with a final hold time 
of 3.0 min. 
 
4.6 Measurement of ethanol intake (II, III) 
 
Measurement of ethanol intake was performed in a single wire mesh cages 
(21 x 38 x 19 cm) where food and water were continuously available. Two 
100-ml drinking tubes containing tap water or 10 % (v/v) ethanol solution 
were placed on the front wall of the cage. The left-right position of the tubes 
was changed twice a week to avoid any side preference. Consumption of 
both liquids was recorded daily as a volume change, while measurements 
for food consumption (by weighing the food pellets before and after addition) 
and body weight were taken twice a week. 
 
In paper III, availability of ethanol was limited to 6 hours a day (09.00–15.00 
hours), three times a week, after 4 weeks of continuous access. Twelve 
training sessions were conducted to achieve a stable base of ethanol 
drinking. Water was freely available throughout the experiment. 
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 4.7 Drug treatments and experimental design 
4.7.1 Behavioral sensitization and accumbal dopamine in AA and 
ANA rats (I) 
 
AA and ANA rats were sensitized to the locomotor stimulatory effects of 
morphine with 15 injections of morphine (s.c., 10 mg/kg) given every other 
day. Controls were given an equal number of vehicle injections. Following 
the injections, locomotor activity was monitored for 4 hours. Seven days 
after termination of the sensitizing injections, all the animals received a 
challenge injection of morphine (10 mg/kg) and locomotor activity was 
measured for 4 hours. This procedure was repeated 4 weeks after the first 
challenge injection. 
Morphine injection regimen in microdialysis experiment was identical to the 
one described above with the exception that locomotor activity was not 
measured after the injections. Challenge experiments were performed 1 and 
5 weeks after the last repeated injection. Six groups were used; 4 groups 
were the same as in the locomotor activity experiment, and the two 
additional control groups were AA rats pre-treated and challenged with 
saline, and an identical ANA group. 
 
4.7.2 Ethanol intake in morphine treated AA rats (II) 
 
Five groups of AA rats receiving different morphine/saline treatments were 
used in the second paper. Two of the groups were given fifteen injections of 
saline and one group was administered fifteen times with morphine (10 
mg/kg). Intermittent injections with escalating doses of morphine (5–20 
mg/kg) were given to a fourth group, five injections in total. All the injections 
mentioned above were given every other day. The last group was treated 
subchronically with morphine (3–10 mg/kg); one injection was given on the 
first day and two injections per day during the next three days. The rats in 
morphine treated groups and one group treated with saline were challenged 
with saline seven days (vehicle challenge), and with morphine (3 mg/kg) ten 
days (challenge 1, ch1) and six weeks (challenge 2, ch2) after termination of 
the repeated injections. The remaining group of rats received three 
challenge injections of saline. After all the challenge injections, horizontal 
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 locomotor activity was recorded at 10-min intervals for 4 hours. The rats 
were then placed into cages where initiation of voluntary ethanol drinking 
was measured for four weeks. 
 
4.7.3 Ethanol intake and morphine sensitization (III)  
 
Two experiments were run in parallel. The first experiment was designed to 
observe interactions between morphine-induced locomotor sensitization and 
ethanol drinking. In the second experiment, effects of repeated 
administration of morphine on ethanol drinking were examined. 
Experiment 1: Rats were first trained to drink ethanol in a limited 6-hour two-
bottle choice paradigm and were then given repeated injections of morphine 
in escalating dosage regimen based on our previous work. Control animals 
received vehicle injections. Ethanol solution (10 vol-%) was accessible for 
two groups of the rats for six hours on intervening days. After the 
pretreatment period, the rats were abstained from both morphine and 
ethanol for five days to minimize any carry-over effects of the drugs. During 
the washout period, the rats were first familiarized with the equipment used 
in the measurement of locomotor activity. After the washout period, the 
animals were challenged twice with morphine. All rats were administered 3 
mg/kg of morphine, and locomotor activity was measured for 4 hours. The 
second challenge with morphine (10 mg/kg) was given after another 
washout period of five days, and locomotion was measured again for 4 
hours. 
 
Experiment 2: This experiment explored first maintenance of ethanol 
drinking in the limited access paradigm during repeated treatment with 
morphine, and then ethanol intake in the same paradigm after 
discontinuation of the repeated treatment with or without a morphine 
challenge. After establishing a stable baseline of ethanol drinking in limited 
access situation, three groups of rats were sensitized to morphine, and three 
were treated repeatedly with saline. The regimen of morphine treatment was 
the same used in the Experiment 1. The rats were then challenged with an 
additional injection of morphine (either 1 or 10 mg/kg) or saline after 
abstaining them from both morphine and ethanol for 5 days. The tubes 
containing ethanol were introduced ten minutes later and consumption of 
ethanol and water was recorded every 30 minutes for the first 2 hours and 
then every 60 minutes for 4 more hours. 
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 4.7.4 Extracellular levels of glutamate and GABA in the VTA (IV) 
 
The rats were injected repeatedly with escalating doses of morphine or 
saline in home cages every other day for five days. Microdialysis samples for 
determination of glutamate and GABA were collected after a challenge with 
an additional injection of morphine (10 mg/kg), saline or ethanol (1.5 g/kg) 
ten days after discontinuation of the repeated injections. A challenge with 
ethanol was only given to a group of AA rats; otherwise, both AA and ANA 
rats were examined. Locomotor activity was used to verify an expression of 
behavioral sensitization in another set of rats after the same morphine 
treatment. 
 
4.8 Statistical analysis 
 
The microdialysis data were analyzed with mixed-design three-way analysis 
of variance (ANOVA) with treatment and rat line as between-subjects factors 
and measuring interval (time) as the within-subjects repeated measure. After 
significant main effects, differences within the rat lines or treatments were 
examined with subsequent repeated measures two-way ANOVA. Post hoc 
comparisons between group means were conducted using Student-
Newman-Keuls (SNK) test when appropriate. Statistical analysis on the 
microdialysis data from the animals challenged with ethanol (IV) was 
performed using two-way ANOVA with repeated measures on time and 
challenge treatment (saline, ethanol) as the between-subjects independent 
variable. The placement of the probes was compared between the groups 
with nonparametric Kruskal-Wallis test. 
 
Locomotor activity scores were analyzed as microdialysis data (I, IV). In the 
papers where only AA rats were used (II, III), analysis was conducted with 
two-way ANOVA (treatment, time) or with three-way ANOVA with repeated 
measures over time with ethanol access and morphine pretreatment as 
independent factors (III). 
 
Ethanol intake (ml) was converted into grams of 100% ethanol/kg body 
weight for data analyses. Preference scores were calculated as a 
percentage of the amount of ethanol consumed (ml) of the total fluid amount 
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 consumed. Ethanol intake was analyzed with mixed-design, two- (II) or 
three-way ANOVA (III) with pretreatment, challenge or morphine doses the 
between-subjects factor and time as the within-subjects repeated measure. 
After significant interactions, simple effects comparisons between groups 
were performed with one- or two-way ANOVAs. Student-Newman-Keuls, 
Dunnett's 2-sided t-test or Tukey’s honestly significant difference test 
(Tukey’s HSD) were used as a post hoc analysis where appropriate. 
 
Criterion for significance was set at p < 0.05 in all analyses. 
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 5 RESULTS 
5.1 Effects of morphine on locomotor activity (I – IV) 
5.1.1 Differences between AA and ANA rats 
 
Morphine challenge (10 mg/kg) increased locomotor activity more in 
repeatedly morphine-treated (15 x 10 mg/kg) than in saline-treated AA and 
ANA rats (Figure 2.). In AA rats this was evident both 1 and 5 weeks after 
withdrawal from repeated injections, while in ANA rats activity was increased 
only after withdrawal of one week. In addition, the level of locomotor 
sensitization was significantly higher in AA rats compared to ANAs. AA rats 
were also activated more by the acute morphine challenge given to 
repeatedly saline treated animals. The challenge injection of morphine 
induced an expected pattern of activity with a sedative (from 10 min to 2.5 
hours after injection) and stimulatory (from 2.5 hours to the end of 
measuring) phases. This pattern was accompanied by an additional 
stimulatory phase in morphine-sensitized AA rats during the first 30 minutes.  
 
Following a treatment with escalating doses of morphine (5–20 mg/kg, 5 
injections in total), a challenge with 10 mg/kg of morphine showed 
sensitization of locomotor-stimulating effects of morphine in the AA rats, 
while only a tendency was seen in the ANA line. The lines did not differ in 
morphine-induced locomotor activity when they were previously injected 
repeatedly with saline. 
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Figure 2. Effect of morphine (10 mg/kg) on locomotor activity in AA and 
ANA rats treated repeatedly with morphine (15 x 10 mg/kg) or 
saline. *** p < 0.001 represents significant difference from the 
saline group; # p < 0.05, ## p < 0.01 from the corresponding group 
of the ANA line, Student’s t-test. 
5.1.2 Differences between morphine treatments 
 
Differences in locomotor activity were not seen in AA rats that were treated 
with different regimens of morphine and given a vehicle challenge seven 
days after discontinuation of the regimens (Figure 3.). When they were 
challenged with morphine (3 mg/kg), there were significant differences 
between the groups after ten days but not after six weeks. The groups that 
were given morphine intermittently every other day (15 x 10 mg/kg or 5 x 5–
20 mg/kg), were significantly more activated by the morphine challenge than 
control group that was given morphine for the first time. Subchronically 
morphine treated rats (twice daily injections of morphine, 3–10 
mg/kg/injection) did not differ from the controls. 
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Figure 3. Locomotor activity in AA rats treated repeatedly with saline or 
morphine (Intermittent 5 = 5 x 5 – 20 mg/kg, Intermittent 15 = 15 x 
10 mg/kg, Subchronic = 3 – 10 mg/kg, twice daily). Locomotion 
was measured following a challenge injection with saline 7 days 
or morphine 10 days (ch1: 3 mg/kg) and 6 weeks (ch 2: 3 mg/kg) 
after termination of the repeated injections. # p < 0.05, relative to 
saline group, * p < 0.05, relative to “acute morphine” group, 
Student-Newman-Keuls t-test. Mean photocell counts ± S.E.M. 
5.1.3 Interactions with ethanol 
 
Figure 4. shows the effect of morphine administration on locomotor activity in 
repeatedly morphine or saline treated AA rats that had access to ethanol 
and water or only to water. Repeated treatment with morphine induced 
sensitization to the locomotor-stimulating effects of morphine demonstrated 
as increased activity when the rats were challenged with 10 mg/kg of 
morphine. A challenge with 3 mg/kg of morphine increased locomotor 
activity more in both of the morphine-treated groups as well as in the ethanol 
drinking saline-treated rats than in the water drinking saline-treated controls.  
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 Sensitized locomotor response was not seen in saline-treated groups after 
the higher challenge dose of morphine. Ethanol intake during the morphine 
sensitization treatment did not induce further increase of activity in 
morphine-treated animals compared to water drinking individuals. 
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Figure 4. Locomotor activity in alcohol-preferring AA rats treated 
repeatedly with saline or morphine (5 x 5 – 15 mg/kg). In addition, 
rats had access to ethanol on intervening days to morphine 
injections in ethanol + saline and ethanol + morphine groups. 
Locomotion was measured for 4 hours following a challenge 
injection of morphine, 3 or 10 mg/kg s.c., given 5 and 10 days, 
respectively, after termination of the repeated treatment with 
morphine. * p < 0.05, ** p < 0.01, relative to the Water + Saline 
group, 1-way ANOVA. Mean photocell counts ± S.E.M. are given, N 
= 7–8 / group. 
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 5.2 Extracellular concentrations of neurotransmitters in 
morphine-sensitized rats (I, IV) 
5.2.1 Dopamine and metabolites 
 
Extracellular concentrations of dopamine and dopamine metabolites in the 
nucleus accumbens shell were measured in the morphine-sensitized AA and 
ANA rats with in vivo microdialysis after an additional morphine challenge 
(10 mg/kg). Morphine increased extracellular dopamine to 270 % of baseline 
in the morphine-treated AA rats and 170 % of baseline in ANA rats 
compared to 210 % and 170 % in the repeatedly saline-treated AAs and 
ANAs, respectively (Fig. 5.). Thus, intermittent treatment with morphine 
induced an elevation in the levels of extracellular dopamine only in AA rats. 
No significant differences were found between the saline-treated animals. 
Saline challenge did not have any effects on the extracellular dopamine 
concentration in the nucleus accumbens. Four weeks later, differential 
response to morphine between the lines had disappeared, and morphine 
increased extracellular dopamine levels similarly in all animals compared to 
saline. The basal extracellular levels of dopamine in the nucleus accumbens 
of the saline-treated AA and ANA rats (challenge 1) were 0.53 ± 0.10 nM 
and 0.66 ± 0.10 nM, respectively. 
 
In agreement with its effect on dopamine, morphine increased the 
extracellular levels of DOPAC and HVA in the nucleus accumbens more in 
the rats challenged with morphine than in those challenged with saline 
Sensitization, however, was not seen in DOPAC or HVA levels after 
repeated morphine-treatment in either of the rat lines. In contrast to the 
dopamine results, the highest levels of both metabolites were measured 
from the saline-treated AA rats. No differences were found between the 
groups after the second challenge. The basal values for DOPAC were 0.44 ± 
0.07 µM and 0.65 ± 0.10 µM, and for HVA 0.22 ± 0.02 µM and 0.30 ± 0.03 
µM in AA and ANA rats, respectively. 
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Figure 5. Extracellular concentrations of dopamine in the nucleus 
accumbens in repeatedly morphine treated AA and ANA rats (15 x 
10 mg/kg) after morphine (10 mg/kg) challenge. # p < 0.05, from 
the corresponding group of the ANA line, Student’s t-test. 
5.2.2 Glutamate 
 
Glutamate levels were determined in the ventral tegmental area in AA and 
ANA rats after repeated morphine treatment. Acute morphine challenge 
affected extracellular glutamate in neither of the lines (Figure 6.). The 
concentration of glutamate was increased in the morphine-sensitized AA rats 
after morphine challenge in comparison to both the saline-treated AAs and 
morphine-treated ANA rats. A challenge with ethanol did not modify the 
levels of glutamate in AA rats treated repeatedly with morphine. Basal levels 
of glutamate in the ventral tegmental area were 0.71 µM for AA and 0.72 µM 
for ANA rats. 
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Figure 6. Extracellular concentrations of glutamate in the VTA shown as a 
difference from saline-challenged controls. Averages of four 15-
minute samples are shown. * p < 0.05, indicates significant 
difference from the saline controls. # p < 0.05, from the 
corresponding group of the ANA line. 
5.2.3 GABA 
 
Challenging the morphine- or saline-treated AA and ANA rats with morphine 
or ethanol did not modify the extracellular levels of GABA in the ventral 
tegmental area. The basal concentrations of GABA were 13.5 nM and 15.5 
nM for AA and ANA rats, respectively (P = 0.36). 
 
5.3 Plasma and brain levels of morphine 
 
Plasma and brain concentrations of morphine were determined 60 minutes 
after an acute subcutaneous injection of morphine. The plasma 
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 concentrations of morphine were 1433 ± 122 ng/ml in AA rats and 1189 ± 72 
ng/ml in ANA rats. In the brain, the levels were 236 ± 16 and 212 ± 8 ng/g. 
There were no significant differences between AA and ANA rats. 
 
5.4 Effects of morphine and morphine-induced behavioral 
sensitization on ethanol drinking 
5.4.1 Continuous ethanol access 
 
Acquisition of ethanol drinking subsequent to repeated morphine 
administration was not significantly affected in morphine-treated rats 
compared to saline controls (Figure 7A.). In contrast, acute morphine 
challenge given to the previously saline-treated rats impaired the acquisition 
of ethanol intake during the first week. Ethanol preference reached almost 
90 % in rats sensitized to morphine with intermittent, escalating doses of 
morphine, while it remained closer to 70 % in the other morphine-sensitized 
rats. These, however, were not significantly different from the controls. 
 
5.4.2 Limited ethanol access 
 
In a limited 6 h access paradigm, an average intake of ethanol was 1.8 g/kg, 
compared to 5.7 g/kg during the continuous 24 h access. Morphine 
injections given on intervening days with limited ethanol access significantly 
decreased ethanol intake. Water and food intake were similarly suppressed 
during the repeated morphine treatment. 
 
Ethanol intake did not differ between morphine and saline treated animals 
five days after discontinuation of the repeated treatment with morphine 
(Figure 7B.). In contrast, a morphine challenge dose-dependently increased 
ethanol intake in previously morphine-treated rats and also modified drinking  
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 in saline-treated animals. Cumulative data on morphine-induced ethanol 
intake showed that the drinking pattern of the morphine-treated rats was 
different from that of the others; they consumed more ethanol at the 
beginning of the session and started their next drinking bout sooner than the 
animals in other groups. 
 
 
 
Figure 7. Acquisition of voluntary ethanol drinking in g/kg b.w. (A), in AA 
rats treated repeatedly with saline or morphine (Intermittent 5 = 5 
x 5 – 20 mg/kg, Intermittent 15 = 15 x 10 mg/kg, Subchronic = 3 – 
10 mg/kg, twice daily). In the panel B an effect of a challenge dose 
of morphine on ethanol intake (g/kg/6 h) by AA rats treated 
repeatedly with morphine is given. Five days after discontinuation 
of the morphine treatment the rats were administered 
subcutaneously with 0, 1, or 10 mg/kg of morphine, and given a 
choice between water and 10 % (v/v) ethanol for 6 hours. * p < 
0.05, *** p < 0.001, relative to corresponding control group injected 
with saline (0), Dunnett’s t-test.  # p < 0.05, ### p < 0.001, Tukey’s 
HSD. Means ± S.E.M. are given. 
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Table 1. Summary of biochemical and behavioral effects of morphine in AA 
and ANA rats that were given morphine acutely or repeatedly. In the first two 
columns, rats are compared to saline treated/challenged animals within the 
lines. In the third column, differences between the rat lines are given. Arrows 
denote either increased/higher (up arrow) or decreased/lower (down arrow) 
intensity of effect, N.A. = Data not available. 
 
Morphine Region         AA       ANA AA compared to ANA
effect on Acute Rep Acute Rep Acute Rep
Locomotion -   / -
Dopamine Nac -
DOPAC NAc -
HVA NAc -
Glutamate VTA - - - -
GABA VTA - - - - - -
Ethanol intake - N.A. N.A. N.A. N.A.  
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 6 DISCUSSION 
6.1 Effects of morphine on locomotor activity 
 
Acute morphine increased locomotor activity in both AA and ANA rats 
compared to saline. This effect was more pronounced in AA rats when they 
were challenged with 10 mg/kg (I) of morphine but not when given 3 mg/kg 
of morphine (IV). Behavioral sensitization to the locomotor stimulatory 
effects of morphine was seen in both lines after intermittent morphine 
treatment (15 x 10 mg/kg), while a treatment with escalating doses of 
morphine (5 x 5 – 20 mg/kg) failed to induce significant increase in activity in 
ANA rats. Furthermore, the levels of activity were significantly higher in AA 
rats compared to ANAs after both morphine regimens. 
 
6.1.1 Differences between AA and ANA rats 
 
High or moderate doses of morphine have previously been shown to cause 
an initial depression of activity followed by a delayed excitatory effect 
(Babbini & Davis, 1972), while lower doses are predominantly stimulatory. 
Since morphine has both stimulatory and sedative properties, increase in 
overall activity can result from either tolerance to its sedative effects or 
sensitization to stimulatory effects. When the activity patterns were 
examined in ten minute intervals in the present study, repeatedly morphine-
treated AA rats showed an increase in activity immediately after the 
challenge dose, and then a second increase starting about three hours after 
the injection and lasting until the end of the recording session (see figure 2 in 
paper I). The high activity pattern at the beginning of the challenge session 
developed during the repeated morphine treatment and it may represent 
tolerance to the initial sedative effects of morphine. However, since this 
phenomenon was not studied further, our results cannot exclude the 
possibility that increased activity represented a conditioned response to the 
morphine injections (see section 6.1.4 below). In contrast, the only clear 
increase in locomotion that could be seen in the ANA rats after morphine 
treatment was that beginning three hours after the challenge dose. Because 
the sedative effect of morphine in the middle of the session was similar in all 
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 treatment groups, it is unlikely that the increase in locomotion results only 
from tolerance to morphine sedation. 
 
Morphine and other µ-opioid agonist have been shown to induce behavioral 
sensitization in rats when administered repeatedly (for review see 
Vanderschuren & Kalivas, 2000), this effect being similar to many other 
drugs of abuse. Accordingly, behavioral sensitization has been shown after 
repeated morphine and cocaine administration in AA or ANA rats (Honkanen 
et al., 1999; Mikkola et al., 2000; 2001; Mikkola et al., 2002). In addition, AA 
animals that first have had continuous and then limited access (10 min/day) 
to ethanol for several weeks showed increase in locomotion after 10 minutes 
of voluntary ethanol intake compared to saccharin and water drinking rats, 
indicating that also ethanol can reinforce locomotor behavior similarly to 
morphine and cocaine in AA rats (Päivärinta and Korpi, 1993). In the present 
study, we were able to induce long-term locomotor sensitization to morphine 
in both alcohol-preferring and alcohol-avoiding rat lines. This effect being 
significantly more robust and long-lasting in AA rats than in ANAs, the data 
supports the hypothesis of different levels of sensitization in the AA and ANA 
rat lines. Furthermore, since we used different regimens of morphine 
administration to sensitize the rats, difference between the lines is not 
specific to the treatment protocol. 
  
6.1.2 Differences between morphine treatments 
 
According to our results, only intermittent morphine administration was able 
to induce sensitization to the locomotor stimulant effects of morphine in AA 
rats. Subchronic, twice daily administration of morphine failed to induce 
significant behavioral sensitization in these animals. The data are in line with 
the results published by other authors suggesting that pattern of exposure 
rather than the dose administered is important in the development of 
behavioral sensitization (Powell and Holtzman, 2001; Vanderschuren et al., 
1997). There was no difference in the level of locomotor activation between 
the two intermittently morphine treated groups, although the total dose of 
morphine administered, number of injections as well as the length of the 
treatment were different. Only a tendency for increased activation was seen 
in the subchronically treated group. While the total dose of morphine given to 
the subchronic group was in the same range as in one of the intermittently 
treated groups and the number of drug exposures was higher, it cannot be 
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 definitely ruled out that the rats were not sensitized because they did not 
meet a certain threshold dose of morphine or length of treatment needed to 
induce behavioral sensitization. 
 
6.1.3 Interactions with ethanol 
 
Repeated treatment with morphine induced locomotor sensitization in AA 
rats that were drinking ethanol on intervening days that was not different 
from the animals having access only to water. Interestingly, after a challenge 
with 3 mg/kg of morphine, we found that ethanol drinking rats that had been 
treated with saline showed a similar locomotor response as the morphine 
treated groups. This suggests that ethanol drinking rats were cross-
sensitized to morphine. In agreement with this view, repeated treatment of 
ethanol has been reported to enhance the locomotor stimulant effects of 
morphine in rats three weeks post-treatment (Nestby et al., 1997). Higher 
challenge dose of morphine (10 mg/kg) did not induce augmented 
locomotion in ethanol drinking rats in the present study. It is possible that in 
contrary to the morphine-treated animals, these rats had not developed 
tolerance to the sedative effects of morphine, and consequently when they 
were given a high dose of morphine there is a possibility that sedative 
effects of morphine had masked the expression of morphine-induced 
stimulation. In conclusion, ethanol did not interfere with the development of 
sensitization to the locomotor stimulatory effects of morphine in alcohol-
preferring AA rats. Furthermore, rats having had limited access to ethanol 
showed enhanced locomotor effects of morphine, indicating that 
neuroadaptations induced by repeated exposure to ethanol were sufficient to 
cause behavioral cross-sensitization to morphine.  
 
6.1.4 Methodological points and limitations 
 
Differences in drug effects can result from different pharmacokinetics 
between the lines under study. It has been shown that morphine distribution 
can vary between different mouse lines (Belknap et al., 1989). Thus, in the 
present work, we examined the distribution of morphine in the plasma and 
brain in AA and ANA rats. There were no significant differences in plasma or 
brain levels of morphine. Supporting our results, morphine distribution was 
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 previously not found to differ between AA and ANA rats (Honkanen et al., 
1999). Therefore, pharmacokinetic factors probably do not explain the 
observed differences between the lines. 
 
In the present set of studies we sensitized the rats to morphine by giving 
morphine injections both in novel environment with contextual cues differing 
from home cage (I) and in the home cages (II – IV). In addition, injections 
were given to animals living in individual (II, III)) and group cages (IV). Stress 
due the isolation housing or differences in environmental conditions may 
have affected the results. Previous studies have shown that exposure to 
stressful stimuli can induce behavioral sensitization (cf. Marinelli and Piazza, 
2002) and that they can cross-sensitize to the effects of drugs of abuse 
(Phillips et al., 1997). Moreover, psychomotor sensitization produced by 
repeated injections, were shown to be greater when drug treatments were 
given immediately after animals were placed into a distinct and relatively 
novel test environment, compared to when treatments were given in a home 
environment (Crombag et al., 2001). If we compare locomotor data from the 
individual works of the present study, there are indeed differences in the 
levels of activity among similarly treated and challenged groups. However, 
the interpretation of the results (AA rats are more susceptible to behavioral 
sensitization than ANA animals) remains the same regardless of the 
absolute differences between the lines. Finally, in a study by Crombag et al. 
they were able show that while environmental cues affected acute locomotor 
responses to amphetamine, habituation to the test environment had no 
effect on ability of amphetamine to facilitate the development of psychomotor 
sensitization. It therefore seems viable to assume that our results supporting 
different vulnerability to drug effects in AA and ANA rats gathered from 
varying test conditions strengthen rather than compete against each other. 
 
We used only horizontal locomotor activity to demonstrate behavioral 
sensitization after repeated morphine treatment in the present studies. At the 
same time, however, we also monitored the stetotyped and rearing 
behaviors with the same photocell apparatus. The results would have been 
very similar to what were published if one of these indicators had been used 
(data not shown). Besides horizontal locomotion, rotational behavior after 
unilateral lesion of nigrostriatal dopamine pathway has been successfully 
used in AA and ANA rats to indicate behavioral sensitization (Mikkola et al., 
2002). 
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 In the first paper activity induced by acute morphine were significantly 
different between AA and ANA rats. This complicates the interpretation of 
the results. Behavioral sensitization was seen in both rat lines in that study, 
while the levels of activity were very different. Unfortunately, it cannot be 
deducted from the results if this difference is only a result from a very 
different innate behavioral response of the lines that is not dependent on any 
drug effects. A number of differences between the lines are known, such as 
response to stressful conditions that could influence their behaviors 
(Kiianmaa et al., 1991; Korpi et al., 1988). In the fourth paper, when a lower 
challenge dose of morphine was given to the rats locomotor activity did not 
differ between the lines. This indicates that different response in the first 
work may be related to acute tolerance or different sensitivity to sedative 
effects of morphine in the lines. 
 
6.2 Extracellular concentrations of neurotransmitters in 
morphine-sensitized rats 
6.2.1 Dopamine and metabolites 
 
Dopaminergic neurotransmission has been shown to be important in acute 
effects of morphine and dopamine and dopamine receptors have been 
suggested to have a role in development and expression of behavioral 
sensitization to morphine and other drugs of abuse (for review see Pierce & 
Kalivas, 1997). In line, morphine injection elevated accumbal dopamine, 
DOPAC and HVA in AA and ANA rats compared to saline-challenged 
controls. Furthermore, dopamine overflow in morphine-sensitized AA rats 
was enhanced compared to ANA animals. This increase was observed only 
after the first challenge injection one week after withdrawal, without 
differences between the lines or treatment groups at the time of the second 
challenge injection of morphine. Similarly, no differences between the rat 
lines or treatment groups were seen in the extracellular concentrations of 
DOPAC and HVA after the second morphine challenge.  
 
In general, our findings are in good agreement with previous studies, and 
indicate that repeated morphine administration is accompanied with 
behavioral sensitization and increased extracellular concentrations of 
dopamine in the nucleus accumbens (Acquas & Di Chiara, 1992; Johnson & 
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 Glick, 1993; Spanagel et al., 1993; Cadoni & Di Chiara, 1999; 
Vanderschuren et al., 1999). However, It is not clear how the enhancement 
of morphine-induced overflow of accumbal dopamine in the morphine-
treated AA rats could be causally related to increased locomotor activity in 
these rats. Our results indicated dissociation between the sensitized 
response to morphine and extracellular dopamine concentrations in the 
nucleus accumbens. Furthermore, ANA rats showed locomotor sensitization 
without increase in extracellular dopamine in the nucleus accumbens after 
both challenge treatments. These data suggest that the elevated locomotor 
activity after morphine is not caused by increased extracellular 
concentrations of dopamine in the nucleus accumbens and points out to a 
possibility that also a non-dopaminergic mechanism is involved. 
 
6.2.2 Glutamate 
 
Activity of mesolimbic dopamine neurons in the level of VTA is modified by 
excitatory glutamatergic and inhibitory GABAergic mechanisms. Changes in 
the activity of these systems by drugs of abuse have been implicated in 
neuronal plasticity related to long-term effects of drugs including behavioral 
sensitization (Johnson and North, 1992b; Karreman et al., 1996; Steffensen 
et al., 1998; Xi and Stein, 1998). 
 
In the present study, an acute dose of morphine did not alter the 
extracellular levels of glutamate in the saline-treated AA or ANA rats. In 
contrast,  AA rats that had been treated repeatedly with morphine showed 
elevated concentrations of glutamate after a challenge injection of morphine, 
while similarly treated ANA rats did not. These findings show that besides 
differing in their sensitivity to morphine-induced locomotor sensitization and 
dopamine release (Ojanen et al., 2003), also glutamatergic transmission 
differs between the AA and ANA rat lines after repeated treatment with 
morphine. This supports earlier data suggesting that adaptations of 
glutamatergic neurotransmission in the VTA are associated with the 
development of behavioral sensitization to drugs of abuse (Wolf and Xue, 
1998)(cf. Carlezon and Nestler, 2002), and may contribute to the higher 
susceptibility to morphine-induced behavioral sensitization in AA rats relative 
to ANA rats. 
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 The higher morphine-induced increase in tegmental levels of glutamate 
found here in AA rats relative to ANA rats may help to understand differential 
susceptibility to behavioral sensitization between the lines. The higher 
glutamate levels after morphine in AA rats can be speculated to produce 
more stimulation of mesolimbic dopaminergic neurons and locomotor activity 
in these rats compared to ANAs. Taken the higher density of µ opioid 
receptors and opioid propeptide mRNA levels in several brain areas in AA 
rats relative to ANA rats (Marinelli et al., 2000), one may speculate that 
higher opioidergic tone in AA rats might account for the difference in the 
effects of morphine. Administration of morphine to AA rats could result in 
enhanced morphine-induced suppression in the levels of GABA in the 
ventral tegmental area relative to ANA rats, which in turn might trigger 
differential adaptation to repeated exposure to morphine between the lines. 
The two findings may, however, not be causally related. Since our earlier 
findings suggested that the role of mesolimbic dopaminergic mechanisms 
are probably only transient in the expression of opioid-induced behavioral 
sensitization, the effect of enhanced glutamate release on locomotion may 
be mediated through dopamine independent mechanisms (Ojanen et al., 
2003). 
 
Challenging morphine-treated AA rats with ethanol produced no changes in 
the levels of glutamate in the ventral tegmental area. While some effects of 
ethanol are mediated through opioid receptors, challenging morphine-
sensitized rats with ethanol did not produce similar increase in the glutamate 
levels in the VTA as morphine did. 
 
6.2.3 GABA 
 
Morphine did not induce significant changes in the extracellular levels of 
GABA in AA or ANA rats. Therefore, involvement of GABAergic neurons in 
the differential susceptibility of AA and ANA rats to the effects of repeated 
morphine remains an open question. Decrease of GABA release via 
activation of µ-opioid receptors located on GABAergic interneurons is 
believed to be a principal mechanism mediating actions of morphine and 
other µ-opioids on dopaminergic transmission (Klitenick et al., 1992; Leite-
Morris et al., 2004). Supporting this hypothesis, morphine was shown to  
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 decrease the levels of extracellular GABA when it was given directly into the 
ventral tegmental area (Klitenick et al., 1992). Furthermore, a role for 
GABAergic mechanisms in morphine-induced behavioral sensitization has 
been established in studies with GABA agonists and antagonists (Leite-
Morris et al., 2004). Our results, however, are not in contradiction to these 
data. To our knowledge, the effect of systemically given morphine on 
extracellular levels of GABA in the VTA has not been studied earlier. It is 
possible that systemic morphine affects GABA levels in the VTA also 
through other neurotransmitter systems or systems originating from different 
brain areas. Accordingly, the importance of other brain areas than VTA has 
been demonstrated by findings showing that µ opioid-receptor antagonist 
injected directly into the ventral pallidum can block the development of 
sensitization to morphine (Bardo, 1998; Pierce and Kalivas, 1997; Xi and 
Stein, 2000). 
 
6.2.4 Limitations with in vivo microdialysis method 
 
There have been speculations of the importance of extracellular amino acid 
levels measured with in vivo microdialysis. A portion of amino acids in the 
extracellular space is derived from sources that are not directly involved in 
neurotransmission (Frantz et al., 2002). Furthermore, due to rather poor 
temporal resolution rapid changes in amino acid levels are not measurable 
with microdialysis technique. However, there are data that clearly establish a 
causal relationship for extracellular levels of amino acids in controlling brain 
function in normal and pathological states of neurotransmission (Nyitrai et 
al., 2006). Thus, the microdialysis data should rather be viewed as an 
indicator of a physiologically significant increase in glutamate or GABA efflux 
that through different mechanisms leads to increase in extracellular amino 
acids that are detectable also by in vivo microdialysis (Wolf and Xue, 1998). 
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 6.3 Effects of morphine and morphine-induced behavioral 
sensitization on ethanol drinking 
6.3.1 Continuous ethanol access 
 
The present study conducted in alcohol-preferring AA rats showed that 
ethanol drinking subsequent to intermittent morphine treatment was not 
different from that in the saline treated controls. Subchronic treatment with 
morphine was likewise unable to affect acquisition of ethanol drinking. 
 
Opioidergic mechanisms have been implicated in the mediation of ethanol 
reinforcement (cf. Gianoulakis, 2001; Herz, 1997), and could contribute to 
enhanced ethanol preference in sensitized animals. This is suggested by 
findings showing that behavioral sensitization to ethanol in mice can be 
prevented by co-administration of opioid antagonist naltrexone (Camarini et 
al., 2000), and that repeated injections with morphine may increase ethanol 
drinking and preference (Hodge et al., 1992; Volpicelli et al., 1991). These 
findings led us to hypothesize that susceptibility to morphine-induced 
behavioral sensitization in AA rats may be related and contributes to the 
predilection towards ethanol drinking in AA rats 
 
In contrast to this hypothesis, our results indicated that ethanol drinking by 
AA rats treated repeatedly with morphine was not different from that by the 
controls whether it was expressed as g/kg/day or as a preference ratio. 
Acquisition of ethanol drinking and ethanol preference were, nonetheless, 
impaired during the first week in the saline-treated rats injected with 
morphine only once. The long-lasting suppression of drinking by the 3 mg/kg 
morphine dose is surprising because similar doses have been shown to 
stimulate locomotor activity in AA rats in the present and previous studies 
(Honkanen et al., 1999) and to increase ethanol intake (Reid and Hunter, 
1984). It should be noted, however, that here it is possible that aversive 
after-effects of morphine administration may have associated with ethanol 
availability. Therefore, the acquisition of ethanol drinking was delayed in this 
group compared with the groups that had received morphine injections 
repeatedly and had developed partial tolerance to the aversive effects. 
However, the present results are in agreement with the general picture 
emerging from earlier reports. Morphine, whether given acutely or 
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 repeatedly, does not affect acquisition of ethanol intake, but increases 
ethanol drinking during the maintenance phase (Hodge et al., 1992; 
Stromberg et al., 1997; Volpicelli et al., 1991).  
 
6.3.2 Limited ethanol access 
 
When morphine-sensitized rats were challenged with saline and exposed to 
ethanol (limited 6 hour access) five days after discontinuation of the 
treatment, they did not differ from the saline controls in ethanol intake. These 
data, together with our earlier findings, suggest that sensitization of AA rats 
to morphine does not promote their ethanol intake. This finding is in contrast 
to our hypothesis, and indicates that sensitization does not contribute to 
reinforcement from voluntarily consumed ethanol. The failure to see changes 
in ethanol intake in rats sensitized to the behavioral effects of morphine may 
point to dissociation between locomotor sensitization and the reinforcing 
properties of ethanol.  
 
When the rats were challenged with 1 mg/kg of morphine ethanol drinking 
was increased in a similar manner in the both saline- and morphine-treated 
rats. Increase in ethanol intake after administration of morphine is consistent 
with earlier studies showing that low acute doses of morphine (1 – 2.5 
mg/kg) increase subsequent ethanol drinking (Hubbell et al., 1993; 
Stromberg et al., 1997; Vacca et al., 2002; Wild and Reid, 1990). It has been 
speculated that this could be explained in terms of morphine functioning as a 
primer for ethanol drinking by stimulating the mesolimbic dopamine system 
and priming it for further stimulation by consumed ethanol (Ulm et al., 1995; 
Colombo et al., 2004).  
 
The higher challenge dose of morphine (10 mg/kg) further augmented 
ethanol intake in the morphine-treated rats, but the saline-treated animals 
did not differ from the ones challenged with the vehicle. This increase might 
be explained by morphine functioning as a primer, as above, and by 
development of tolerance to the sedative effects of morphine, while lack of 
tolerance probably was responsible for the controls not showing increased 
ethanol intake. Tolerance is, however, an unlikely explanation for facilitated 
ethanol drinking, since similar doses of morphine suppressed ethanol 
drinking during repeated administration of morphine. One may therefore 
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 postulate that it reflects neuroadaptations related to behavioral sensitization 
to morphine. According to this view, the effects of morphine that augment 
ethanol intake and possibly its rewarding properties in morphine-naïve 
animals are enhanced in the rats sensitized to morphine, and contribute to a 
further increase in ethanol consumption. Since some of the neurobehavioral 
changes induced by morphine and ethanol may be mediated through 
activation of µ-opioid receptors (cf. Johnson and Napier, 2000; Sanchis-
Segura et al., 2004), it is tempting to speculate that repeated treatment with 
morphine and ethanol had induced neuroadaptations in signaling through µ-
opioid receptors that were expressed as increased ethanol drinking when 
ethanol-deprived animals were challenged with morphine and given access 
to ethanol. 
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 7 CONCLUSIONS 
The key findings of this work were: 
 
1. Alcohol-preferring AA rats showed more morphine-induced locomotor 
activity than morphine-treated ANA rats after repeated treatment with 
morphine that was independent on regimen of morphine treatment. This 
strengthens the view that AA rats are more vulnerable to the effects of drugs 
compared to ANA animals beyond voluntary ethanol drinking that was used 
in their selection. Intermittent morphine administration induced sensitization 
to the locomotor stimulant effects of morphine in AA rats, while subchronic 
treatment did not. This supports the importance for pattern of drug exposure 
over the total dose administered in the development of behavioral 
sensitization. 
 
2. The present study indicated a dissociation between sensitized locomotor 
response to morphine and extracellular concentrations of dopamine in the 
nucleus accumbens, suggesting that also a non-dopaminergic mechanism is 
involved in the observed line differences in sensitization to repeated 
morphine treatment. Similarly to the dopamine results, AA and ANA rat lines 
differed in their sensitivity to effects of repeated administration of morphine 
on glutamatergic transmission. Glutamatergic transmission in the VTA is 
therefore potentially involved in the higher susceptibility to morphine-induced 
behavioral and neurochemical sensitization in AA rats relative to ANAs. The 
role of GABA transmission in the VTA in the effects of acute or repeated 
administration of morphine remains unclear. 
 
3. Our results suggest that stimulation of the endogenous opioid system with 
repeated morphine injections does not enhance the learning of the reward 
value of ethanol during initial exposure to it. Moreover, sensitization of AA 
rats to the behavioral effects of morphine alone neither enhanced the 
reinforcing properties of voluntarily consumed ethanol nor contributed to 
increase in its intake. Therefore, the neuronal mechanisms underlying 
behavioral sensitization to morphine probably are distinct from those 
mediating ethanol reinforcement. Furthermore, the increase in ethanol intake 
found after an acute dose of morphine was augmented in rats treated 
repeatedly with morphine. This suggests that the neuroadaptations induced 
by repeated morphine further enhance the reinforcement from ethanol when 
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 the rats are challenged with morphine, but that the mechanisms contributing 
to the increase in ethanol drinking require stimulation with morphine. 
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Abstract
Alcohol-preferring AA (Alko Alcohol) and alcohol-avoiding ANA (Alko Non-Alcohol) rats have well-documented differences in their
voluntary ethanol consumption and brain opioidergic systems. The aim of the present study was to investigate whether these rat lines
differ in their susceptibility to morphine-induced behavioural and neurochemical sensitization. The rats were given 15 injections of
morphine (10 mg/kg, s.c.) or saline every other day. Locomotor activity and release of dopamine in the nucleus accumbens were
monitored after a challenge with additional morphine injections (10 mg/kg) 1 and 5 weeks after withdrawal from the repeated treatment.
Morphine increased locomotion more in the previously morphine-treated rats than in the saline-treated controls. Furthermore, AA rats
were more sensitive to this effect of morphine than ANA rats. Accumbal morphine-induced dopamine release was significantly higher in
the morphine-treated AA than ANA rats after the first challenge injection 1 week from withdrawal, but no differences were observed
after the second challenge. The brain and plasma concentrations of morphine were similar among the lines suggesting that the
differences in the effects of morphine cannot be explained in terms of differential pharmacokinetics of morphine in these lines. These
data show that AA rats are more susceptible to morphine-induced behavioural sensitization than ANA rats. Furthermore, it suggests
that mesolimbic dopamine has at best only a transient role in the expression of opioid-induced behavioural sensitization. The
relationship between the mechanisms underlying the differential sensitivity of these rat lines to the effects of repeated morphine and
voluntary ethanol drinking remains to be determined.
Introduction
Repeated intermittent administration of many drugs of abuse leads to
an increase in the magnitude of their locomotor–stimulatory effects; a
phenomenon called behavioural sensitization (Kalivas & Weber, 1988;
Wise & Leeb, 1993). It has been demonstrated after repeated injections
of cocaine (Kalivas et al., 1988), amphetamine (Kuczenski & Leith,
1981; Cador et al., 1995), nicotine (Benwell & Balfour, 1992; Kita
et al., 1992; Kiianmaa et al., 2000), ethanol (Nestby et al., 1997; Fish
et al., 2002), and morphine (Babbini & Davis, 1972; Bartoletti et al.,
1983; Vezina et al., 1987).
Behavioural sensitization has been suggested to be an expression of
long-lasting adaptations in the central nervous system produced by
repeated administration of abused drugs (Stewart & Badiani, 1993).
The brain systems probably involved include those mediating incen-
tive motivation and drug reward (Robinson & Berridge, 1993, 2001).
Dopamine and dopamine receptors have been suggested to have a role
in development and expression of sensitization (reviewed in Pierce &
Kalivas, 1997), but also excitatory amino acids have been implicated
(reviewed in Wolf, 1998). Development of sensitization of brain
reward systems has been proposed to be an important process con-
tributing to development of drug addiction (Lett, 1989; Acquas & Di
Chiara, 1992; Vanderschuren et al., 2001; Tzschentke et al., 2002),
maintenance of drug-seeking behaviour, and relapse (Vanderschuren
et al., 1999; Lu et al., 2002).
Inbred and selected rodent lines often differ with respect to their
responses to various drug effects, including behavioural sensitization.
Therefore, genetic variation between rodent lines can be used as a tool
for dissecting the neurochemical mechanisms contributing to the
specific behavioural phenotypes (Phillips, 1997). Alcohol-preferring
AA (Alko Alcohol) and alcohol-avoiding ANA (Alko Non-Alcohol)
rats have been developed by bidirectional breeding for high and low
voluntary alcohol drinking, respectively (Eriksson, 1968; Sinclair
et al., 1989). In addition to alcohol-preference, AA rats consume
more aqueous solution of m-opioid receptor agonist, etonitazene, than
ANA or nonselected Wistar rats (Hyytia¨ & Sinclair, 1993) and they
also learn to lever press for intravenous heroin more rapidly than ANAs
do (Hyytia¨ et al., 1996). The distribution of opioid receptors, receptor
density (de Waele et al., 1994, 1995; Soini et al., 1998; Soini et al.,
1999), amounts of opioid propeptides and their mRNA content
(Gianoulakis et al., 1992; Nylander et al., 1994; Marinelli et al.,
2000) differ in various areas of the limbic system between AA and
ANA rats. Furthermore, m-opioids have been found to be involved in
the regulation of ethanol self-administration in the AA line (Hyytia¨,
1993; Hyytia¨ & Kiianmaa, 2001). Finally, it has been shown that with
repeated administration of low doses of morphine (1 and 3 mg/kg),
only AA rats are sensitized to the locomotor stimulating effects of
morphine (Honkanen et al., 1999). These findings suggest that there is
a genetic correlation between alcohol consumption and sensitivity to
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morphine-induced behavioural sensitization that could be mediated by
the endogenous opioid system.
Previous studies have shown that morphine-induced behavioural
sensitization involves enhancement of mesolimbic dopamine trans-
mission (Kalivas & Duffy, 1987; Acquas & Di Chiara, 1992; Johnson
& Glick, 1993; Spanagel et al., 1993). However, no differences in
morphine-induced overflow of dopamine in the nucleus accumbens
were observed between AA or ANA rats after acute or 4-day repeated
administration of low doses of morphine (Mikkola et al., 2000).
Because the failure to see dopaminergic differences between the lines
in that study could be due to insufficient morphine dosage, the purpose
of the present study was to compare the behavioural and neurochem-
ical expression of sensitization in AA and ANA rats after a repeated
morphine treatment capable of inducing long-term behavioural sensi-
tization. Both morphine-induced locomotor activity and accumbal
dopamine release were measured 1 and 5 weeks after termination of
the 15-day morphine treatment.
Materials and methods
Animals
Alcohol-preferring AA (Alko Alcohol) and alcohol-avoiding ANA
(Alko Non-Alcohol) male rats (Alcohol Research Centre, National
Public Health Institute, Helsinki) from generations F8283 were used
throughout the experiments. All animals were at least 3 months old at
the beginning of the experiments. The rats were housed in groups of
four or five with free access to food (SDS RM1 (E) SQC, Witham,
Essex, England) and water. Ambient temperature was maintained at
22 1 8C and humidity at 55 10%. The light : dark cycle was
12 h : 12 h (lights on at 06.00 h). In the locomotor activity experiment,
the rats were transferred to single wire mesh cages two weeks before
the beginning of the experiment; in the microdialysis studies, animals
were placed in individual Plexiglas cages (24 24 30 cm3) after the
surgical implantation of guide cannula. The experiments were con-
ducted in accordance with the European Communities Council Direc-
tive (86/609/EEC) and approved by the Institutional Animal Care and
Use Committee at the National Public Health Institute and the Chief
Veterinarian of the County Administrative Board.
Measurement of locomotor activity
The rats were habituated to handling and all treatment procedures
properly before starting the experiment. Locomotor activity was
measured in transparent plastic cages (18 33 15 cm3) by using
computer-controlled photocells (Cage Rack Activity System, San
Diego Instruments, CA, USA). Horizontal locomotor activity was
recorded at 10-min intervals. Activity was measured in a quiet room
with normal lighting. Before the morphine injections, each animal was
habituated to the activity cages during one session without injection
and during two sessions with saline injections.
At the beginning of each experimental day, the rats were weighed
and then placed into activity cages that were located in an adjacent
experimental room. With this arrangement, the contextual cues of the
testing environment were different from those of the home environ-
ment. Rats were left undisturbed for 15 min before morphine or saline
injections after placing them into the test cages. The subjects were then
given an injection of morphine-HCl (s.c., 10 mg/kg in 0.9% NaCl) or
saline. Following the injections, locomotor activity was monitored for
3 h. These sessions were held every other day, 15 times in total. Aweek
after termination of the sensitizing injections, all animals received a
challenge injection of morphine (10 mg/kg) and locomotor activity
was measured for 4 h. This procedure was repeated 4 weeks after the
first challenge injection.
Surgery for microdialysis
Rats anaesthetised with halothane (4% during induction for 5 min and
1.5–2% during surgery) were attached to a stereotactic frame for
implantation of the guide cannula. The guide cannula was aimed at
the shell of the nucleus accumbens. The coordinates used were 1.7 mm
anterior to bregma, 1.2 mm lateral to midline and 6.5 mm below the
dura, according to the atlas by Paxinos and Watson (Paxinos & Watson,
1997). The guide cannula was fastened to the skull with stainless steel
screws and dental cement. After the surgery, the rats were administered
once with buprenorphine (s.c., Temgesic, 0.05 mg/kg) and were
allowed to recover for at least 7 days. During the recovery period,
the rats were handled daily and tethered to the counterbalancing arm
for a few hours to habituate them to experimental procedures.
Microdialysis
The extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid
(DOPAC), and homovanillic acid (HVA) were measured with in vivo
microdialysis in freely moving rats. The repeated morphine treatment
was identical with the one used in the locomotor activity experiment
with the exception that activity was not measured after injections.
Challenge experiments were performed 1 and 5 weeks after the last
sensitizing injection. Six groups were used; four groups were the same
as in the locomotor activity experiment, and the two additional groups
were AA rats pretreated and challenged with saline, and an identical
ANA group. All microdialysis experiments were conducted in separate
cages in which animals had received morphine treatment. Therefore,
the testing environment was different from the home environment. In
the morning (at 08:00 h), the rats were first tethered and a microdialysis
probe (CMA/12, membrane length 2 mm, o.d. 0.5 mm, polycarbonate
membrane with a 20 000-Da cutoff, CMA Microdialysis, Stockholm,
Sweden) was inserted into the guide cannula. Modified Ringer solution
(147 mM NaCl, 3 mM KCl, 1.3 mM CaCl2, 1 mM MgCl2 in 0.1 M
Na2HPO4, pH 7.25) was infused through the probe with a flow rate
of 1.4 mL/min using a CMA 100 microinjection pump. The collection
of microdialysis samples (every 15 min, 21mL/sample) was started 3 h
after insertion of the probe. The baseline samples were collected for
1 h: thereafter the rats were given a morphine or saline injection, and
the samples were collected for the next 4 h. The samples were collected
into the vials containing 3mL of 1 mM glutathion in 0.15 M HCl and
were immediately refrigerated.
Determination of dopamine concentrations in the nucleus
accumbens
The samples were analyzed with high performance liquid chromato-
graphy (HPLC) using electrochemical detection. The HPLC system
used for determination of the extracellular concentrations of dopa-
mine, DOPAC and HVA consisted of an isocratic pump with a degaser
unit and a refrigerated autoinjector (Hewlett Packard 1100 series, Palo
Alto, CA, USA). Concentrations were measured with amperometric
detector (Antec Intro, Leyden, The Netherlands) with a glassy-carbon
VT-03 cell. The glassy-carbon working electrode was set to þ700 mV
vs. Ag/AgCl reference electrode. The column used was MIC 10–3-C18,
100 1 mm i.d. with a particle size of 3 mm (Hypersil, LC-Packings,
The Netherlands). The mobile phase was 11% (v/v) methanol in 50 mM
phosphate/50 mM citric acid buffer, 0.15 mM ethylenediaminetetra
acetic acid (EDTA), 10 mM NaCl, and 0.22 mM sodium octylsulpho-
nate at pH 4.8. The solution was filtered through a polyvinylidene
fluoride filter with 0.45-mm pores (Millipore, Milford, MA, USA). The
flow rate of the HPLC pump was set to 35mL/min, and the injection
volume was 15 mL. The limit of detection for dopamine was 0.35 fmol/
mL. The chromatograms were processed with Waters 820 Maxima
Software, version 3.31 (Waters Association, Milford, MA, USA). The
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raw microdialysis data (pmol or fmol/15 min) were converted into
percentages of the baseline consisting of the mean of the last three
baseline samples.
Histology
After a brief carbon dioxide anaesthesia, animals were killed by
decapitation and their brains were removed. The positions of the
probes were verified by fixing the brain in 10% formalin solution
and making frozen 100mm coronal sections stained with thionine after
completion of the experiments.
Determination of morphine concentrations in brain tissue and
plasma samples
Ten AA and 10 ANA rats without prior experience with morphine were
used in determination of plasma and brain concentrations of morphine.
Animals were anaesthetized with carbon dioxide and killed by decap-
itation 60 min after morphine injection (10 mg/kg). The deep frozen rat
brains were dissected sagitally along the fissura longitudinalis cerebri;
the right hemispheres were weighed, homogenized in 4 mL of freshly
prepared 0.1 M HClO4, and centrifuged. For the extraction, 1.0-mL
aliquots of the supernatants were transferred into clean test tubes, after
which roughly 50 mg of Na2HPO4H2O was added in each sample.
Morphine was extracted from 1.0 mL of plasma samples or pretreated
brain tissue samples by mixing with 1.0 mL of 0.5 M Na2HPO4H2O
buffer and 5 mL of n-butyl acetate containing 17 ng/mL of deuterated
morphine as internal standard. The derivatization reagent, 100mL of
N –methyl-N-trimethylsilyltrifluoroacetamide in acetonitrile (1 : 4.3)
was added to the processed sample, and the mixture was injected into
the gas chromatograph in a volume of 2mL.
Quantification of morphine was carried out with an Agilent 6890
series gas chromatograph equipped with an Agilent 5973 mass selective
detector (Agilent Technologies, Inc, Palo Alto, CA). The system was
operated in the splitless injector mode. The length of the HP-35
column was 30 m, internal diameter 0.32 mm and film thickness
0.25 mm. Helium was used as a carrier gas. The inlet and detector
temperatures were maintained at 250 8C and 300 8C, respectively. The
column temperature was initially 150 8C with a hold time of 1.0 min,
and was increased 15 8C/min to 320 8C, with a final hold time of 3.0 min
The limit of detection for morphine was less than 10 ng/mL and the
upper limit of linearity was above 2000 ng/mL. All concentrations
measured in the samples were between these limits. The repeatability
of the procedure, expressed as the relative standard deviation, was
2.0% and 4.3% for brain and plasma samples, respectively, at a
concentration level of 50 ng/mL.
Chemicals and reagents
Morphine sulphate pentahydrate, deuterated morphine (morphine-D3),
and morphine-HCl were purchased from RBI (Natick, MA, USA), and
Radian International (Austin, TX, USA), and University Pharmacy
(Helsinki, Finland), respectively. N-methyl-N-trimethylsilyl trifluor-
oacetamide (MSTFA) was obtained from Sigma-Aldrich Chemie
GmbH (Steinheim, Germany). The other common reagents were the
highest quality and were obtained from Sigma-Aldrich or Merck
(Darmstadt, Germany).
Statistical analysis
Both locomotor activity and microdialysis data were analyzed with
mixed-design ANOVAs with treatment (saline, morphine) and rat line
(AA, ANA) as between-subjects factors, and interval (time) as the
within-subjects repeated measure. After significant interactions, sim-
ple effects were further analyzed with two-way repeated measures
ANOVAs. The criterion for significance was set at 0.05.
Results
Locomotor activity
Following repeated pretreatment with morphine or saline, locomotor
activity was measured after additional injections of morphine during
challenge 1 (ch1) at 1 week after the treatment and challenge 2 (ch2)
5 weeks after treatment. Morphine increased locomotor activity more in
previously morphine-treated than in saline-treated rats after both chal-
lenge injections (ch1, F1,28¼ 30.054, P< 0.001; ch2, F1,28¼ 24.072,
P< 0.001, for treatment) (Fig. 1). This indicates that our pretreatment
procedures were able to induce behavioural sensitization in these rat
lines. Furthermore, the significant rat line–treatment interactions
showed that AA rats were sensitized more than ANA rats (ch1,
F1,28¼ 7.498, P¼ 0.011; ch2, F1,28¼12.607, P¼ 0.001). AA rats were
also activated more by the morphine challenges in general, regardless
of prior treatment, as indicated by significant line differences (ch1,
F1,28¼ 13.014, P¼ 0.001; ch2, F1,28¼ 17.694, P< 0.001, for rat line).
In saline-treated rats and morphine-treated ANA rats, the challenge
dose of morphine was sedative for 2 or 2.5 h, after which rats were
gradually activated at the end of the 4-h measurement (Fig. 2A and B).
In contrast to other groups, morphine-treated AA rats showed high
activity during the first 30 min, which decreased to low levels between
30 and 150 min, and increased again after 150 min. Activity reached
60–70 photocell counts/10 min compared to 20–30 counts in
morphine-treated ANA rats. A three-way analysis of variance con-
ducted on the activity counts revealed that AA rats responded differ-
ently to the morphine challenge compared to ANA rats (ch1,
F23,644¼ 1.633, P¼ 0.032; ch2, F23,644¼ 1.958, P¼ 0.005, for rat
line treatment time interaction).
In order to analyze further the significant interactions, simple effects
analyzes with pairwise comparisons between rat lines and treatment
groups were performed with two-way ANOVAs. Repeated morphine
increased locomotor activity in both lines compared to the correspond-
Fig. 1. Locomotor activity of alcohol-preferring AA and alcohol-avoiding
ANA rats treated repeatedly with morphine (15 10 mg/kg, s.c.) or saline
(15 1 mL/kg s.c.) and challenged with morphine 7 days (challenge 1) or
5 weeks (challenge 2) after termination of the injections. In this and the
following figures, AA-MM stands for AA rats pretreated and challenged with
morphine, while AA-SM represents AA rats pretreated with saline but chal-
lenged with morphine. ANA-MM and ANA-SM are the corresponding groups
with the ANA line. P< 0.05, P< 0.001, relative to saline group; #P< 0.05,
##P< 0.01, relative to corresponding group of the other rat line, Student’s t-test.
Mean photocell counts SEM, n¼ 8 in each group.
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ing saline-treated groups in challenge 1 (AA rats, F23,322¼ 4.360,
P< 0.001; ANA rats, F23,322¼ 2.942, P< 0.001, for treatment time)
and challenge 2 (AA rats, F23,322¼ 3.525, P< 0.001; ANA rats,
F23,322¼ 2.150, P¼ 0.002, for treatment time). Moreover, saline-
treated AA rats had higher activity after the first morphine challenge
than ANA rats (ch1, F23,322¼ 3.235, P< 0.001; ch2, P¼ 0.265 NS, for
rat line time). Finally, both morphine challenges activated morphine-
treated AA rats significantly more than the corresponding ANA group
(ch1, F23,322¼ 2.221, P¼ 0.001; ch2, F23,322¼ 2.491, P< 0.001, for
rat line time).
Extracellular concentration of dopamine and its metabolites
in the nucleus accumbens
After repeated administration (15 times) of saline or morphine
(10 mg/kg), rats were challenged with an additional dose of morphine
or saline. Extracellular concentrations of dopamine were measured in
the nucleus accumbens with in vivo microdialysis in freely moving rats
for 4 h. However, as the peak levels of dopamine were found within one
hour after morphine or saline injections, all subsequent statistical
analyzes are based on the values measured during the 60-min period
following the challenge injections. Saline injections did not have any
effects on extracellular dopamine concentration in the nucleus accum-
bens shell. The levels of dopamine were significantly higher in all
groups challenged with morphine than in the saline controls (P-
values< 0.01) (Fig. 3A and B). Morphine elevated dopamine levels
to 210% and 170% of baseline in saline-treated AA and ANA rats,
respectively (Fig. 3A and B). However, no significant differences
between the saline-treated AAs and ANAs were found during chal-
lenge sessions (ch1, P¼ 0.682 NS, ch2, P¼ 0.584 NS, for rat line -
 time). Prior morphine treatment increased extracellular dopamine
even further in AA rats, but not in ANA rats. The peak levels were
270% of baseline in morphine-treated AA rats and 170% of baseline
in ANA rats. A three-way ANOVA revealed that morphine challenges
had differential effects in the lines during the first challenge but not
Fig. 2. Time course of the stimulatory effect of the challenge injections of
morphine (10 mg/kg) on locomotor activity of alcohol-preferring AA and
alcohol-avoiding ANA rats treated repeatedly with saline or morphine
(15 10 mg/kg, s.c.) and challenged with morphine at 1 week (challenge 1,
Panel A) and 5 weeks (challenge 2, Panel B) after termination of the sensitizing
injections. Groups are defined as in Fig. 1. Mean photocell counts SEM, n¼ 8
in each group.
Fig. 3. Time course of the effect of challenge injections of morphine (10 mg/
kg) at 1 week (A) and 5 weeks (B) after the termination of the sensitizing
injections on dopamine release in the nucleus accumbens of alcohol-preferring
AA and alcohol-avoiding ANA rats treated repeatedly with saline or morphine
(15 10 mg/kg). AA-SS represents the AA line pretreated and challenged with
saline, while ANA-SS is the corresponding group with the ANA line. Other
groups are as defined in the legend to Fig. 1. Morphine or saline was given at
0 min. P< 0.05 between the AA-MM and ANA-MM groups, Student’s t-test.
MeansSEM, n¼ 6–9 per group.
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during the second one (ch1, F3,90¼ 4.23, P¼ 0.008; ch2, P¼ 0.954
NS, for rat line treatment time interaction). Further simple effects
analyzes indicated that repeated, intermittent treatment with morphine
prior to challenge 1, induced a sensitized response in AA rats, but not
in ANA rats. The response in morphine-treated AA rats was different
from morphine-treated ANA rats (ch1, F3,45¼ 5.944, P¼ 0.002, for rat
line time) and saline-treated AA rats (ch1, F3,45¼ 6.599, P¼ 0.001,
for treatment time). Five weeks after termination of morphine
treatment (challenge 2) this differential response to morphine injection
had disappeared (ch2, P¼ 0.607 NS, for rat line time and P¼ 0.894
NS, for treatment time).
As both DOPAC and HVA levels reached their maximum values 3–
4 h after morphine injection (Figs 4A and 5A) compared to dopamine
where maximum levels were reached within 60 min (Fig. 3A), statis-
tical analyzes include the data from the whole 4-h measurement period.
In agreement with its effect on dopamine, morphine increased the
extracellular levels of DOPAC in the nucleus accumbens more in the
rats challenged with morphine than in those challenged with saline
(P-values 0.001) (Fig. 4A and B). However, sensitization was not
seen in DOPAC levels after repeated morphine-treatment in either of
the rat lines (ch1, P¼ 0.627, NS; and ch2, P¼ 0.392, NS, for treat-
ment). The effect of morphine on DOPAC levels in AA rats was
different from that in ANA rats during the first challenge
(F15,540¼ 1.786, P¼ 0.034, for rat line treatment time interac-
tion), but not during the second challenge (P¼ 0.757 NS). In contrast
to the dopamine results, the highest DOPAC levels were measured
from saline-treated AA rats; these differed from those in morphine-
treated AA rats (F15,270¼ 2.407, P¼ 0.003, for treatment time) and
saline-treated ANA rats [F15,270¼ 2.604, P¼ 0.001, for rat line -
 time). No differences were found between the ANA groups during
the challenges or between the AA groups during the second challenge.
In line with the DOPAC results, HVA levels were increased after the
morphine challenge more in the previously morphine-treated rats than
in saline controls (P-values< 0.001). The response in AA rats was
different from ANA rats in challenge 1 (F15,525¼ 2.162, P¼ 0.007, for
rat line treatment time) (Fig. 5A). Saline-treated AA rats had the
highest levels of HVA; they were significantly different from both
Fig. 4. Time course of the effect of the challenge injections of morphine at
1 week (A) and at 5 weeks (B) on DOPAC levels in the nucleus accumbens of
alcohol-preferring AA and alcohol-avoiding ANA rats treated repeatedly with
saline or morphine (15 10 mg/kg). Morphine or saline was given at 0 min.
Groups are defined as in Fig. 3. Means SEM, n¼ 6–10 per group.
Fig. 5. Effect of the challenge 1 (A) and challenge 2 (B) injections of morphine
on HVA levels in the nucleus accumbens of alcohol-preferring AA and alcohol-
avoiding ANA rats treated repeatedly with saline or morphine (15 10 mg/kg).
Morphine or saline was given at 0 min. Groups are defined as in Fig. 3.
P< 0.05 between the AA-MM and ANA-MM groups, #P< 0.05 between
the AA-SM and ANA-SM groups, Student’s t-test. Means SEM, n¼ 6–10
per group.
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morphine-treated AA rats (F15,270¼ 1.910, P¼ 0.022, for treatment
time) and saline-treated ANA rats (F15,255¼ 8.211, P <0.001, for rat
line time). The difference between saline-treated and morphine-
treated ANA rats also reached significance (F15,255¼ 1.727, P¼ 0.046,
for treatment time). No differences were found between any groups
in challenge (P-values> 0.05 NS).
The basal extracellular levels of dopamine in the nucleus accumbens
of the saline-treated AA and ANA rats (challenge 1) were 0.53
0.10 nM and 0.66 0.10 nM, respectively. The values for DOPAC were
0.44 0.07 mM and 0.65 0.10 mM, and for HVA 0.22 0.02 mM and
0.30 0.03 mM, respectively (means SEM).
Histology
Verification of the probe placements did not reveal any differences
between the rat lines or treatment groups that could have affected the
observed neurochemical responses (Fig. 6). Only the data from rats in
which at least 50% of the probe membrane was verified to be in the
nucleus accumbens shell region were included in the final data
analysis; 51 of the 53 operated rats met this criterion.
Plasma and brain concentrations of morphine
The morphine concentrations in plasma and brain 60 min after
an acute subcutaneous injection of morphine are shown in Table 1.
The concentrations did not differ significantly between AA and
ANA rats.
Discussion
In the present study, alcohol-preferring AA rats treated repeatedly with
saline had higher locomotor activity than the corresponding group of
alcohol-avoiding ANA rats after acute administration of morphine
(10 mg/kg, s.c.). This line difference in activity was not accompanied
by differences in extracellular dopamine overflow in the nucleus
accumbens after the morphine injection.
Repeated intermittent morphine treatment (10 mg/kg, 15 injections
in total) sensitized both rat lines to the locomotor activating effects of
morphine. Activation was significantly higher in AA rats after both
challenge treatments (1 and 5 weeks after termination of the sensitizing
injections). Nucleus accumbens dopamine release was increased in AA
rats after the first challenge session, but this effect had disappeared in
the second challenge 4 weeks later. Increased dopamine release after
the morphine challenge was not seen in ANA rats treated repeatedly
with morphine compared to the saline-treated controls.
Locomotor activity
Alcohol-preferring AA and alcohol-avoiding ANA rats have been
selected for high and low voluntary alcohol consumption. In addition,
they show many differences in their endogenous opioidergic system
(Gianoulakis et al., 1992; Hyytia¨ & Sinclair, 1993; de Waele et al.,
1995; Soini et al., 1999; Marinelli et al., 2000). These findings led to
the hypothesis that they could also differ in susceptibility to morphine-
induced sensitization. High or moderate doses of morphine have been
shown to cause an initial depression of activity followed by a delayed
excitatory effect (Babbini & Davis, 1972). Similarly, in our work the
10 mg/kg morphine dose induced virtually no horizontal locomotor
activity in the drug-naı¨ve rats during the first 3 h. After this period, the
activity began to rise slowly.
Sensitization from multiple morphine injections raised locomotor
activity to higher levels than were ever seen in the drug-naı¨ve rats. In
AA rats this enhanced response was greater after both the 1-week and
the 5-week morphine challenges. The sensitized AA rats showed an
increase in locomotor activity immediately after the challenge dose,
and then a second increase starting approximately three hours after
the injection and continuing until the end of the recording session
(Fig. 2A and B). The high activity pattern at the beginning of the
challenge session developed during the repeated morphine treatment
(data not shown) and may represent tolerance to the initial sedative
effects of morphine. However, as this phenomenon was not studied
further, our results cannot exclude the possibility that increased acti-
vity represented a conditioned response to the morphine injections. In
contrast, the only clear increase in locomotion that could be seen in
the ANA rats after sensitization was that beginning three hours after
the 1-week challenge dose. Because the sedative effect of morphine
in the middle of the session was similar in all treatment groups, it is
Fig. 6. Summary of microdialysis probe placements (membrane length 2 mm)
in subjects included in the final data analysis. Each bar (length 2 mm) represents
an individual rat and is fitted to the coronal section closest to the actual anterior–
posterior placement of the probe. Anterior-posterior placement of the section is
indicated relative to bregma. Coronal sections were adapted from the atlas of
Paxinos & Watson (1997).
Table 1. Morphine concentration in plasma and brain of AA and ANA rats
60 min after acute administration of morphine (10 mg/kg s.c.)
Rat line Weight (g)
Morphine concentration
Plasma ng/ml Brain ng/g
AA 340 9 1433 122 236 16
ANA 411 16 1189 72 212 8
MeansSEM; n¼ 10; P< 0.001 between the rat lines.
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unlikely that the increase in locomotion results only from tolerance to
morphine sedation.
Morphine and other m-opioid agonist have been shown to induce a
robust behavioural sensitization in rats when administered repeatedly
(reviewed in Vanderschuren & Kalivas, 2000). In previous studies with
AA and ANA rats, the alcohol-preferring line has been found to be
more sensitive to morphine-induced sensitization (Honkanen et al.,
1999; Mikkola et al., 2000, 2001; Mikkola et al., 2002). In contrast to
the present study, those studies were unable to find indications of sensi-
tization in the nonselected Wistar rats or alcohol-avoiding ANA rats.
However, it must be pointed out that the drug regimens and challenge
injections used in the present study (15 injections with 10 mg/kg,
challenge 1 and 5 weeks after withdrawal) differed greatly from those
of Mikkola et al. (four injections with 1 mg/kg or 3 mg/kg, challenge 1
or 12 days after withdrawal). Because our regimen was able to induce
long-term locomotor sensitization in both alcohol-preferring and
alcohol-avoiding rat lines, we can conclude that the mechanisms
mediating sensitization of locomotor activity are enhanced in AA
rats, but are also present in ANA rats. Together, these data support
our hypothesis of different levels of sensitization in the AA and
ANA rat lines. The alcohol-preferring rats were activated signifi-
cantly more both 7 days (challenge 1) and 5 weeks (challenge 2) after
withdrawal from sensitizing injections than were the alcohol-avoiding
ANA rats.
It has been shown previously that morphine distribution can vary
between different mouse lines (Belknap et al., 1989). However, activa-
tion of AA rats in the present work was not due to pharmacokinetic
factors because no significant line differences were found in plasma
and brain concentrations of morphine (Table 1). The pharmacokinetics
were studied only after acute morphine administration because pre-
vious results have shown that differential pharmacokinetics of
morphine cannot explain the differences in morphine sensitivity
after acute and repeated administration either within rat lines or
between the lines (Kalivas & Duffy, 1987; Latimer et al., 1987;
Mas et al., 2000).
Extracellular dopamine and dopamine metabolite
concentrations in the nucleus accumbens
Extracellular concentrations of dopamine and its metabolites in the
nucleus accumbens were measured with in vivo microdialysis. Mor-
phine injection elevated accumbal dopamine, DOPAC and HVA in
drug-naı¨ve animals compared to saline-challenged controls (Figs 3, 4
and 5). There was a tendency for higher dopamine release in acutely
morphine-treated AA than ANA rats after morphine administration,
but the difference was not statistically significant. Acute morphine
injections have been shown to increase the extracellular levels of
dopamine in the nucleus accumbens in AA, ANA and other rats in
many studies (Kalivas et al., 1983; Devine et al., 1993; Johnson &
Glick, 1993; Mikkola et al., 2000; Maisonneuve et al., 2001). Also the
concentrations of DOPAC and HVA were found to rise both in AA and
ANA rats after acute administration of morphine 1 or 3 mg/kg (Mik-
kola et al., 2000, 2001). In contrast to these studies, the effect of acute
administration of 10 mg/kg morphine on the extracellular concentra-
tions of DOPAC and HVA in the nucleus accumbens was enhanced in
AA compared to ANA rats in the present study. In contrast to dopamine
results, the saline-treated AA rats showed a larger morphine-induced
increase in DOPAC concentrations than AA rats pretreated with
intermittent morphine.
The repeated morphine treatment increased the morphine-induced
dopamine release in the nucleus accumbens of AA rats compared to
ANA rats. However, this increase was observed only after the first
challenge injection 1 week after withdrawal, with no differences
between the lines or treatment groups at the time of the second
challenge injection of morphine. Similarly, no differences between
the rat lines or treatment groups were seen in the extracellular
concentrations of DOPAC and HVA after the second morphine chal-
lenge. The difference between AA and ANA rats in accumbal dopa-
mine was not seen in the earlier microdialysis study (Mikkola et al.,
2000). In that study the extracellular concentrations of dopamine or its
metabolites were not increased after repeated morphine administration
(four daily injections, 1 or 3 mg/kg) compared to morphine-challenged
controls treated repeatedly with saline. It has been shown that there is a
marked reduction of extracellular dopamine concentration in the
nucleus accumbens shell in morphine-dependent rats at least 1–7 days
after withdrawal from morphine, but when challenged with morphine
on days 3 and 5 the dopamine output is potentiated (Acquas & Di
Chiara, 1992). In the present study, this potentiation was also observed
after 7 days from withdrawal. Repeated treatment with high doses of
morphine has been shown to sensitize locomotor activity and extra-
cellular dopamine release in the nucleus accumbens in Sprague–
Dawley rats after morphine challenges 3 days and 30 days following
chronic treatment (Spanagel & Shippenberg, 1993; Spanagel et al.,
1993). The effect on dopamine decreased during the 30 days, and there
was only a small increase in extracellular dopamine at the beginning of
the measurements after the 30 days challenge.
It is not clear how the enhancement of morphine-induced overflow
of accumbal dopamine in the morphine-treated AA rats could be
causally related to increased horizontal locomotor activity in these
rats. In these rats the locomotor activity was increased between 0 and
30 min and again after 150 min (Fig. 2A), while dopamine was elevated
most during the intervening time from 45 to 105 min (Fig. 3A).
Similarly, after the second challenge, locomotor sensitization was
not accompanied by similar elevation of extracellular dopamine con-
centrations. Furthermore, ANA rats showed locomotor sensitization
without increase in extracellular dopamine in the nucleus accumbens
after both challenge treatments. These data suggest that the elevated
locomotor activity after morphine treatment is not caused by the
elevated extracellular concentrations of dopamine in the nucleus
accumbens. The dopamine-independent component mediating loco-
motor activity is supported also by some previous studies (Kalivas
et al., 1983; Cornish et al., 2001). These studies have shown that
increase in locomotor activity after N-methyl-D-aspartate (NMDA) -
antagonists microinjected into ventral tegmental area and enkephalin
analogue D-Ala2-Met5-enkephalinamide (DALA) into nucleus
accumbens are independent of the mesolimbic DA system. Increased
locomotor activity was not affected by dopamine D1-receptor antago-
nists, 6-hydroxydopamine lesions or stimulation of dopamine neurons
inhibiting nociceptin/orphanin FQ receptors in the ventral tegmental
area, and was not due to altered dopamine release or metabolism in the
nucleus accumbens or other dopamine terminal fields.
The present results support earlier findings suggesting the time-
dependent dissociation between the mesolimbic dopamine and opiate
sensitization (Vanderschuren et al., 1999) and reinstatement of drug-
seeking behaviour (De Vries et al., 1998; David et al., 2002; De Vries
& Shippenberg, 2002). In a study by Vanderschuren et al., (1999) the
morphine sensitized locomotor stimulation could not be induced by a
dopamine D2/D3-receptor agonist, quinpirole, after 3 weeks from the
termination of repeated morphine treatment. In another study, rein-
statement of cocaine-seeking and heroin-seeking was obtained with
quinpirole administered during the early phases of withdrawal
(<1 week), but not after longer abstinence (>3 weeks) (De Vries
et al., 1998; De Vries et al., 2002). Similarly, maintenance of morphine
self-administration into the ventral tegmental area was transiently
dependent on D2/D3 receptors (David et al., 2002). In superfused
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striatal slices obtained from repeatedly morphine-treated rats, dopa-
mine release increased gradually above the control values during
the 21-day monitoring session (Tjon et al., 1994). In contrast,
Cadoni & Di Chiara (1999) showed that morphine administered
15 days after withdrawal from repeated morphine treatment caused
a decrease in the extracellular concentration of dopamine in the
nucleus accumbens shell compared to saline-pretreated controls.
Collectively, these results suggest that increased dopamine output
in the nucleus accumbens after repeated opioid administration is
not critically involved in behavioural sensitization and opiate reinfor-
cement after a period of 1–3 weeks.
Our data are consistent also with earlier studies demonstrating that
some genetically distinct rat strains show differential sensitivity to
opioids. A larger dose of morphine was required to induce conditioned
place preference and to produce a significant increase in dopamine
release in the nucleus accumbens in Wistar rats than Sprague–Dawley
rats (Shoaib et al., 1995). Inbred mouse strains have been shown to
have differential responses to morphine-induced locomotor activity,
conditioned place preference and dopamine release in the nucleus
accumbens (Murphy et al., 2001). Nevertheless, no correlation
between morphine-induced locomotion and mesolimbic dopamine
was found between or within inbred mouse strains (C57BL6, 129Sv
and DBA2). In addition, the morphine-induced increase in mesolimbic
dopamine correlated negatively with conditioned place preference in
the previously reported studies (Cunningham & Kelley, 1992). Finally,
interpretation and comparison of sensitization studies is difficult
because the dopaminergic system is sensitive to the specific experi-
mental details of morphine treatment, including morphine dose,
elapsed time between withdrawal and challenge treatment, as well
as the genetic background of experimental animals (Spanagel et al.,
1993; Shoaib et al., 1995; Vanderschuren et al., 1997; Mikkola et al.,
2000; Murphy et al., 2001; Vanderschuren et al., 2001; Mikkola et al.,
2002).
Conclusions
In general, our findings are in good agreement with previous studies,
and indicate that repeated morphine administration is accompanied
with behavioural sensitization and increased extracellular concentra-
tions of dopamine in the nucleus accumbens (Acquas & Di Chiara,
1992; Johnson & Glick, 1993; Spanagel et al., 1993; Cadoni & Di
Chiara, 1999; Vanderschuren et al., 1999). However, as our present
results indicated dissociation between the sensitized responses to
morphine and the extracellular dopamine concentrations in the nucleus
accumbens, we conclude also that a nondopaminergic mechanism is
involved in the observed line differences in sensitization to repeated
morphine treatment. Further studies are needed to clarify the possible
dopamine-independent substrates of opioid sensitization. Theoreti-
cally, the selected AA and ANA lines should differ from each other
only in the trait that was used in selection or traits that are genetically
or otherwise correlated with it (Sinclair et al., 1989). Therefore,
neurobiological mechanisms underlying the differences in sensitiza-
tion to morphine may also contribute to the differences in alcohol
consumption. These aspects make the AA and ANA rat lines a valuable
tool for studying the relationship between sensitization and alcohol
consumption.
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The purpose of the study was to investigate the effects of three different regimens of morphine treatment on subsequent voluntary ethanol
drinking in alcohol-preferring AA (Alko Alcohol) rats. The rats were given morphine subcutaneously either intermittently on alternating days
(1510 mg/kg or 55–20 mg/kg in escalating doses) or subchronically on four consecutive days (3–20 mg/kg/d). Horizontal locomotor
activity was monitored after challenges with additional morphine injections (3 mg/kg) ten days and six weeks after termination of the
pretreatment to test if behavioral sensitization was induced by repeated morphine administration. Both intermittent pretreatments induced
sensitized locomotor response after the first challenge, whereas subchronic injections did not. After the challenge the rats were given a free
choice between tap water and 10% (v/v) ethanol solution for four weeks. The rats pretreated and challenged with morphine did not differ
significantly in the acquisition of ethanol drinking from the saline-treated controls. In contrast, ethanol drinking was impaired during the first
week of ethanol access in the saline-treated rats given a single morphine injection. The second morphine challenge given after the ethanol-
drinking phase did not reveal sensitization in any of the groups. The results suggest that pattern of morphine administration rather than the
dose or number of exposures to the drug is the most important factor in induction of behavioral sensitization, and that exposure to ethanol
may interfere with this process. They also support earlier findings showing that acute morphine may suppress voluntary ethanol drinking, but
failed to provide clear evidence for behavioral sensitization to morphine contributing to predilection towards ethanol in AA rats.
D 2004 Elsevier Inc. All rights reserved.
Keywords: Alcohol; Alcohol preference; Morphine; Opioids; Self-administration; Selected rat lines; Sensitization1. Introduction
Repeated administration of ethanol and other drugs of
abuse results in progressive enhancement of both behavioral
and neurochemical responses to the drug. This phenomenon,
sensitization, is seen as an expression of long-lasting
adaptations in the central nervous system as a result of
repeated exposure to a drug (cf. Robinson and Becker, 1986;
Stewart and Badiani, 1993). Consequently, evidence has
been presented showing that self-administration of drugs of0091-3057/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.pbb.2004.11.012
* Corresponding author. Tel.: +358 9 4744 8111; fax: +358 9 4744
8133.
E-mail address: kalervo.kiianmaa@ktl.fi (K. Kiianmaa).abuse is enhanced in sensitized animals, suggesting that
sensitization may be an important process in the develop-
ment of drug addiction and relapse (Lessov et al., 2001; Lu
et al., 2002; Vezina et al., 2002).
Rodent lines differing in ethanol-related phenotypes,
such as the alcohol-preferring AA (Alko Alcohol) and
alcohol-avoiding ANA (Alko Non-Alcohol) rats selected
by bidirectional breeding for high and low voluntary
consumption of ethanol, respectively (Eriksson, 1968),
have been widely used as tools for identifying behavioral
and neuronal mechanisms underlying addiction to ethanol.
Recent work has demonstrated that alcohol-preferring AA
rats are more susceptible to morphine-induced behavioral
and neurochemical sensitization than alcohol-avoiding
ANA rats (Honkanen et al., 1999; Mikkola et al., 2002;Behavior 80 (2005) 221–228
S.P. Ojanen et al. / Pharmacology, Biochemistry and Behavior 80 (2005) 221–228222Ojanen et al., 2003). This finding suggests that there may
be a linkage between ethanol consumption and liability to
develop sensitization to morphine and possibly to other
drugs of abuse, and raises the question whether sensitiza-
tion is an important mechanism in predilection towards
ethanol drinking in AA rats. Furthermore, it is also in
line with the view that opioidergic mechanisms contribute
to reinforcement from ethanol, and high ethanol prefer-
ence in AA rats (Hubbell et al., 1986; Hyytia¨ and
Kiianmaa, 2001; Hyytia¨ and Sinclair, 1993; Stromberg
et al., 1997).
The relationship between ethanol consumption and
liability to develop sensitization as well as the question
of the effect of sensitization on ethanol self-administration
seems to be rather complex. The finding that locomotor
sensitization was seen in high-alcohol preferring HAP
mice but not in low-alcohol preferring LAP mice after
repeated injections with ethanol suggests that there is
relation between sensitization and ethanol-preference
(Grahame et al., 2000). Such a link was not seen in
ethanol-preferring C57BL/6 and ethanol-avoiding DBA/2J
inbred mice: fewer ethanol exposures were required in
DBA/2Js than in C57BL/6s to express locomotor sensi-
tization (Lessov et al., 2001). Interestingly, ethanol
drinking, however, was increased in C57BL/6 mice but
not in DBA/2J mice after repeated injections of ethanol
suggesting that sensitization to the locomotor stimulant
effects of ethanol may be associated with increased
ethanol intake in mice with high ethanol preference.
One may speculate that morphine-induced sensitization
is also expressed in ethanol-related behaviors such as
ethanol self-administration. Cross-sensitization between the
locomotor stimulant effects of ethanol and those of
morphine has been described (Lessov and Phillips, 2003;
Nestby et al., 1997). There are also both behavioral and
neurochemical data suggesting that opioidergic mecha-
nisms contribute to reinforcement from ethanol and ethanol
self-administration. Self-administration studies have shown
that, ethanol-preferring AA rats and C57BL/6 mice
consume more aqueous solutions of A-opioid receptor
agonists, etonitazene or morphine, than alcohol-avoiding
lines or unselected strains (Belknap et al., 1993; Eriksson
and Kiianmaa, 1971; Hyytia¨ and Sinclair, 1993). More-
over, acute administration of morphine has been shown to
suppress or increase ethanol drinking in rats depending on
the dose, while opioid antagonists can effectively suppress
it (Hubbell et al., 1986; Hyytia¨ and Kiianmaa, 2001; Reid
and Hunter, 1984; Sinclair et al., 1973, 1982). In line with
the behavioral data, neurochemical studies on opioidergic
systems have shown that hypothalamic release of h-
endorphin following exposure to ethanol is markedly
higher in C57BL/6 mice than in DBA/2 mice (De Waele
et al., 1992). Consistently, ethanol elevated the amount of
enkephalin precursor peptide more within the nucleus
accumbens of AA than ANA rats (Nylander et al., 1994).
Furthermore, the distribution of opioid receptors, receptordensity, opioid propeptide mRNA levels, as well as G-
protein coupled receptor function in various nuclei of the
limbic system differs between AA and ANA rats (de
Waele et al., 1995; Gianoulakis et al., 1992; Marinelli
et al., 2000; Soini et al., 2002). Preclinical findings are
supported by data collected from human alcoholics and
subjects from families with a history of alcoholism (cf.
Gianoulakis, 1996; Sinclair, 2001).
Since behavioral sensitization may be associated with
increased drug self-administration in selected rodent lines,
and opioidergic systems seem to contribute to reinforcement
from ethanol in AA rats, we hypothesized that increased
susceptibility to behavioral and neurochemical sensitization
may also be important in their high ethanol consumption.
Therefore, AA rats exposed to different regimens of
morphine treatment were tested for morphine-induced
behavioral sensitization and were then given a free choice
between tap water and alcohol solution for four weeks. The
study evaluated whether the neuroadaptations induced by
repeated morphine administration affect the acquisition of
voluntary alcohol drinking in the alcohol-preferring AA
rats. Since differences have been found between various
morphine treatments in their ability to induce sensitization
(Powell and Holtzman, 2001; Vanderschuren et al., 1997),
our second goal was to examine different regimens of
morphine administration in terms of dosage, temporal
pattern, and length of treatment for producing behavioral
sensitization in AA rats.2. Materials and methods
2.1. Animals
Male alcohol-preferring AA (Alko Alcohol) rats (Alco-
hol Research Centre, National Public Health Institute,
Helsinki, Finland) from generation F84 were used in the
experiments. This rat line together with its counterpart, the
alcohol-avoiding ANA (Alko Non-Alcohol) rats, has been
outbred from a common founder population by bidirec-
tional selection for high and low voluntary alcohol
consumption, respectively (Eriksson, 1968; Sinclair
et al., 1989). The experiments were started with three
months old AA rats that were housed in groups of four
until the measurement of ethanol drinking. Standard
maintenance food (SDS RM1 (E) SQC, Witham, Essex,
England) and water was freely available, except during the
tests for locomotor activity. Ambient temperature was
maintained at 22F1 8C and humidity at 55F10%. The
rats were kept on 12/12 h light cycle (lights on at 06.00
hours), and they were habituated to handling before
starting the experiments. The experiments were performed
in compliance with the European Communities Council
Directive 86/609/EEC and were approved by the Institu-
tional Animal Care and Use Committee at the National
Public Health Institute.
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Morphine–hydrochloride (University Pharmacy, Hel-
sinki, Finland) was dissolved in isotonic saline (0.9% NaCl,
final morphine concentration 3–20 mg/ml). Ethanol (EtOH)
was diluted in tap water for a final solution of 10% (v/v).
2.3. Morphine treatments
Morphine–HCl or saline was administered subcutane-
ously in a volume of 1 ml/kg b.w. according to one of the
following regimens (Table 1). Fifteen injections of saline
were given to saline+saline (SS) and saline+morphine (SM)
groups; injections every other day. Five morphine injections
in escalating doses were given to group intermittent 5
(IM5); injections every other day (day 1: 5 mg/kg, days 3
and 5: 10 mg/kg, days 7 and 9: 20 mg/kg). The rats
belonging to group intermittent 15 (IM15) were given 15
injections of morphine (all 10 mg/kg); injections every other
day. Subchronic group CM received seven morphine
injections; two injections per day except on day 1 when
only one injection was given (day 1: 3 mg/kg, day 2: 23
mg/kg, days 3 and 4: 210 mg/kg). The total amount of
morphine administered was in group IM5 65, in group IM15
150, and in group CM 49 mg/kg. The rats in groups SM,
IM5, IM15, and CM were challenged with saline seven days
(vehicle challenge), and with morphine (3 mg/kg) ten days
(challenge 1, ch1) and six weeks (challenge 2, ch2) after
termination of the repeated injections; the rats in group SS
received three challenge injections of saline. The first
morphine challenge was given ten days after the treatment
to avoid any short-term effects of repeated morphine
administration. Since the sedative effects of morphine and
development of tolerance to them may confuse interpreta-
tion of the results, a morphine dose (3 mg/kg), which is
predominantly stimulatory, was used in the challenges (ch1
and ch2). Repeated injections were given in the home cagesTable 1
The regimens of morphine treatment
Code Pretreatment Vehi
4 days–5 weeks 7 da
pretr
Saline+saline (SS) 15 injections of saline (1 ml/kg) every
second day
salin
Saline+morphine (SM) 15 injections of saline (1 ml/kg) every
second day
salin
Intermittent 5 (IM5) 5 escalating doses of morphine:
day 1: 5 mg/kg, days 3 and 5:
10 mg/kg, days 7 and 9: 20 mg/kg
salin
Intermittent 15 (IM15) 15 equal injections of morphine 10 mg/kg,
every second day
salin
Subchronic (CM) 7 escalating doses of morphine, twice a day:
day 1: 3 mg/kg, day 2: 23 mg/kg, days 3
and 4: 210 mg/kg
salin
All injections were subcutaneous.
EtOH=ethanol.and challenges in the cages used for measuring locomotor
activity. Morphine treatments of different groups were
conducted in such a way that all rats were tested for
sensitization and started and finished their ethanol drinking
within two consecutive days.
2.4. Locomotor activity
The rats were familiarized to handling and treatment
procedures related to measuring of locomotor activity in two
measuring sessions without injections (2 h each) during the
seven-day period between the completion of the repeated
injections and the vehicle challenge session. Horizontal
locomotor activity was measured in transparent plastic cages
(183315 cm3) by using computer controlled photocells
(Cage Rack Activity System, San Diego Instruments, CA,
USA). Ambulatory activity in which the rat blocks two or
more light beams (7 evenly spaced horizontal beams 6 cm
above the base) in rapid succession was used as a
measurement for horizontal locomotion. At the beginning
of the experiment the rats were weighed, placed into activity
cages, and left undisturbed for 15 min to reduce handling-
induced activity. After the challenge injection, horizontal
locomotor activity was recorded at 10-min intervals for 4 h.
Experiments were conducted in a regular colony room with
standard lighting. The same procedures were used in all
challenge sessions.
2.5. Voluntary ethanol drinking
All AA rats used in the experiments were ethanol naRve.
About 5 h after receiving the ch1 injection and about an
hour after the test for locomotor activity, the rats were
placed into single wire mesh cages (213819 cm3) where
food, water and 10% (v/v) ethanol were continuously
available. Two 100-ml drinking tubes containing tap water
or 10% ethanol solution were placed on the front wall of thecle challenge Challenge 1 EtOH drinking Challenge 2
ys after
eatment
10 days after
pretreatment
4 weeks ~6 weeks after
pretreatment
e saline 10% EtOH or water saline
e 3 mg/kg 10% EtOH or water 3 mg/kg
e 3 mg/kg 10% EtOH or water 3 mg/kg
e 3 mg/kg 10% EtOH or water 3 mg/kg
e 3 mg/kg 10% EtOH or water 3 mg/kg
S.P. Ojanen et al. / Pharmacology, Biochemistry and Behavior 80 (2005) 221–228224cage and the left–right position of the tubes was changed
twice a week to avoid any side preference. Ethanol and
water consumption were recorded daily, while measure-
ments for food consumption as well as body weight were
taken twice a week for four weeks.
2.6. Statistical analysis
Ethanol intake (ml) was converted to grams of 100%
ethanol/kg body weight for data analyses. Preference scores
were calculated as a percentage of consumed ethanol (ml) of
the total fluid consumed. Both locomotor activity and
ethanol intake were analyzed with mixed-design, 2-way
analysis of variance (ANOVA) with treatment (SS, SM,
IM5, IM15, CM) as the between-subjects factor and
measuring interval (time) as the within-subjects repeated
measure. After significant main effect of treatment, pairwise
comparisons between the groups were conducted with 2-
factor ANOVAs or between means by using post hoc
Student–Newman–Keuls (SNK) procedure. Criterion for
significance was set at pb0.05.Fig. 2. Effects of morphine (3 mg/kg, s.c.) on locomotor activity in alcohol-
preferring AA rats treated repeatedly with saline or morphine according to
one of the regimens described in Table 1. The rats were challenged with
morphine 10 days (ch1, upper panel) and 6 weeks (ch2, lower panel) after
termination of the sensitizing treatment. *pb0.05, relative to saline group
(SM), Student–Newman–Keuls t-test. Mean photocell countsFS.E.M.,
N=5–8.3. Results
3.1. Locomotor activity
As shown in Fig. 1, locomotor activity of the rats did not
differ between the groups following the vehicle challenge
given seven days after discontinuation of the repeated
injections with morphine [F(4,35)=1.96, p=0.13, for treat-
ment]. When challenged with morphine, there were sig-
nificant differences between the treatment groups after the
first but not after the second morphine challenge [ch1:
F(4,35)=10.22, pb0.001; ch2: F(4,35)=1.48, p=0.23].
Further tests (2-way ANOVA) indicated that after the first1200
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Fig. 1. Locomotor activity in alcohol-preferring AA rats treated repeatedly
with saline or morphine according to one of the regimens described in Table
1. Locomotion was measured for 4 h following a challenge injection with
saline 7 days or morphine (3 mg/kg) 10 days (ch 1) and 6 weeks (ch 2) after
termination of the repeated injections. #pb0.05, relative to saline group
(SS), *pb0.05, relative to SM group, Student–Newman–Keuls t-test. Mean
photocell countsFS.E.M., N=5–8.challenge, all groups given the morphine injection were
activated more than the saline group (SS) [F(1,34)= 19.56,
pb0.001, for ch1 injection morphine vs. saline]. Moreover,
subsequent post hoc analysis (SNK) between the treatment
groups (SS, SM, IM5, IM15 and CM) showed that the
groups that had received intermittent morphine treatment
(IM5 and IM15), were significantly more activated than the
acute morphine group (SM), while the CM group did not
differ from the SM group.
Fig. 2 shows the pattern of locomotor activity during the
morphine challenge sessions. Morphine (ch1, ch2) stimu-
lated locomotor activity in all groups compared with saline
challenged controls across the experiment, 15–210 min after
the injection [ch1: F (1,34)=19.56, pb0.001; ch2:
F(1,34)=5.70, p=0.023, for treatment across the 240-min
period]. The peak of activity in all morphine challenged
groups was recorded approximately 120–150 min after the
injection (ch1). Two-way ANOVAs on pairs of groups of
the first challenge (ch1) showed that the IM5 and IM15 rats
were activated more than the SM [IM5: F(23,253)=4.13,
pb0.001; IM15: F(23,299)=3.82, pb0.001, for treat-
menttime] and CM rats [IM5: F(23,253)=1.76, p=0.019;
IM15: F(23,299)=2.41, pb0.001, for treatmenttime](Fig.
2A). The CM group did not differ from the SM group.
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significant differences among the groups injected with
morphine. Moreover, the activity of SM controls was
compared between the challenges 1 and 2 in order to show
possible residual effect of the previous morphine exposure.Fig. 3. Daily voluntary ethanol drinking in g/kg b.w. (panel A), ethanol
preference (panel B) and total fluid intake (panel C) in alcohol-preferring
AA rats treated repeatedly with saline or morphine according to one of the
regimens described in Table 1. MeansFS.E.M., N=5–8.Significant difference was not found between the challenges
[F(1,7)=1.99, p=0.20, for challenge].
3.2. Voluntary ethanol drinking
Daily consumption of ethanol in g/kg across the 28 days
of the experiment is shown in Fig. 3A. An ANOVA of the
results (28 d) indicated a tendency for differential ethanol
drinking among the groups [F(4,31)=2.50, p=0.063, for
treatment; F(108,837)=1.25, p=0.053, for treatmenttime
interaction]. Hence, a more detailed comparison of the
weekly drinking levels revealed a significant main effect for
treatment [F(4,31)=3.79, p=0.013] during the first week of
ethanol access, but not for the second [F(4,31)=2.18,
p=0.095], third [F(4,31)=2.12, p=0.102] or fourth week
[F(4,31)=1.02, p=0.412]. Therefore, pairwise comparisons
using 2-way ANOVAs with time as the within-subjects
repeated measure were conducted only for the first week
data. These analyses showed that ethanol intake by the SM
group only differed significantly from the SS rats
[F(1,14)=14.65, p=0.02, for treatment]. Moreover, ethanol
intake by the SM rats was also lower than that by the IM5,
IM15 and CM rats [IM5: F(1,12)=6.67, p=0.024; IM15:
F(1,14)=12.378, p=0.003; CM: F(1,15)=8.35, p=0.011, for
treatment].
Fig. 3B shows the average daily ethanol preference
ratios. Ethanol preference reached almost 90% in the SS and
IM5 groups within two weeks and was maintained at this
level thereafter. In contrast, in the SM, IM15, and CM
groups ethanol preference was maintained at 60–80% after
reaching this level. Comparisons of the preference ratios
across the 28 days showed significant main effects for both
treatment [F(4,31)=2.84, p=0.041] and treatmenttime
interaction [F(108,837)=1.72, pb0.001]. Further analysis
of the data between individual groups with 2-factor
ANOVAs with repeated measures on time revealed that
ethanol preference was significantly lower in the SM and
CM rats [SM: F(1,14)=11.20, p=0.005; CM: F(1,14)=7.46,
p=0.016, for treatment] than in the SS rats, showing that the
lower intake of ethanol in SM rats was not only due to
reduced intake of all fluids (Fig. 3C). In fact, total fluid
intake in SM rats increased across the experiment. Fur-
thermore, ethanol preference in the IM5 group was
significantly higher than in the SM group [F(1,11)=5.28,
p=0.042, for treatment].4. Discussion
Repeated administration of various drugs of abuse,
including ethanol and morphine, leads to an increase of
their stimulatory effects; a phenomenon called behavioral
sensitization (Babbini and Davis, 1972; Nestby et al., 1997;
Phillips et al., 1994). It can also be induced by mild stressors
such as isolation or food deprivation (cf. Kalivas and
Stewart, 1991; Marinelli and Piazza, 2002). Interestingly,
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of ethanol and those of morphine has been described
(Lessov and Phillips, 2003; Nestby et al., 1997). There are
also data suggesting that sensitization contributes to the
development of drug addiction and promotes drug-seeking
behavior (Lu et al., 2002; Vezina et al., 2002).
The present study conducted in alcohol-preferring AA
rats showed that intermittent morphine treatments induced
sensitization of locomotor activity, but subsequent acquis-
ition of ethanol drinking behavior was not different from
that in the saline-treated controls. Subchronic treatment with
morphine was unable to either induce behavioral sensitiza-
tion or affect acquisition of ethanol drinking. Furthermore,
none of the groups showed sensitized locomotor response to
morphine when challenged again after four weeks of ethanol
drinking.
According to our results, only the intermittent drug
administration was able to induce sensitization to the
locomotor stimulant effects of morphine in AA rats. The
data are in line with the results published by other authors
suggesting that pattern of exposure rather than the dose
administered is important in the development of behavioral
sensitization (Powell and Holtzman, 2001; Vanderschuren
et al., 1997). Sensitization was evident in animals that were
treated intermittently with morphine (groups IM5 and
IM15). There was no difference in the amount of behavioral
sensitization between the two groups although the total dose
of morphine administered, number of injections as well as
the length of the treatment was lower in the IM5 than in the
IM15 group. Only a tendency for increased activation was
seen in the group CM receiving morphine subchronically,
although similar treatment has been found to produce
behavioral sensitization elsewhere (Powell and Holtzman,
2001). While the total dose of morphine given to the CM
rats was in the same range as in the IM5 rats and the number
of drug exposures was even higher, it cannot be definitely
ruled out that the CM rats were not sensitized because they
did not meet a certain threshold dose of morphine or length
of treatment needed to induce behavioral sensitization.
However, this seems unlikely since previous studies have
shown behavioral and neurochemical sensitization as a
consequence of a single 10 mg/kg morphine injection in rats
(Vanderschuren et al., 2001).
The second challenge with morphine given after four
weeks ethanol drinking and about six weeks after
discontinuation of the pretreatment did not induce a
sensitized response in any of the groups. Our previous
studies showed that behavioral sensitization in AA rats is
very long-lasting, and consequently we expected the rats
to show a sensitized response also in the present study
(Ojanen et al., 2003). In contrast to the previous study, the
rats were here tested for acquisition of ethanol drinking
between the first and second challenge with morphine.
These findings thus raise the possibility that ethanol
drinking following morphine treatment interfered with
the neuronal processes underlying morphine-inducedbehavioral sensitization. In line with this view, Kosten
and Bombace (2000) reported that intraperitoneal injec-
tions of ethanol given during repeated treatment with
morphine attenuated locomotor sensitization to morphine.
Because the same was true in animals receiving morphine
and the noncompetitive N-methyl-d-aspartate (NMDA)
receptor antagonist MK-801, they concluded that ethanol
may alter plasticity effects of repeated morphine admin-
istration because of its NMDA antagonist properties. In
another study, chronic voluntary ethanol drinking sup-
pressed nicotine-induced behavioral sensitization in rats
(Darbra et al., 2004).
It is also possible that environmental conditions, such
as stress caused by isolation housing during the ethanol-
drinking phase, altered neural responses to morphine and
resulted in the attenuation of the sensitized response to the
second challenge in the present experiment. Earlier data
on the interaction between different stressors and sensiti-
zation, however, suggest that stress predominantly
increases morphine-induced locomotion (del Rosario
et al., 2002; Deroche et al., 1994; Sto¨hr et al., 1999).
Therefore, it seems improbable that stress related to
housing or some other environmental conditions can
explain the absence of enhanced behavioral response
during the second challenge.
The idea that sensitization may contribute to ethanol self-
administration has gained support from some recent findings
by other authors. Lessov et al. (2001) showed that C57Bl/6
mice sensitized to ethanol consumed more ethanol than their
saline-treated controls. On the other hand, this did not seem
to be true for ethanol-avoiding animals, since DBA/2J mice
consumed little ethanol despite of sensitization of ethanol-
induced locomotion. Opioidergic mechanisms that have
been implicated in the mediation and modulation of ethanol
reinforcement (cf. Gianoulakis, 2001; Herz, 1997), could
contribute also to enhanced ethanol preference in sensitized
animals. This is suggested by findings showing that
behavioral sensitization to ethanol in mice can be prevented
by co-administration of opioid antagonist naltrexone
(Camarini et al., 2000), and that repeated injections with
morphine may increase ethanol drinking or preference
(Hodge et al., 1992; Volpicelli et al., 1991). These findings
led us to hypothesize that susceptibility to morphine-
induced behavioral sensitization in AA rats is related and
contributes to the acquisition of and the predilection towards
ethanol drinking in AA rats.
In contrast to this hypothesis, our results indicated that
ethanol drinking by the rats treated repeatedly with
morphine was not different from that by the SS controls
whether it was expressed as g/kg/d (IM5, IM15, CM) or as a
preference ratio (IM5, IM15). Acquisition of ethanol
drinking and ethanol preference were, nonetheless, impaired
during the first week in the saline-treated SM rats injected
with morphine only once. The long-lasting suppression of
drinking by the 3 mg/kg morphine dose is surprising
because similar doses have been shown to stimulate
S.P. Ojanen et al. / Pharmacology, Biochemistry and Behavior 80 (2005) 221–228 227locomotor activity in the AA rats in the present and previous
studies (Honkanen et al., 1999) and to increase ethanol
intake (Reid and Hunter, 1984). It should be noted,
however, that the ethanol drinking session started here 6 h
after the acute morphine injection, when the morphine naRve
animals were possibly experiencing aversive after-effects of
morphine administration. These effects may have been
associated with ethanol availability, and therefore the
acquisition of ethanol drinking was delayed in this group
compared with the groups that had received morphine
injections repeatedly and had developed partial tolerance to
the aversive effects.
The failure to see enhancement of ethanol drinking in the
groups sensitized with morphine seems to contradict with
the studies where repeated injections of morphine increased
ethanol intake in rats (Hodge et al., 1992; Stromberg et al.,
1997; Volpicelli et al., 1991). However, the general picture
emerging from these studies is that morphine, whether given
acutely or repeatedly, does not affect acquisition of ethanol
drinking, but increases ethanol drinking during the main-
tenance phase. Besides, the comparison of the previous
studies with our design is difficult, because we do not know
whether repeated morphine administration resulted in
sensitization in them. In any case, our results support the
notion that during initial exposure to ethanol, stimulation of
the endogenous opioid system with repeated morphine
injections does not enhance learning of the reward value of
ethanol. Further studies are warranted to investigate the role
of sensitization in acquired ethanol intake or in intake
stimulated by opioids.Acknowledgements
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Enhanced Morphine-Induced Ethanol Drinking in Alcohol-
Preferring Alko Alcohol Rats Sensitized to Morphine
Sami P. Ojanen, Petri Hyytia¨, and Kalervo Kiianmaa
Background: Alcohol-preferring alko alcohol (AA) rats are more susceptible to morphine-
induced behavioral and neurochemical sensitization than alcohol nonpreferring alko nonalcohol
(ANA) rats. Alko alcohol rats sensitized to morphine, however, do not show enhanced acquisition of
ethanol drinking. The purpose of the present study was to clarify further interactions between mor-
phine-induced behavioral sensitization and voluntary ethanol drinking in the AA rats.
Methods: Alko alcohol rats drinking ethanol in a limited 6-hour access paradigm were sensitized
to morphine with repeated injections of morphine (5–15 mg/kg). Injection days alternated with days
of ethanol access. Controls had access only to water and/or were given injections of saline. After a
5-day washout period from ethanol and morphine, the rats were challenged with morphine or saline
and subsequent ethanol drinking or locomotor activity was recorded.
Results: Ethanol intake was suppressed during the repeated treatment with morphine, and the
morphine-treated rats did not differ in ethanol intake from the controls when given access to ethanol
after the washout. Intake of ethanol was, however, increased when the rats were challenged with
morphine [1 or 10 mg/kg, subcutaneously (s.c.)], while in the controls an increase in ethanol intake
was seen only after 1 mg/kg morphine. Sensitization to the locomotor stimulating effects of morphine
was revealed in the morphine-treated rats after a challenge with morphine (3 or 10 mg/kg, s.c.). The
controls that had been drinking ethanol also showed a sensitized response after morphine (3 mg/kg).
Conclusions: Ethanol did not interfere with the development of sensitization to morphine. Fur-
thermore, the neuroadaptations induced by repeated exposure to ethanol were sufﬁcient to cause
behavioral cross-sensitization to morphine. Sensitization to the behavioral effects of morphine alone,
however, neither enhances the reinforcing properties of voluntarily consumed ethanol nor contributes
to increase in its intake. The increase in ethanol intake found after an acute dose of morphine was
augmented in rats withdrawn from repeated treatment with morphine. The data suggest that the
neuronal mechanisms underlying behavioral sensitization to morphine probably are distinct from
those mediating reinforcement from ethanol and that the morphine-induced neuroadaptations con-
tribute to the enhancement of increase in ethanol intake by morphine.
Key Words: Ethanol, Opioids, Selected Lines, Self-administration, Sensitization.
BEHAVIORAL SENSITIZATION IS a manifestationof long-term adaptations in the central nervous sys-
tem (CNS) induced by repeated administration of drugs
of abuse (Phillips et al., 1997; Pierce and Kalivas, 1997;
Stewart and Badiani, 1993; Vanderschuren and Kalivas,
2000). It has been consistently demonstrated in experimen-
tal animals, and there is increasing evidence supporting its
importance in the development of drug addiction (Lessov
et al., 2001; Lett, 1989; Morgan and Roberts, 2004; Vezina
et al., 2002). Interestingly, repeated administration of one
drug can induce cross-sensitization to another drug, and
therefore the drug-induced neuroadaptive changes in the
CNS possibly promote development of addiction to a sec-
ond substance (see e.g., Lessov and Phillips, 2003; Vezina
and Stewart, 1990).
Selectively bred and inbred rodent lines differing in
ethanol-related phenotypes have been widely used to iden-
tify the neuronal mechanisms underlying drug and ethanol
abuse (for a review, see McBride and Li, 1998). Bidirec-
tionally outbred high ethanol drinking alko alcohol (AA)
and low drinking alko nonalcohol (ANA) rats, developed
in this laboratory, are among these line pairs (Eriksson,
1968). Alko alcohol and nonalcohol rats have been shown
to differ in their susceptibility to morphine-induced beha-
vioral and neurochemical sensitization (Honkanen et al.,
1999; Mikkola et al., 2002; Ojanen et al., 2003). Alko
alcohol rats treated repeatedly with morphine were more
susceptible than ANA rats to morphine-induced locomo-
tor activity, rotational behavior, and mesolimbic
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dopaminergic neurotransmission. In theory, the selection
for high and low ethanol drinking should create differ-
ences in other traits than the selected ones only when they
are genetically or otherwise related to the selected trait
(Bergstrom et al., 2003; Sinclair et al., 1989). Conse-
quently, we have speculated that increased susceptibility
to morphine-induced sensitization in AA rats compared
with ANA rats may be a reﬂection of functional differenc-
es in their opioidergic systems and may further contribute
to their differential ethanol self-administration behavior.
This hypothesis would also predict enhanced ethanol rein-
forcement in AA rats sensitized to morphine.
A role for opioidergic systems in differential drinking
between the AA and ANA lines of rats has been suggested
by some earlier ﬁndings. For instance, AA rats consume
more aqueous solution of a m-opioid receptor agonist,
etonitazene, than ANA rats (Hyytia¨ and Sinclair, 1993).
In line with the behavioral data, neurochemical studies on
opioidergic systems have shown that ethanol elevated the
amount of enkephalin precursor peptide more within the
nucleus accumbens of AA rats than ANA rats (Nylander
et al., 1994) and that the distribution of opioid receptors,
receptor density, opioid propeptide mRNA levels, as well
as G-protein-coupled receptor function in various nuclei
of the limbic system differ between AA and ANA rats
(Gianoulakis et al., 1992; Marinelli et al., 2000; Soini
et al., 2002; de Waele et al., 1995).
Further support for the involvement of opioidergic sys-
tems in ethanol-related behaviors comes, on the one hand,
from self-administration studies that have shown mor-
phine given in low doses to increase, and in high doses to
attenuate ethanol drinking (Critcher et al., 1983; Hubbell
et al., 1993; Linseman and Harding, 1990; Sinclair, 1974;
Sinclair et al., 1973; Stromberg et al., 1997; Vacca et al.,
2002; Volpicelli et al., 1991; Wild and Reid, 1990) and that
blockade of opioid receptors with nonselective antagonists
or antagonist selective to either m-opioid or d-opioid
receptors suppresses ethanol consumption. (Coonﬁeld
et al., 2004; Hyytia¨ and Kiianmaa, 2001; Koistinen et al.,
2001). Conversely, ethanol-induced locomotion in mice
seems to be related to the ability of ethanol to release
b-endorphins and to activate m-opioid receptors (Sanchis-
Segura et al., 2004).
However, little is known about the relationship between
ethanol consumption and liability to develop sensitization
as well as the effect of sensitization on ethanol self-admin-
istration. The ﬁnding that locomotor sensitization was
seen in high-alcohol-preferring HAP mice but not in
low-alcohol-preferring LAP mice after repeated injections
with ethanol supports the idea of a relationship between
sensitization and ethanol preference (Grahame et al.,
2000). Such a link was, however, not seen in ethanol-
preferring C57BL/6 and ethanol-avoiding DBA/2J inbred
mice: fewer ethanol exposures were required in DBA/2Js
than in C57BL/6s to express locomotor sensitization
(Lessov et al., 2001). Interestingly, ethanol drinking was
increased in C57BL/6 mice but not in DBA/2J mice after
repeated injections of ethanol suggesting that sensitization
to the locomotor stimulant effects of ethanol may be asso-
ciated with increased ethanol intake in mice with high
ethanol preference.
The present experiments assessed interactions between
behavioral sensitization to morphine and ethanol drinking
in alcohol-preferring AA rats. In an earlier study, where
AA rats sensitized to morphine were given access to
ethanol, contribution of sensitization to morphine to the
acquisition of ethanol drinking could not be demon-
strated, which was against our hypothesis (Ojanen et al.,
2005). Ethanol has, however, been found to alter m-opioid-
induced locomotor activity and attenuate locomotor
sensitization to morphine, suggesting a complex inter-
action between ethanol and morphine (Kosten and Bomb-
ace, 2000; Milton et al., 1995). This raises the possibility
that consumption of ethanol interfered with the neuronal
processes underlying morphine-induced behavioral sensi-
tization, and the effects of sensitization on subsequent
ethanol drinking were suppressed. Therefore, our ﬁrst goal
was to see whether ethanol self-administration affects
development of behavioral sensitization to morphine in
AA rats. This was evaluated by studying development of
sensitization to the locomotor-stimulant effects of mor-
phine in AA rats that were drinking ethanol in a limited
6-hour free-choice paradigm. Our second goal was to
investigate if sensitization to the behavioral effects of mor-
phine alters subsequent ethanol drinking in AA animals
showing a stable baseline of ethanol intake in the
paradigm above. As stimulation of opioid receptors with
morphine seems to modify the reinforcing properties of
ethanol and increases its intake, a group of rats was also
challenged with additional doses of morphine before
giving them access to ethanol (Colombo et al., 2004; Ulm
et al., 1995).
MATERIALS AND METHODS
Animals
Five-months-old, male alcohol-preferring AA rats (Alcohol
Research Centre, National Public Health Institute, Helsinki,
Finland) from generation F87 were used in the study. The rats were
housed in a single wire mesh cages (21 cm38 cm19 cm) and had
free access to standard maintenance food [SDS RM1 (E) SQC,
Witham, Essex, UK] and tap water. Ambient temperature was
22  1 1C and humidity was 55  10%. The light cycle was 12/12
hours (lights on at 06:00 hours). The experiments were conducted
during the light period of the cycle starting at 09:00 hours. The studies
were performed in accordance with the European Communities
Council Directive (86/609/EEC) and were approved by the Institu-
tional Animal Care andUse Committee at the National Public Health
Institute and the Chief Veterinarian of County Administrative Board.
Procedures
Drugs. Ethanol (Etax A, 96% v/v, Altia, Rajama¨ki, Finland)
was diluted in tap water for a ﬁnal solution of 10% (v/v). Mor-
phine-hydrochloride (University Pharmacy, Helsinki, Finland) was
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dissolved in isotonic saline (0.9% NaCl, Baxter International Inc.);
ﬁnal morphine concentration was 5 to 15 mg/mL.
Ethanol Drinking. Two 100-mL drinking tubes containing water
or 10% (v/v) ethanol were placed on the front wall of the cage, and
the left–right position of the tubes was changed 3 times a week to
avoid any side preference. Consumption of both liquids was record-
ed daily as a volume change, while measurements for food consump-
tion (by weighing the food pellets before and after addition) and
body weight were taken twice a week. After 4 weeks the availability
of ethanol was limited to 6 hours a day (09:00–15:00 hours), 3 times a
week. Twelve sessions of limited access were carried out to ensure a
stable level of ethanol drinking. Ten minutes before the session, 13
the rats were given a subcutaneous injection of saline (vehicle chal-
lenge 1) to test the effect of vehicle administration on ethanol intake.
Water was freely available throughout the experiments. The proce-
dure is described in Table 1.
Locomotor Activity. Experiments were conducted in a quiet room
with standard lighting. The rats were weighed, placed into
activity cages, and left undisturbed for 10 minutes to reduce
handling-induced activity before recording of locomotor activity.
Horizontal locomotor activity was measured in transparent plastic
cages (18 cm33 cm15 cm) with computer controlled photocells
(Cage Rack Activity System, San Diego Instruments, San Diego,
CA). Blockade of 2 light beams (7 horizontally located beams 6 cm
above the ﬂoor of the cage) in rapid succession was counted as 1 unit
of ambulatory horizontal locomotion. Activity was recorded for 4
hours after challenge injections of saline or morphine.
Experimental Design
The investigation consisted of 2 experiments run in parallel. The
purpose of the ﬁrst experiment (Experiment 1) was to verify that the
repeated morphine treatment used here induces robust and long-
lasting behavioral sensitization and to observe any interactions with
ethanol drinking. The second experiment (Experiment 2) examined
the effects of repeated administration of morphine on ethanol
drinking.
Experiment 1: Behavioral Sensitization
Acquisition of Ethanol Drinking. The regimens of ethanol and
morphine treatment are summarized in Table 1. Half of the 30
rats used in this experiment were trained to drink ethanol in a lim-
ited 6-hour 2-bottle-choice paradigm. After establishing a stable
base of ethanol drinking the rats were divided into 2 groups
(ethanol1saline, ES; ethanol1morphine, EM) matched according
their ethanol consumption over the last 5 training sessions (sessions
8–12). The remaining half of the animals (2 groups, water1saline,
WS; water1morphine, WM) had tap water as the only drinking
solution at all times, but were otherwise treated as groups ES and EM.
Repeated Treatment with Morphine. Starting 3 days after the
vehicle challenge the rats were injected with morphine or vehicle
every other day (Tuesday, Thursday, and Saturday), 5 injections in
total. The injections were given subcutaneously in a volume of 1
mL/kg. Groups WM and EM received morphine in escalating doses
(day 1, 5 mg/kg; days 3 and 5, 10 mg/kg; days 7 and 9, 15 mg/kg),
while groups WS and ES were treated with saline. Ethanol
solution was accessible for 6 hours on intervening days
(Monday, Wednesday, and Friday) for ES and EM rats. Sunday
was a drug-free day. The morphine treatment regimen was based on
our previous work (Ojanen et al., 2005), which was modiﬁed from
the study by Powell and Holtzman (2001). After the pretreatment
period the rats were abstained from both morphine and ethanol
for 5 days to minimize any carryover effects of the drugs. During
the washout period the rats were ﬁrst familiarized with the equip-
ment used in the measurement of locomotor activity in 2 sessions
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(2 hours each) without giving them any injections and were then put
through a 4-hour session including an injection with vehicle (vehicle
challenge 2).
Sensitized Animals. After the washout period, the animals were
challenged twice with morphine. All rats were administered 3 mg/kg
morphine (Challenge 1), and locomotor activity was measured for 4
hours. The second challenge with morphine (10 mg/kg) (Challenge 2)
was given after another washout period of 5 days, and locomotion
was measured again for 4 hours. One rat from the WM group died
before the second challenge and therefore Challenge 2 was conducted
with 29 animals.
Experiment 2: Voluntary Ethanol Drinking
This experiment explored ﬁrst maintenance of ethanol drinking in
the limited access paradigm during repeated treatment with mor-
phine and then ethanol intake in the same paradigm after discontin-
uation of the repeated treatment with morphine with or without a
challenge with morphine. The regimens of ethanol and morphine
treatment are summarized in Table 1.
Acquisition of Ethanol Drinking. After establishing a stable base-
line of ethanol drinking 48 rats were divided into 6 equally drinking
groups matched according to their ethanol consumption over the last
5 limited access sessions (sessions 8–12).
Repeated Treatment with Morphine. Three groups (24 rats)
(groups: morphine1saline, MS; morphine1morphine1, MM1; mor-
phine1morphine10, MM10) were sensitized to morphine, and the
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100
300
500
700
Lo
co
m
ot
or
 a
ct
iv
ity
 (c
ou
nt
s/4
h)
*
**
***
*
Water+Saline
Water+Morphine
Ethanol+Saline
Ethanol+Morphine
Fig. 1. Locomotor activity in alcohol-preferring alko alcohol rats treated
repeatedly with morphine. Locomotion was measured for 4 hours following a
challenge injection of morphine, 3 or 10 mg/kg subcutaneously, given 5 and 10
days, respectively, after termination of the repeated treatment with morphine.
po0.05, po0.01, relative to the water1saline group, 1-way analysis of
variance. Mean photocell counts  SEM. are given, N5 7 to 8/group.
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Fig. 2. Effects of repeated administration of morphine on voluntary ethanol
drinking by alcohol-preferring alko alcohol rats. The rats trained to drink
ethanol in a limited 6-hour 2-bottle-choice paradigm were treated with saline
or escalating doses of morphine (5–15 mg/kg, subcutaneously), given every
other day, and ethanol intake was measured on the intervening days. Groups
SS, SM1, and SM10 were given saline, and groups MS, MM1, and MM10
received morphine. BL, baseline, po0.01, po0.001, 1-way analysis of
variance for treatment. Although individual groups are depicted separately in
the figure, the statistical analysis on differences is given between all saline-
and morphine-treated rats (n5 24/treatment). Means  SEM. are given.
Table 2. Intake of Ethanol and Water in Experiment 2.
Group
Continuous
ethanol (24 h)
Limited
ethanol (ethanol 6 h/
water 24 h) Vehicle
challenge (6 h)
Morphine
last (6 h)
Morphine
challenge (6 h)
Day(s) 1 28–32 34 52–61 63 77 82
Ethanol intake (g/kg) SS 1.8  0.2
SM1 1.9  0.1 2.4  0.1
SM10 1.6  0.3 5.7  0.2 1.1  0.1 1.8  0.1 1.6  0.1 1.6  0.1
MS 1.2  0.1
MM1 0.7  0.1 2.6  0.2
MM10 3.6  0.4
Water intake (mL/kg) SS 2.7  0.5
SM1 6.1  0.9 2.6  0.9
SM10 37.7  2.8 8.9  1.8 54.6  1.9 51.9  1.8 3.8  0.4 6.6  5.2
MS 3.0  0.9
MM1 2.8  0.7 1.3  0.9
MM10 7.1  5.0
Days 52–61 correspond to limited ethanol access sessions 8–12.
Morphine last, the session after the last morphine injection.
po0.05,
po0.01, and
po0.001, compared with saline-treated rats/SS rats (1-way ANOVA/Dunnett’s t test) means  SEM.
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remaining 3 groups (24 rats) (groups: saline1saline, SS; saline1
morphine1, SM1; saline1morphine10, SM10) were treated with
saline. The regimen of morphine treatment was the same used in
Experiment 1.
Sensitized Animals. Following the repeated treatment with mor-
phine, the rats were challenged with an additional injection of mor-
phine or saline after abstaining them from both morphine and
ethanol for 5 days. Groups SM1, SM10, MM1, and MM10 were
injected with either 1 or 10 mg/kg morphine (M1 for 1 mg/kg; M10
for 10 mg/kg), and the rats in groups SS andMS rats with saline. The
tubes containing ethanol were introduced 10 minutes later and con-
sumption of ethanol and water was recorded every 30 minutes for the
ﬁrst 2 hours and then every 60 minutes for 4 more hours.
Statistical Analysis
Locomotor activity scores were analyzed with 3-way analysis of
variance (ANOVA) with repeated measures over time with ethanol
access (water or ethanol) and morphine pretreatment (saline or mor-
phine) as independent factors. Ethanol intake (mL) was converted
into grams of 100% ethanol/kg body weight for data analyses. Pref-
erence scores were calculated as a percentage of the amount of
ethanol consumed (mL) of the total ﬂuid amount consumed.
Ethanol intake was analyzed with mixed-design, 3-way ANOVA
with pretreatment (saline, morphine), treatment (SS, MS, SM1,
SM10, MM1, MM10), and/or morphine dose (0, 1, 10 mg/kg) as the
between-subjects factor and measuring interval (time) as the within-
subjects repeated measure. After significant interactions, simple
effects comparisons between groups were performed with 1-way or
2-way ANOVA. Dunnett’s 2-sided t test or Tukey’s honestly signif-
icant difference test (Tukey’s HSD) were used as a post hoc analysis
where appropriate. Criterion for significance was set at po0.05.
RESULTS
Experiment 1: Behavioral Sensitization
Acquisition of Ethanol Drinking. The ES and EM
groups of rats drank ethanol on average 1.8 and 0.6 g/kg/
6 h, respectively, during their last ethanol drinking session
before the morphine treatment was started (session 12).
The consumption was comparable with the similarly
treated rats in the second experiment (1.9 and 0.7 g/kg,
respectively, Table 2).
Sensitized Animals. Figure 1 shows the effect of mor-
phine administration on locomotor activity in repeatedly
morphine- or saline-treated AA rats. Repeated treatment
with morphine induced sensitization to the locomotor-
stimulating effects of morphine demonstrated as increased
activity when the rats were challenged with 10 mg/kg mor-
phine [F(1, 25)5 18.90, po0.001, for pretreatment]. An
additional ANOVA performed between the treatment
groups (WS, WM, ES, EM) [Challenge 1: F(3, 26)5 3.10,
p5 0.04; Challenge 2: F(3, 25)5 6.66, p5 0.002, for treat-
ment] indicated that the challenge with 3 mg/kg morphine
increased locomotor activity more in both of the mor-
phine-treated groups (WM, EM) as well as in the
ethanol-drinking saline-treated rats (ES) than in the
water-drinking saline-treated controls (WS) (po0.05).
The second challenge with morphine (10 mg/kg) also
produced a sensitized response in locomotion in the
morphine-treated animals (WM, EM), but the saline-treated
groups (WS, ES) did not differ in the effect of morphine.
There were no significant differences in locomotor activity
between the morphine-treated groups (WM, EM) after
either of the challenge doses of morphine.
Experiment 2: Ethanol Drinking
Acquisition of Ethanol Drinking. Table 2 depicts the
average ethanol and water intake in animals having
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Fig. 3. Effect of a challenge dose of morphine on ethanol intake (g/kg/6 h)
by alcohol-preferring AA rats treated repeatedly with morphine. Five days
after discontinuation of the morphine treatment the rats were administered
subcutaneously with 0, 1, or 10 mg/kg morphine and given a choice
between water and 10% (v/v) ethanol for 6 hours. po0.05, p  0.001,
relative to corresponding control group injected with saline (0), Dunnett’s
t test. #po0.05, ### po0.001, Tukey’s HSD. Means  SEM. are given, N5 6/
group for morphine challenged rats and 12/group for the saline controls.
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Fig. 4. Cumulative ethanol intake by alcohol-preferring alko alcohol rats
treated repeatedly with morphine. Five days after discontinuation of the mor-
phine treatment the rats were administered subcutaneously with 0, 1, or 10
mg/kg morphine and given a choice between water and 10% (v/v) ethanol for
6 hours. Ethanol intake was recorded every 30 minutes for the first 2 hours
and then hourly for 4 more hours. N5 6 per group for morphine challenged
rats and 12 per group for the saline controls.
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continuous or limited access to ethanol. Ethanol consump-
tion rapidly increased from 1.6 g/kg (day 1) to 5.7 g/kg
(average of days 28–32), and preference ratio from 35% to
89%, respectively, when ethanol was available 24 h/d.
During the last 5 sessions (sessions 8–12) of limited access
to ethanol, average intake was 1.8 g/kg. Challenging the
rats with a vehicle injection, given 10 minutes before
session 13, did not modify ethanol intake; average ethanol
intake was 1.6 g/kg. There were no significant differences
between the groups.
Repeated Treatment with Morphine. Ethanol intake
during intervening days was significantly decreased by
the repeated injections of morphine (Fig. 2). Two-way
ANOVA revealed significant effects for pretreatment
(saline or morphine) on ethanol drinking [F(1, 46)5
54.85, po0.001] and for timepretreatment interaction
[F(4, 184)5 19.84, po0.001]. Simple effects analysis
showed that morphine-treated rats drank less ethanol
after both 10 and 15 mg/kg morphine, but the initial dose
of 5 mg/kg morphine did not affect ethanol intake. Water
intake was similarly suppressed during the repeated
morphine treatment [F(1, 46)5 11.22, p5 0.002, for pre-
treatment] (Table 2) as well as food intake [F(1, 46)5
82.06, po0.001, for pretreatment].
Sensitized Animals. Ethanol drinking after discontinua-
tion of the repeated treatment with morphine is given in
Figs. 3 and 4. Morphine-treated rats challenged with saline
(MS) did not differ in ethanol drinking from the
SS controls (Fig. 3). The challenges with morphine,
however, dose-dependently increased ethanol drinking
[F(1, 48)5 9.20, p5 0.004, for pretreatment; F(2, 48)5
17.25, po0.001, for pretreatment  dose interaction].
The morphine-treated groups challenged with 1 (MM1)
or 10 mg/kg (MM10) morphine drank significantly more
ethanol than the controls (MS) (p5 0.002, po0.001,
respectively), and the MM10 rats consumed more than
the MM1 (p5 0.041) or SM10 (po0.001) rats. Ethanol
intake by the saline-treated groups (SS, SM1, SM10) was
also modiﬁed by morphine [F(2, 21)5 4.01, p5 0.033, for
treatment]. Post hoc analysis revealed that the SM1 rats
drank more ethanol than the SS animals (p5 0.043), while
the SM10 group did not differ from the controls. In contrast
to what was found during the repeated treatment with
morphine, there were no differences in water consumption
[F(5, 42)5 0.89, p5 0.50, for treatment] among the groups.
Cumulative data on ethanol intake show that the drink-
ing pattern of the morphine-treated rats was different from
that of others; they consumed more ethanol at the begin-
ning of the session and started their next drinking bout
sooner than the animals in other groups. In fact, the
increase in drinking during the ﬁrst 30 minutes and again
at about 2 hours may have been limited by ethanol-induced
incapacity of rats to drink more. Morphine increased
ethanol drinking in the MM1 group up to 2 hours of access
to ethanol, while in the MM10 group maximal level of
ethanol intake was not reached until at 4 to 5 hours (Fig. 4).
Although the amount of ethanol drank by MM10 rats dur-
ing the ﬁrst 30 minutes of the session was only moderately
higher than by, e.g., SS rats, it was notable that MM10
animals consumed ethanol in a shorter period of time than
rats in other groups, and in contrast to SS or SM10 rats they
were clearly intoxicated (personal observations). The drink-
ing pattern of the SM1 rats was very similar to that of the
MM1 rats, but ethanol drinking by the SM10 group was
suppressed initially and tended to recover at 5 to 6 hours.
DISCUSSION
The current studies demonstrated that alcohol-prefer-
ring AA rats sensitized to morphine do not show
augmented intake of ethanol, but a challenge dose of
morphine increases their ethanol drinking. Furthermore,
rats that had been drinking ethanol showed enhanced
locomotor activation for morphine administration.
Behavioral sensitization to morphine did not contribute
to the acquisition of ethanol drinking in AA rats in our
previous study (Ojanen et al., 2005). Thus, in the present
study, we investigated the effects of repeated administra-
tion of morphine on ethanol drinking during the treatment
as well as after discontinuation of the treatment in rats
with a history of voluntary ethanol intake. In agreement
with earlier ﬁndings, ethanol drinking was significantly
attenuated in animals administered with high, 10 or 15 mg/
kg, doses of morphine the day before (Fig. 2). The
suppression was long lasting, as intake of ethanol in the
morphine-treated animals had not completely recovered to
the control level when the rats were reexposed to ethanol
and morphine after 5 days of abstinence from both of the
drugs (Table 2). In parallel to reduced ethanol drinking,
consumption of water and food were also attenuated,
demonstrating the ability of morphine to impair all con-
summatory behaviors, as has been found earlier in both
rodents and humans (Hubbell et al., 1993; Stromberg
et al., 1997; Yeomans and Gray, 2002).
When the morphine-sensitized rats were challenged with
saline (MS) and exposed to ethanol 5 days after discontin-
uation of the treatment, they did not differ from the saline
controls (SS) in ethanol intake. These data, together with
our earlier ﬁndings, suggest that sensitization of AA rats to
morphine does not promote their ethanol intake. This
ﬁnding is in contrast to our hypothesis and indicates that
sensitization does not contribute to reinforcement from
voluntarily consumed ethanol. However, there is evidence
that psychostimulant or morphine-induced sensitization
promotes drug-seeking behavior and augments self-
administration (Lu et al., 2002; Vezina et al., 2002).
Furthermore, ﬁndings showing cross-sensitization between
the locomotor stimulant effects of ethanol and those of
morphine suggest that the neuroadaptive changes induced
by a drug possibly promote development of addiction to the
other substance (Lessov and Phillips, 2003; Nestby et al.,
1997; Vezina and Stewart, 1990). Indeed, amphetamine-
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sensitized rats were found to consume significantly more
ethanol than the saline-treated controls following a
3-month drug-free interval (Fahlke et al., 1994). However,
in line with our studies, cocaine-induced sensitization did
not modify either the acquisition or the maintenance of
ethanol drinking in Wistar-derived hyperactive and hyper-
tensive rat strains (Cailhol and Morme`de, 2000). It
remains to be seen whether the discrepancies among the
studies are related to differences in methodological issues
or in the mechanisms mediating reinforcement from
different drugs.
The failure to see changes in ethanol intake in rats sen-
sitized to the behavioral effects of morphine may point to
dissociation between locomotor sensitization and the
reinforcing properties of ethanol. The reinforcing proper-
ties of ethanol, morphine as well as other drugs of abuse
are thought to involve mainly the mesolimbic dopamine
pathway, but locomotor sensitization to morphine in AA
and ANA rats may also depend upon m-opioid receptor–
mediated modulatory mechanisms in nuclei belonging to
the nigrostriatal dopamine pathway. For instance, activa-
tion of m-opioid receptor regulated G-proteins in the subst-
antia nigra and dopamine terminal areas have been shown
to correlate positively with morphine-induced locomotor
activation in AA rats (Soini et al., 2002), and behavioral
sensitization to morphine augments dopamine transmis-
sion also in the nigrostriatal dopamine pathway more in
AA than in ANA rats (Mikkola et al., 2000, 2002).
When challenged with 1 mg/kg morphine, ethanol
drinking was increased in a similar manner in both the
saline-treated (SM1) and the morphine-treated (MM1)
rats. The increase in ethanol intake after administration
of morphine is consistent with earlier studies showing that
low acute doses of morphine (1–2.5 mg/kg) increase sub-
sequent ethanol drinking (Hubbell et al., 1993; Stromberg
et al., 1997; Vacca et al., 2002; Wild and Reid, 1990). It has
been speculated that this could be explained in terms of
morphine functioning as a primer for ethanol drinking by
stimulating the mesolimbic dopamine system and priming
it for further stimulation by consumed ethanol (Colombo
et al., 2004; Ulm et al., 1995).
The higher challenge dose of morphine (10 mg/kg) fur-
ther augmented ethanol intake in the morphine-treated
rats (MM10), but the saline-treated animals did not differ
from the ones challenged with the vehicle. The increased
drinking of ethanol by the morphine-treated rats might be
explained by morphine functioning as a primer, as above,
and by development of tolerance to the sedative effects of
morphine, while lack of tolerance probably was respon-
sible for the controls not showing increased ethanol intake.
Tolerance is, however, an unlikely explanation for facili-
tated ethanol drinking, as similar doses of morphine
suppressed ethanol drinking during repeated administra-
tion of morphine. One may therefore postulate that it
reﬂects neuroadaptations related to behavioral sensitizat-
ion to morphine. According to this view, the effects of
morphine that augment ethanol’s intake and possibly its
rewarding properties in morphine-naı¨ve animals are
enhanced in the rats sensitized to morphine and contrib-
ute to a further increase in ethanol consumption. An
example of a possible mechanism contributing to such an
increase has recently been given by Tang et al. (2005), who
suggested that opioidergic transmission in the ventral pal-
lidum is a critical mediator of reinstatement of cocaine
seeking. They found that stimulation of m-opioid receptors
with a low intracerebral dose of morphine in the ventral
pallidum reinstated cocaine-seeking behavior, while higher
doses had no effect. They speculated that neuroadapta-
tions augmented the ability of morphine to reduce extra-
cellular g-aminobutyric acid in the ventral pallidum in
animals withdrawn from chronic cocaine, which may be a
necessary condition for reinstatement of cocaine seeking to
occur. Similarly, keeping in mind that neurobehavioral
changes induced by morphine and ethanol may both be
mediated by activation of m-opioid receptors (cf. Johnson
and Napier, 2000; Sanchis-Segura et al., 2004), it is temp-
ting to speculate that repeated treatment with morphine
and ethanol had induced neuroadaptations in signaling
through m-opioid receptors that were expressed as
increased ethanol drinking when ethanol-deprived animals
were challenged with morphine and given access to
ethanol.
Ethanol may alter the plasticity effects of morphine
administration: it has been shown to attenuate morphine-
induced locomotor sensitization and disrupt morphine
discrimination (Kosten and Bombace, 2000, 2001). Here,
repeated treatment with morphine induced locomotor sen-
sitization in alcohol-preferring AA rats that were drinking
ethanol on intervening days (Ojanen et al., 2003, 2005),
with no evidence of ethanol interfering with sensitization
process. The stimulatory effect of morphine did not differ
between ethanol and water drinking animals (WM vs EM).
This may be related to the manner of ethanol exposure;
days of morphine administration and ethanol drinking
were alternating in the present study, while in the study by
Kosten and Bombace (2000) rats were injected with
ethanol 30 minutes before or 120 minutes after adminis-
tration of morphine.
Interestingly, the ethanol-drinking rats (ES) that had
been treated with saline but had had access to ethanol
showed a response in locomotor activity similar to that of
the morphine-treated groups (WM and EM) when chal-
lenged with 3 mg/kg morphine. This suggests that the
ethanol-drinking rats had been cross-sensitized to mor-
phine. In agreement with this view, repeated treatment of
ethanol has been reported to enhance the locomotor
effects of morphine in rats 3 weeks posttreatment (Nestby
et al., 1997). Cross-sensitization to morphine was, howev-
er, not found in mice that had been sensitized to the
stimulatory effect of ethanol (Fish et al., 2002; Lessov and
Phillips, 2003). Augmented locomotion was not seen here
in the saline-treated ES rats after the higher 10 mg/kg dose
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of morphine. Unlike the morphine-treated animals, these
rats could not develop tolerance to the sedative effects of
morphine, and consequently there is the possibility that
the sedative effects of morphine may have masked the
expression of morphine-induced stimulation.
Three major conclusions may be drawn from the present
results. First, ethanol did not interfere with the develop-
ment of sensitization to the locomotor stimulatory effects
of morphine in alcohol-preferring AA rats. Furthermore,
rats having had limited access to ethanol showed enhanced
locomotor effects of morphine, indicating that neuro-
adaptations induced by repeated exposure to ethanol were
sufﬁcient to cause behavioral cross-sensitization to mor-
phine. Second, sensitization of AA rats to the behavioral
effects of morphine alone neither enhances the reinforcing
properties of voluntarily consumed ethanol nor contrib-
utes to increase in its intake. Therefore, the neuronal
mechanisms underlying behavioral sensitization to mor-
phine probably are distinct from those mediating ethanol
reinforcement. Third, the increase in ethanol intake
found after an acute dose of morphine is augmented in
rats withdrawn from repeated treatment with morphine.
This suggests that the neuroadaptations induced
by repeated treatment with morphine further enhance the
reinforcement from ethanol when challenged with mor-
phine and that the mechanisms contributing to the
increase in ethanol drinking require stimulation with
morphine.
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ABSTRACT 
 
Glutamate and γ-amino-butyric acid (GABA) have been implicated in neuronal plasticity related to 
behavioral sensitization. In the present study, we examined morphine-induced changes in the 
extracellular concentrations of glutamate and GABA in the ventral tegmental area in alcohol-
preferring Alko Alcohol (AA) and alcohol-avoiding Alko Non-Alcohol (ANA) rats that have 
previously been shown to differ in morphine-induced sensitization. The rats were given escalating 
doses (5-20 mg/kg) of morphine every other day for five days. This treatment produced 
behavioral sensitization to locomotor effects of morphine in AA, but not in ANA rats, when 
challenged with an additional injection of morphine (10 mg/kg) 10 days later. Morphine also 
increased the levels of glutamate in the ventral tegmental area only in AA rats, while no 
significant changes were found in the extracellular concentrations of GABA between the lines. 
Challenging the morphine-treated AA rats with ethanol (1.5 g/kg) did not modify the levels of 
glutamate or GABA. No changes in the concentrations of glutamate or GABA were seen in saline-
treated AA and ANA rats after morphine challenge. These results render increased glutamate 
transmission in the ventral tegmental area a potential contributor to the higher susceptibility of AA 
rats to morphine-induced behavioral and neurochemical effects relative to ANA rats. 
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1. INTRODUCTION 
 
Drugs of abuse induce persistent adaptations, such 
as tolerance and sensitization, in the central nervous 
system. Behavioral sensitization, a progressive and 
long-lasting increase in behavioral and 
neurochemical effects of the drugs, can be seen as a 
model of neuroplastic changes associated with 
addiction (cf. Morgan and Roberts, 2004; Pierce and 
Kalivas, 1997). It has been shown to develop in 
experimental animals after repeated administration of 
various substances including morphine, ethanol and 
psychostimulants, and it is commonly demonstrated 
as an increase in their motor stimulant effects 
(Phillips et al., 1997; Vanderschuren and Kalivas, 
2000).  
 
The mesolimbic dopaminergic system seems to 
have a role in the mediation of reinforcing effects of 
abused drugs, and to be a substrate for 
neuroadaptations associated with repeated 
exposure to them (Anderson and Pierce, 2005; 
Kalivas and Duffy, 1987; Kerns et al., 2005). The 
activity of dopaminergic neurons in the ventral 
tegmental area is modified by excitatory 
glutamatergic afferents from the prefrontal cortex, 
amygdala and tegmental nuclei and inhibitory γ-
amino-butyric acid (GABA) interneurons and 
descending afferents from the nucleus accumbens 
and ventral pallidum (Johnson and North, 1992b; 
Karreman et al., 1996; Steffensen et al., 1998; Xi 
and Stein, 1998). Drugs of abuse share an ability to 
intervene with this system and alter the function of 
the dopaminergic cells either directly or indirectly 
through other neurotransmitter systems (cf. Elliott 
and Beveridge, 2005; Kahlig and Galli, 2003). 
Morphine, for instance, binds to µ-opioid receptors 
on the GABAergic interneurons or on the 
descending GABAergic afferents in the ventral 
tegmental area, and by inhibiting their activity 
disinhibits the dopaminergic neurons (Johnson and 
North, 1992a; Klitenick et al., 1992). 
  
Besides mediating the acute effects of drugs of 
abuse, glutamatergic and GABAergic 
neurotransmission have also been shown to have 
an important role in the adaptations induced by 
their repeated administration. Glutamatergic 
innervations to the dopaminergic cells in the ventral 
tegmental area are probably needed for the 
development of behavioral sensitization to 
psychostimulants and morphine (Vanderschuren 
and Kalivas, 2000; Vezina and Kim, 1999; Wolf, 
1998). GABAergic mechanisms are likewise 
suggested to have a role in the neuroadaptations 
related to opioid-induced motor sensitization and 
reward (Laviolette et al., 2004; Leite-Morris et al., 
2004).  
 
Susceptibility to and intensity of the drug-induced 
behavioral and neurochemical changes differs 
among selectively bred or inbred rodent lines 
(Grahame et al., 2000; Lessov et al., 2001). 
Consequently, selectively bred alcohol-preferring 
AA (Alko Alcohol) and alcohol-avoiding ANA (Alko 
Non-Alcohol) rat lines (Eriksson, 1968) have been 
shown to differ in their susceptibility to morphine-
induced sensitization (Honkanen et al., 1999; 
Mikkola et al., 2002; Ojanen et al., 2003). 
Furthermore, neurochemical and behavioral studies 
have revealed that there are specific differences in 
the opioidergic systems between the two rat lines. 
In addition to showing higher preference for 
ethanol, the AA rats also consume more aqueous 
solutions of µ-opioid receptor agonist, etonitazene, 
than the ANA rats (Hyytiä and Sinclair, 1993). 
Moreover, studies on the distribution of opioid 
receptors, receptor density, opioid propeptide 
mRNA levels, as well as G-protein coupled receptor 
function in various nuclei of the mesolimbic system 
suggest higher opioidergic tone in the AA than ANA 
rats (de Waele et al., 1995; Gianoulakis et al., 
1992; Marinelli et al., 2000; Nylander et al., 1994; 
Soini et al., 2002). Therefore, we have speculated 
that increased susceptibility to morphine-induced 
sensitization in AA rats compared to ANA rats may 
be a reflection of functional differences in their 
opioidergic systems and may further contribute to 
their differential ethanol self-administration behavior 
(Hyytiä and Sinclair, 1993; Ojanen et al., 2005; 
2006). In theory, selection for high and low ethanol 
drinking should have created differences in other 
traits than the selected ones only when they are 
genetically correlated to the selected trait (Sinclair 
et al., 1989). 
 
Considering the possible role tegmental 
glutamatergic and GABAergic innervations have in 
the mediation of the effects of acute and repeated 
administration of morphine, one can speculate that 
the differential sensitivity of AA and ANA rats to the 
locomotor and neurochemical effects of morphine 
may be based on morphine-induced changes in the 
glutamatergic or GABAergic input of the mesolimbic 
dopaminergic neurons on the level of ventral 
tegmental area. The mechanisms involved may 
also contribute to the differences in ethanol intake 
between the lines. The present study sought to 
determine with the help of in vivo microdialysis, if 
repeated administration of morphine produces 
differential changes in the extracellular levels of 
glutamate or GABA in the ventral tegmental area of 
AA and ANA rats after a challenge dose of 
morphine. Since cross-sensitization between the 
locomotor stimulant effects of morphine and those 
of ethanol has been reported (Lessov and Phillips, 
2003; Nestby et al., 1997), we also investigated, if 
an ethanol challenge modifies the extracellular 
levels of glutamate or GABA in AA rats sensitized 
to morphine.  
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2. MATERIALS AND METHODS 
 
2.1 Animals 
 
Male alcohol-preferring AA and alcohol-avoiding 
ANA rats (Alcohol Research Centre, National 
Public Health Institute, Helsinki) from generation 
F84 were used. They were about three months old 
and weighed from 250 to 300 g at the beginning of 
the experiments. The rats were housed in groups of 
four in plastic cages (Macrolon IV, 31 cm x 54 cm x 
19 cm) with free access to food (SDS RM1 (E) 
SQC, Witham, Essex, England) and water. In the 
microdialysis experiments, the animals were 
housed individually in Plexiglas cages (24 cm x 24 
cm x 30 cm) after surgical implantation of the guide 
cannula. Ambient temperature was 22 ± 1 ºC, 
humidity 55 ± 10 % and the light/dark cycle 12/12 h 
(lights on at 0600 hours). A group of 24 rats was 
used to test locomotor activity and 71 rats were 
used in the microdialysis studies. The experiments 
were conducted in accordance with the European 
Communities Council Directive (86/609/EEC), and 
were approved by the Institutional Animal Care and 
Use Committee at the National Public Health 
Institute and the Chief Veterinarian of the County 
Administrative Board. 
 
2.2 Morphine treatment 
 
The rats were injected repeatedly with morphine or 
saline in home cages every other day for five days, 
and challenged with an additional dose of morphine 
or saline ten days after discontinuation of the 
repeated injections. The injections were given 
subcutaneously in a volume of 1 ml/kg. Groups AA 
morphine-morphine (AA-MM) and ANA morphine-
morphine (ANA-MM) received escalating doses of 
morphine (day 1: 5 mg/kg, days 3 and 5: 10 mg/kg, 
days 7 and 9: 20 mg/kg), while groups AA saline-
morphine (AA-SM), ANA saline-morphine (ANA-
SM), AA saline-saline (AA-SS) and ANA saline-
saline (ANA-SS) received an equal number of 
vehicle (0.9 % sodium chloride) injections. Groups 
AA-MM, ANA-MM. AA-SM and ANA-SM were 
challenged with morphine (10 mg/kg) and groups 
AA-SS and ANA-SS with saline. In the ethanol 
experiment, all animals received repeated 
injections of morphine, but animals in group AA-ME 
were challenged with ethanol (1.5 g/kg, 12 % w/v, 
i.p.) and animals in group AA-MS with vehicle (i.p.). 
 
2.3 Locomotor activity 
 
The rats were first familiarized to the measuring 
apparatus in three training sessions during the 
interval between termination of the repeated 
injections and challenging them with morphine. Two 
sessions were carried out without injections and 
one with a vehicle injection. The rats were weighed, 
placed into transparent plastic cages (18 cm x 33 
cm x 15 cm), and left undisturbed for 10 minutes to 
reduce handling-induced activity. After an injection, 
horizontal locomotor activity was recorded for 4 
hours with computer controlled photocells (Cage 
Rack Activity System, San Diego Instruments, CA, 
USA). The session with morphine challenge took 
place ten days after the end of the repeated 
treatment with saline or morphine. Training and 
experiments were conducted in a quiet room 
adjacent to the colony room, where the animals 
were maintained. 
 
2.4 Surgery for microdialysis 
 
Three days after discontinuation of repeated 
morphine or saline injections the rats were 
anaesthetized with halothane (4 % during induction 
for 5 minutes and 1.5–2 % during surgery) and 
attached to the stereotaxic frame for the 
implantation of a guide cannula into the brain. The 
cannula was lowered above the ventral tegmental 
area, angled toward the midline at 11° from the 
vertical to avoid damage to the periaqueductal gray 
area. The coordinates used for the microdialysis 
probe were 5.2 mm posterior to bregma, 0.6 mm 
lateral to midline and 8.4 mm below dura (Paxinos 
and Watson, 1997). The cannula was fastened to 
the skull with three stainless steel screws and 
dental cement. After the surgery, the rats were 
administered buprenorphine (0.05 mg/kg, s.c.) 
once, placed in individual cages, and allowed to 
recover for 7 days. The rats were habituated to the 
experimental procedures by tethering them to a 
counterbalancing arm several times during this 
recovery period. 
 
2.5 Microdialysis 
 
Microdialysis was performed in the home cages. A 
microdialysis probe (CMA/12, membrane length 1 
mm, o.d. 0.5 mm, polycarbonate membrane with a 
20,000-Da cutoff, CMA Microdialysis, Stockholm, 
Sweden) was inserted into the guide cannula at 
1600 hours in the day preceding the experiment 
and was left there without perfusion until the next 
morning. In the morning (at 0700 hours), the rats 
were tethered to the counterbalancing arm and 
modified Ringer solution (147 mM NaCl, 3 mM KCl, 
1.3 mM CaCl2, 1 mM MgCl2 in 0.1 M Na2HPO4, pH 
7.25) was perfused through the probe with a flow 
rate of 1.5 µl/min using a CMA 100 microinjection 
pump. Collection of microdialysis samples (every 
15 min, 22.5 µl/sample) were started one hour after 
turning the flow on with a refrigerated sample 
collector (Univentor 820, Zejtun, Malta). A baseline 
collection (60 minutes, four samples) was followed 
by an injection of morphine, ethanol, or saline, and 
collection of the samples was continued for four 
hours. An aliquot (6 µl) was taken from the vial for 
the determination of glutamate content, while the 
remaining 16.5 µl was used for the determination of 
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GABA content. The samples were stored at -70ºC, 
and were analyzed later.  
 
2.6 Analysis of glutamate and GABA 
 
The concentrations of glutamate and GABA in the 
microdialysis samples were determined with a high 
performance liquid chromatography (HPLC) system 
using fluorescent detection. The system consisted 
of an isocratic pump with a degasser unit and a 
refrigerated autoinjector (Hewlett Packard 1100 
series, Palo Alto, CA, USA), and a multi wavelength 
fluorescence detector (Waters 2475, Milford, MA, 
USA). The detector was equipped with an 8 µl flow-
cell and was operated at maximal excitation 
wavelength of 354 nm and emission at 489 nm. 
The column was a Discovery RP Amide C16, 150 X 
3 mm i.d. with a particle size of 5 µm (Supelco, 
Bellefonte, PA, USA). The concentrations of GABA 
and glutamate were determined in separate runs. 
The mobile phase for glutamate was a 0.3 M acetic 
acid buffer containing 17 % (v/v) acetonitrile and 
0.1 mM ethylenediaminetetra acetic acid (EDTA) at 
pH 5.80, and for GABA a 0.1 M acetic acid buffer 
containing 37 % (v/v) methanol and 0.1 mM EDTA 
at pH 5.36. The flow rate of the mobile phase was 
set to 0.3 ml/min. The microdialysis samples for 
glutamate assay were mixed with 1 µl (reaction 
time 90 s), and those for GABA assay with 2 µl (60 
s) of O-phthalaldehyde-β-mercaptoethanol for pre-
column derivatization. The injection volumes were 
4.5 µl and 15 µl for glutamate and GABA, 
respectively. The chromatograms were acquired 
and processed with Class VP software (v 6.12, 
Schimadzu Corporation, Kyoto, Japan). The raw 
microdialysis data (µM or nM) were converted into 
percentages of the baseline consisting of the mean 
of four baseline samples. The limit of detection for 
glutamate was 20 nM and for GABA 5 nM.  
 
2.7 Histology 
 
The brains fixed in 10 % formalin solution were 
frozen and cut into 100 µm thick coronal sections. 
The positions of the probes were verified by 
microscopic examination of the sections stained 
with thionine. Only the rats where more than 50 % 
of the probe membrane was verified to be in the 
ventral tegmental area were included into the 
results. 
 
2.8 Chemicals and reagents 
 
Morphine-hydrochloride was purchased from 
University Pharmacy (Helsinki, Finland) and was 
dissolved in sterile saline to reach the final 
concentration of 5 - 20 mg/ml. O-phthalaldehyde-β-
mercaptoethanol was obtained from Pickering 
Laboratories (Mountain View, CA, USA). Other 
reagents and solvents were HPLC-quality, and 
were obtained from Sigma-Aldrich Finland Oy 
(Helsinki, Finland) or Merck GmbH (Darmstadt, 
Germany).  
 
2.9 Statistical analysis 
 
The locomotor activity scores and the microdialysis 
data were analyzed with a mixed-design three-way 
analysis of variance (ANOVA) with treatment 
(saline, morphine) and rat line (AA, ANA) as the 
between-subjects factors and measuring interval 
(time) as the within-subjects repeated measure. 
After significant main effects, differences within the 
rat lines were examined with a subsequent 
repeated measures two-way ANOVA. Post hoc 
comparisons between the group means (AA-SS, 
AA-SM, AA-MM, ANA-SS, ANA-SM and ANA-MM) 
were conducted using a Student-Newman-Keuls 
test when appropriate. The statistical analysis on 
the data from the animals challenged with ethanol 
was performed using a two-way ANOVA with 
repeated measures on time and the challenge 
treatment (saline, ethanol) as the between-subjects 
independent variable. The placement of the probes 
was compared between the groups with a 
nonparametric Kruskal-Wallis test. The criterion for 
significance was set at 0.05. 
 
 
3. RESULTS 
 
3.1 Locomotor activity 
 
Following repeated treatment with saline or 
morphine, differential patterns of locomotor activity 
were induced in morphine challenged AA and ANA 
rats [F(23,644) = 3.16, P < 0.001, for time x rat line] 
and treatment [F(23,644) = 4.68, P < 0.001, time x 
treatment] (Fig 1). The separate ANOVAs  
 
 
 
Figure 1. Effect of a challenge dose of morphine (10 mg/kg 
sc) on locomotor activity in AA and ANA rats treated 
repeatedly with morphine (5 – 20 mg/kg, five injections in 
total). * P < 0.05, represents difference from the AA-SM 
group, # P < 0.05, relative to the corresponding group of the 
ANA line. Mean photocell counts per 10 min ± S.E.M. are 
given, n = 8. 
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conducted on the treatments showed that the AA 
rats treated with morphine were sensitized to the 
locomotor-stimulating effects of morphine [F1,14] = 
11.25, P = 0.005], while only a tendency for 
stimulation was seen in the ANA rats [F(1,14) = 
4.30, P = 0.057]. Post hoc comparisons between 
the group means showed that the AA and ANA rats 
injected with saline did not differ in morphine-
induced locomotor activity. 
 
 
 
Figure 2. Effect of a challenge dose of morphine (10 mg/kg 
sc) on the extracellular concentrations of glutamate in the 
ventral tegmental area of AA (A) and ANA (B) rats treated 
repeatedly with morphine (5 – 20 mg/kg). The raw 
microdialysis data were converted into percentages of the 
baseline consisting of the mean of the four baseline 
samples. The data are given as a moving average of three 
consecutive time points ± S.E.M., n = 8 - 11 / group. * P < 
0.05, relative to SM group; # P < 0.05, relative to the 
corresponding group in the ANA line, Student-Newman-
Keuls post hoc comparison. 
 
 
3.2 Extracellular glutamate 
 
Fig 2. shows the effect of morphine challenge on 
the extracellular concentrations of glutamate in the 
ventral tegmental area of AA and ANA rats treated 
repeatedly with morphine or saline. As seen in the 
figure, the glutamate levels in the saline-treated 
animals were not affected by the saline or morphine 
challenge. In the morphine-treated groups the 
effect of the morphine challenge on the 
concentrations of glutamate was significant [F(1,58) 
= 16.85, P < 0.001, for treatment]. The rat lines also 
showed a differential response to the morphine  
challenge [F(15,810) = 2.55, P = 0.001, for time x 
rat line x treatment]. Post hoc analyses revealed 
that the concentration of glutamate was increased 
in the AA-MM rats after the morphine challenge in 
comparison to the both AA-SM rats (P < 0.01) and 
ANA-MM rats (P < 0.05). Basal levels of glutamate 
in the ventral tegmental area were 0.71 µM in AA 
and 0.72 µM in ANA rats with no significant 
differences between the experiments, rat lines or 
treatments. 
 
3.3 Extracellular GABA 
 
Challenging the morphine- or saline-treated AA and 
ANA rats with morphine did not modify the 
extracellular levels of GABA in the ventral 
tegmental area (Fig 3). The basal concentrations of 
GABA were 13.5 nM and 15.5 nM for AA and ANA 
rats, respectively (P = 0.36). 
 
 
 
Figure 3. Effect of a challenge dose of morphine (10 mg/kg 
sc) on the extracellular concentrations of GABA in the 
ventral tegmental area of AA (A) and ANA (B) rats treated 
repeatedly with morphine (5 – 20 mg/kg). The raw 
microdialysis data were converted into percentages of the 
baseline consisting of the mean of the four baseline 
samples. The data are given as a moving average of three 
consecutive time points ± S.E.M., n = 7 - 11 / group. 
 
3.4 Ethanol challenge 
 
As shown in Fig. 4, the challenge with ethanol 
could not significantly modify the levels of 
glutamate or GABA in the AA rats treated 
repeatedly with morphine. 
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Figure 4. Extracellular concentrations of glutamate and 
GABA in the ventral tegmental area of AA rats treated 
repeatedly with morphine and challenged with ethanol 
(group AA-ME). The data are shown as a difference from 
the saline injected controls (group AA-MS). The data are 
given as a moving average of three consecutive time points 
± S.E.M, n = 6 – 7 / group. 
 
 
3.5 Histology 
 
A total of 71 rats (58 rats in the morphine 
experiment and 13 in the ethanol experiment) were 
included in the final data analysis. There were no 
significant differences in the coordinates (AP = 5.3 
± 0.2, L = 0.6 ± 0.3, DV = 8.5 ± 0.4, mean of all rats 
± S.D.) among the groups (P > 0.05, for AP, L and 
DV, Kruskal-Wallis test). 
 
 
4. DISCUSSION 
 
In parallel with our earlier findings, alcohol-
preferring AA rats showed more morphine-induced 
locomotor activity than morphine-treated ANA rats 
after repeated treatment with morphine (Ojanen et 
al., 2003). Since the regimen of morphine 
administration was different from the one used in 
our earlier study and context dependent cues of the 
testing environment were missing in the present 
study, the difference between the lines is not 
specific to the treatment protocol. In contrast to the 
earlier study, where the rats were tested for 
locomotion after every saline injection, the 
difference between the saline-treated AA and ANA 
rats in locomotor activity did not reach significance 
here after an acute dose of morphine.  
 
The AA rats that had been treated repeatedly with 
morphine showed elevated extracellular 
concentrations of glutamate after the challenge 
injection of morphine, while similarly treated ANA 
rats did not. This shows that besides differing in 
their sensitivity to morphine-induced locomotor 
sensitization and dopamine release after repeated 
treatment with morphine (Ojanen et al., 2003), AA 
and ANA rat lines also differ in their sensitivity to 
the effects of repeated administration of morphine 
on glutamatergic transmission, and suggests that 
glutamatergic mechanisms are involved in the 
higher susceptibility to morphine-induced 
behavioral sensitization in AA rats relative to ANA 
rats.  
 
Morphine-induced increase in the level of glutamate 
in AA rats seen in the present study is consistent 
with earlier findings showing enhanced drug-
induced glutamate levels in the ventral tegmental 
area after intermittent administration of 
amphetamine or cocaine (Kalivas and Duffy, 1998; 
Xue et al., 1996). A possible explanation for this 
effect is given by Carlezon and Nestler, (2002). 
Drugs of abuse have been shown to enhance the 
extracellular levels of dopamine in both the nucleus 
accumbens and ventral tegmental area. In the 
ventral tegmental area, this could lead to 
stimulation of dopamine D1 receptors on excitatory 
glutamatergic neurons and enhanced glutamate 
release, which in turn result in activation of α-
amino-3-hydroxy-5-methyl-isoxazole propionate 
(AMPA) and N-methyl-D-aspartate (NMDA) 
receptors on dopaminergic or other neurons. 
Repeated exposure to drugs leads then to specific 
alterations within the ventral tegmental area, 
including changes in glutamate receptor subunits. 
These alterations coincide with potentiation of drug-
induced increases in dopamine and glutamate 
levels, and contribute to behavioral sensitization 
(Carlezon and Nestler, 2002). Supporting this 
hypothesis, blocking the dopamine D1 receptors 
attenuates cocaine- or amphetamine-induced 
increase in the glutamate levels and the 
development of behavioral sensitization (Giorgetti 
et al., 2002; Kalivas and Duffy, 1998; Vezina and 
Stewart, 1989; Wolf and Xue, 1998). The findings 
on the role of dopamine D1 receptors in 
sensitization to morphine are not, however, equally 
consistent. While the dopamine D1 receptor 
antagonist SCH-23390 diminishes the expression 
of sensitization to morphine, it does not block the 
development of sensitization induced by morphine 
administered systemically or directly into the ventral 
tegmental area (Jeziorski and White, 1995; Vezina 
and Stewart, 1989).  
 
The mechanisms underlying the insensitivity of 
ANA rats to the effect of repeated administration of 
morphine on morphine-induced increase in 
locomotion and in the levels of glutamate are not 
clear. Opioids enhance the extracellular levels of 
dopamine in both the nucleus accumbens and 
ventral tegmental area probably by binding to µ-
opioid receptors on GABAergic interneurons or 
afferents thereby disinhibiting mesolimbic 
dopaminergic neurons (Johnson and North, 1992a; 
Klitenick et al., 1992). Taken the higher density of µ 
opioid receptors and opioid propeptide mRNA 
levels in several brain areas in AA rats relative to 
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ANA rats (Marinelli et al., 2000), one may speculate 
that higher opioidergic tone in AA rats might 
account for the difference in the effects of 
morphine. Administration of morphine to AA rats 
would possibly result in enhanced morphine-
induced suppression in the levels of GABA in the 
ventral tegmental area relative to ANA rats, which 
in turn might trigger differential adaptation to 
repeated exposure to morphine between AAs and 
ANAs. In line of this view, we previously found that 
morphine, if given 7 days after discontinuation of 
repeated treatment with morphine, also induces 
enhanced release of dopamine in the nucleus 
accumbens of AA but not in that of ANA rats 
(Ojanen et al., 2003). The augmented increase in 
the levels of dopamine was not seen, however, in 
the AA rats challenged with morphine five weeks 
after discontinuation of the repeated treatment with 
morphine, although similarly treated animals still 
showed behavioral sensitization. Whether this is 
true also for the levels of glutamate in the ventral 
tegmental area is not known, since in the present 
study the animals were challenged with morphine 
only at 10 days after discontinuation of the 
morphine treatment.  
 
The involvement of GABAergic mechanisms in the 
differential susceptibility of AA and ANA rats to the 
effects of repeated morphine remains an open 
question. In the present study, a challenge dose of 
morphine did not affect the extracellular levels of 
GABA in the ventral tegmental area. In contrast, a 
study by Klitenick et al., (1992) showed a reduction 
in the levels of GABA when morphine was 
administered through a dialysis probe directly into 
the ventral tegmental area. Nevertheless, we 
administered here morphine systemically and it is 
possible that morphine-induced effects in other 
neurotransmitter systems or brain areas could have 
masked the effect of morphine on GABA levels in 
the ventral tegmental area. Alternatively, as has 
been pointed out by others, there may be problems 
in detecting subtle changes in amino acid levels 
with in vivo microdialysis technique (Wolf and Xue, 
1998), possibly because a portion of amino acids in 
the extracellular space is derived from sources that 
are not directly involved in neurotransmission 
(Frantz et al., 2002). This, however, does not 
necessarily argue against the functional 
significance of changes in the extracellular amino 
acid levels in the brain (Nyitrai et al., 2006).   
 
Challenging the morphine-treated AA rats with 
ethanol produced no changes in the levels of 
glutamate or GABA in the ventral tegmental area. 
This experiment was conducted, because activation 
of µ-opioid receptors may have a role in ethanol-
induced locomotor activity and behavioral 
sensitization (Pastor and Aragon, 2005; Pastor et 
al., 2005; Sanchis-Segura et al., 2004), and cross-
sensitization between the locomotor stimulant 
effects of ethanol and those of morphine has been 
reported (Lessov and Phillips, 2003; Nestby et al., 
1997; Ojanen et al., 2006). Furthermore, morphine-
treated AA rats show enhanced morphine-induced 
ethanol intake (Ojanen et al., 2006).  
 
Augmented morphine-induced increase in the 
tegmental levels of glutamate found here in AA rats 
relative to ANA rats may help to understand the 
differential susceptibility to behavioral sensitization 
between the lines. This can be speculated to 
produce more stimulation of mesolimbic 
dopaminergic neurons and locomotor activity in AA 
rats than in ANA rats. The two findings may, 
however, not be causally related. Since our earlier 
findings suggested that the role of mesolimbic 
dopaminergic mechanisms are probably only 
transient in the expression of opioid-induced 
behavioral sensitization, the effect of enhanced 
glutamate release on locomotion may be mediated 
through dopamine independent mechanisms 
(Ojanen et al., 2003). A divergent, multi-structural 
origin of opioid effects is suggested by studies 
showing that the reinforcing and stimulatory 
properties of opiates are not mediated exclusively 
by the mesolimbic dopaminergic system 
(Piepponen et al., 2002; Sotomayor et al., 2005). 
Direct non-dopaminergic connections between 
ventral tegmental area, nucleus accumbens and 
areas like ventral pallidum are also potentially 
important in the adaptations induced by repeated 
administration of morphine (Caille and Parsons, 
2004; Hubner and Koob, 1990; Kalivas et al., 
1983). Antagonist of µ opioid-receptors injected 
directly into the ventral pallidum can block the 
development of sensitization to morphine 
suggesting an important role for the ventral 
pallidum in psychomotor stimulant and reinforcing 
effects of opioids (Bardo, 1998; Pierce and Kalivas, 
1997; Xi and Stein, 2000), and that self-
administration of heroin by rats decreases GABA 
efflux and onsets a late glutamate efflux in the 
ventral pallidum (Johnson and Napier, 2000). Since 
the levels of glutamate and GABA were measured 
here neither in the nucleus accumbens nor ventral 
pallidum, the effects of morphine administration on 
the concentrations of amino acids in these areas 
are not known, and a divergent explanation for the 
present results cannot be provided. 
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